Neuroimaging, Cognitive and Metabolic Profiles in Children with Hypoglycaemia by Kumaran, A
1  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Neuroimaging, cognitive and metabolic profiles in 
children with hypoglycaemia 
 
 
A thesis submitted by 
 
 
 
 
 
 
Dr Anitha Kumaran 
 
 
 
 
 
 
 
 
For the degree of Doctor of Philosophy in University College London 
 
 
 
 
 
 
Clinical and Molecular Genetics Unit 
Institute of Child Health  
University College London 
 
 
November 2012 
2  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I, Anitha Kumaran, confirm that the work presented in this 
thesis is my own. Any informatiom and contribution derived 
from other sources and persons have been indicated in the 
thesis. 
3  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I dedicate this thesis to my mother for her unconditional 
love and support that has encouraged and inspired me 
– thank you Amma. 
4  
 
 
 
 
Acknowledgments 
 
 
My sincere thanks to: 
 
 
 
Dr Khalid Hussain, for giving me this excellent opportunity. I am grateful for your 
guidance and encouragement throughout the period of my study. Thank you also for 
your patience and support in writing this thesis. 
 
 
Professor Peter Hindmarsh for his supervision and advice especially with the statistical 
aspects of this study. 
 
 
Professor  Gadian,  Professor  Khadem  and  Dr.Chris  Clark  for  their  expertise  and 
valuable guidance on the cognitive and quantitative imaging aspects of my studies. 
 
 
Dr Kling Chong for reviewing all the scans and Kiran Seunarine for teaching me the 
intricacies of DTI analysis 
 
 
Great Ormond Street Hospital charity, for sponsoring this study and the children and 
parents who participated in this study 
 
 
My friends and colleagues Raja Padidela and Ritika Kapoor for the good times, their 
support and advice and Emma Webb for her input regarding several aspects of the 
imaging studies 
 
 
Jemima Bullock for her friendship and her attempts to demystify cognitive 
neuroscience over several cups of flat white! 
 
 
My husband Vijay for being a rock of support and his sense of perspective (‘Have you 
found anything yet”?), that has kept me focused! I am also indebted to my in-laws 
for their enthusiasm and support and above all to my 17 month old son Ashvath for his 
smiles and unconditional love that constantly rejuvenated me. 
5  
 
Abstract 
 
Background: Glucose is a major fuel for brain function, and persistent and recurrent 
hypoglycaemia of any aetiology can cause brain injury. Children with hyperinsulinaemic 
hypoglycaemia (HH) are at a high risk of brain injury, as the inappropriate secretion of 
insulin during hypoglycaemia inhibits lipolysis thereby reducing the availability of ketone 
bodies (KB) that are an important source of alternate fuel for the brain during 
hypoglycaemia. 
In contrast children with ketotic hypoglycaemia (KH) are believed to be neurologically 
protected,  due  to  the presence  of  abundant  ketone  bodies  during  hypoglycaemia. 
However, in both these groups of children, a comprehensive assessment of the 
neurocognitive profile with correlation to neuroimaging is not available. 
 
 
Aims: The aims of this thesis are  
1. To understand the magnitude and rate of ketone body response during a diagnostic 
fast between children with KH and a ‘control’ group (children with suspected or 
previous history of hypoglycaemia that were subsequently normoglycaemic on the 
diagnostic fast).   
2. To investigate and compare the neurocognitive profiles of children with HH and 
KH (used as a control group), and to correlate the profile of deficits in the HH 
group to the underlying structural abnormalities. 
The studies on children with KH (biochemical, neurocognitive and neuroimaging) were 
utilised to understand the neuroprotective role of KB during hypoglycaemia. 
 
 
Methods: 30 children with KH and 74 children from the ‘control’ group underwent a 
diagnostic fast with measurements of plasma glucose, lactate, catecholamines and 
serum  insulin,  cortisol,  growth  hormone,  non-esterified  fatty  acids  (NEFA)  and  3- 
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βhydroxybutyrate (ketone body) concentrations at the beginning, middle and end of 
fast. 
The neurocognitive profile of 21 children with HH was compared to a group of 14 
children with KH, using a combination of standardised tests to investigate IQ, memory, 
attention, academic attainment, movement, emotion and behaviour. The structural 
integrity of the brain was evaluated using conventional neuroradiological assessments, 
hippocampal volumetry and diffusion tensor imaging (DTI). 
 
 
 
Results: Fasting studies have shown that children with KH demonstrate a significant 
increase (87% per hour) in the rate and magnitude of 3-βhydroxybutyrate 
concentrations relative to ‘controls’.  Cortisol concentrations are a significant predictor 
of KB concentrations at the end of the fast. The performance of KH children as a group 
was within the normal range for the neurocognitive measures.  However four children  in 
the  KH  group  scored  in  the borderline (77-79) and low average range (81-84) for full 
scale IQ, and memory scores in one KH child was lower than predicted by 19 points. 
Neuroimaging revealed small hippocampi in one child, focal white matter lesions in two 
children and diffuse white matter lesions in two children with KH. 
 
Children with HH underperformed significantly (relative to KH and standard population 
means) in the tests for intelligence (especially perceptual reasoning), memory, and 
sustained attention and manual dexterity. Memory impairments in children with HH did 
not correlate with hippocampal pathology. 
However, analysis of DTI studies has revealed the presence of white matter 
microstructural deficits that correlate with IQ and perceptual reasoning indices in 
these (HH) children. The genu and splenium of the corpus callosum were highlighted as 
specific white matter regions vulnerable to injury in the HH group. 
 
 
Conclusions: Children with hypoglycaemia are at risk of white matter injury. Children 
with HH manifest widespread cognitive deficits that are partly explained by the white 
matter microstructural deficits noted in the DTI studies. The increased rate and 
magnitude of KB response in KH group during fasting supports increased metabolic 
utilisation and a glucose sparing effect. However some chidren with KH in this study 
exhibit white matter injury and a wide variation in the neurocognitive scores is also 
noted, indicating the presence of neurocognitive impairment in certain children with KH. 
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1 Maintenance of glucose homeostasis 
 
 
1.1 Introduction 
 
 
A constant supply of glucose is critical for the organs that are obligate glucose users, 
such as the brain (Amiel et al., 1995). Blood glucose concentrations are 
maintained in a steady state despite wide variations in diet, physical activity, and 
periods of starvation (Rizza et al., 1980; Wahren et al., 1978; Consoli et al., 1987). This 
is achieved by a balance between glucose production and utilisation, mediated by a 
complex interaction between insulin and a counterregulatory neuro-hormonal system 
comprising of glucagon, catecholamines, cortisol and growth hormone (GH). 
 
 
Insulin decreases glucose production and increases glucose utilisation, whereas 
glucagon, catecholamines, cortisol and GH increase glucose production and decrease 
glucose utilisation (Bolli et al., 1999). Any factor that disrupts this balance will lead to 
hypoglycaemia (Figure 1). 
 
 
 
 
 
 
Figure 1 The effects of insulin, GH, cortisol, glucagon and catecholamines on 
maintenance of glucose homeostasis. Insulin lowers blood glucose concentrations 
while the actions of glucagon, GH, cortisol and catecholamines result in an elevation of 
blood glucose concentrations. 
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1.2 Glucose production 
 
 
In the fed state, glucose is mainly derived from dietary carbohydrates. 
 
 
 
In the fasted state blood glucose concentrations are maintained  by mobilizing glycogen 
stores from the liver (glycogenolysis), or production of glucose from non-carbohydrate 
sources known as gluconeogenesis (liver and kidney) (Cersosimo et al., 2000) 
 
 
Glycogenolysis is a process that involves breakdown of glycogen to produce glucose. 
Liver, kidneys and muscle store glycogen. During fasting glycogen is converted to 
glucose-1-phosphate and glucose-6-phosphate by glycogen phosphorylase and 
phosphoglucomutase respectively. 
 
 
Glucose-6-phosphatase then converts glucose-6-phosphate to free glucose. Due to the 
high glycogen content and presence of glucose-6-phosphatase, liver is the main organ 
that contributes to glycogenolysis, in comparison to muscle and the kidney that have 
only small quantities of stored glycogen. In addition muscle lacks glucose-6-
phosphatase required to release glucose into circulation. 
 
 
When sufficient energy (ATP) is available, excess glucose is converted to glycogen by 
glycogen synthase and stored (glycogenesis). This balance between glycogenesis and 
glycogenolysis is regulated by insulin (favours glycogenesis) and glucagon (favours 
glycogenolysis). Insulin activates glycogen synthase (Larner et al., 1988) and inactivates 
the enzyme glycogen phosphorylase that causes glycogenolysis (Cohen et al., 1985) 
 23 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gluconeogenesis is the production of glucose from non-carbohydrate sources. The 
main substrates for gluconeogenesis are pyruvate, lactate, glycerol and glucogenic 
amino acids alanine and glutamine. 
 
 
In gluconeogenesis the crucial steps are the conversion of pyruvate to oxaloacetate and 
to phosphoenol pyruvate and the conversion of fructose-1, 6-biphosphate to fructose-6- 
biphosphate (rate limiting step in gluconeogenesis). The ultimate step is conversion of 
glucose-6-phosphate to glucose. 
 
 
In healthy adults gluconeogenesis contributes to 50% of glucose production after an 
overnight fast and nearly all glucose production after 42 hours (Landau et al., 1996). In 
comparison to adults, children have limited glycogen stores that sustain blood glucose 
concentrations for only 12 -16 hours, beyond that period gluconeogenesis becomes 
important (Chaussain et al., 1977; Jahoor et al., 1990).
Glycogen 
Glucose-6-phosphate 
Glucose 
Glycogen  
phosphorylase 
Glycogen 
 synthase 
  
 
Insulin 
 
Glucagon 
 
Figure 2 Glycogenesis and glycogenolysis. Insulin favours glycogenesis and glucagon 
favours glycogenolysis 
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Based  on  glucose  production  following  glucagon  injection  after  a  24  hour  fast  in 
children, Chaussain et al were able to show a wide variability in liver glycogen reserves 
and its mobilization during starvation (Chaussain et al., 1974). Following a 30 hour fast 
gluconeogenic substrates (alanine) and glucose concentrations were low in children in 
comparison to adults (Haymond et al., 1982). 
 
The brain is the principal consumer of glucose (Amiel et al., 1995) and as children 
have greater brain to bodyweight ratio, they have higher glucose production rates in 
comparison to adults (Bier et al., 1977; Huidekoper et al., 2008). Accordingly 
endogenous glucose production has also been shown to decrease with age (Bier et al., 
1977). 
 
 
 
Renal contribution to glucose homeostasis 
 
Traditionally the liver was assumed to be the key site of gluconeogenesis, with an 
insignificant contribution from the kidneys (Aber et al., 1966; Bjorkman et al., 1980; 
Castellino et al., 1990). It is now known that, following an overnight fast the kidney 
contributes to 20-25% of the glucose released into the circulation (Consoli et al., 1987; 
Moller et al., 2001; Ekberg et al., 1999). 
 
 
The renal medulla is the site of glucose utilisation as it contains glycolytic enzymes, 
whereas glucose production is a function of the renal cortex that contains 
gluoneogeogenic enzymes (Guder & Ross et al., 1984). Renal gluconeogenesis is 
inhibited by insulin and stimulated by catecholamines, as epinephrine infusion rather 
than glucagon infusion during hypoglycaemia was associated with increased and 
sustained glucose release (Stumvoll et al., 1998; Stumvoll et al., 1995). 
 
 
Stumvoll et al have demonstrated that in healthy adult humans, the renal contribution to 
systemic glucose release increases twofold in response to epinephrine infusion 
(Stumvoll et al., 1995).
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In the postprandial state, hepatorenal glucose reciprocity exists whereby a reduction in 
the hepatic glucose production is compensated by a twofold increase in renal 
gluconeogenesis (Meyer et al., 2002). This hepatorenal glucose reciprocity is thought to 
enable   replenishment   of   hepatic   glycogen   stores   and   also   maintain   glucose 
homeostasis in certain pathological and physiological conditions such as prolonged 
fasting, liver transplantation and acidosis (Gerich 2002). 
 
In addition kidneys also contribute to glucose homeostasis by reabsorbing glucose from 
the proximal convoluted tubules through the sodium glucose transporters (SGLT’s) 
(Wright et al., 2001). 
 
 
1.3 Glucose Utilisation 
 
 
Glucose is utilised by all tissues. Insulin contributes to glucose utilisation by promoting 
peripheral uptake of glucose, promoting glycogenesis and inhibiting lipolysis and 
ketogenesis. Increased blood glucose concentrations in the postprandial state are 
sensed by the β-cell, resulting in increased insulin secretion. Binding of insulin to its 
receptor  in  the  peripheral  tissues  causes  up  regulation  of  glucose  transporters 
(synthesis and mobilisation to cell surface) (Thorens et al., 1996) and enables tissue 
uptake of glucose. 
 
 
Following a meal, the rate of gastric emptying also influences the circulating glucose 
concentrations. Mixed meals (carbohydrate combined with protein and fat), decrease 
gastric emptying and stimulate the production of incretins (hormones produced by the 
gut), thereby lowering postprandial glucose concentrations (Rayner et al., 2001) 
(Horowitz et al., 1993). 
 
 
Glucose  is  transported  into  the  cells  by  a  process  of  carrier  mediated  facilitated 
diffusion. The carriers are a group of proteins known as glucose transporters (GLUT). 
Fourteen glucose transporters have been discovered in humans (Thorens  et al., 2010), 
but the most well described are the glucose transporters GLUT 1-5 that are crucial for 
glucose utilisation and each of them have a specific tissue distribution and function.
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GLUT1 and GLUT3 are distributed in all the tissues including the nervous system and 
glucose transport is insulin independent (Thorens et al., 1996). As they have a high 
affinity for glucose they transport glucose readily and are crucial in ensuring a constant 
glucose supply to brain. 
 
GLUT 2 is an insulin independent transporter located in the liver, small intestine, kidney 
and pancreatic β-cells (Bell et al., 1991). They have a high capacity but low 
affinity for glucose and function as glucose sensors (Matschinsky et al., 1996). GLUT 4 
is an insulin dependent glucose transporter present in the muscle, heart and adipose 
tissue (James et al., 1989), while GLUT 5 is a fructose transporter in the jejunal brush 
border (Thorens et al., 1996) 
 
 
 
Another family of sodium dependent glucose transporters (SGLT) enable energy 
dependent glucose uptake. They are predominantly located in the luminal surface of the 
small intestine (SGLT-1) and the proximal renal tubule of the kidney (SGLT2) (Wright 
et al., 2001). 
 
 
 
Following uptake glucose can undergo glycolysis to generate ATP and/or be stored as 
glycogen or fat. Glucose uptake by tissues also depends on the availability of plasma 
glucose, glycaemic state (fed or fasted), presence of alternate substrates, tissue 
requirements and sensitivity for insulin (Kelley et al., 1988).
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Figure 3 Glucose production and utilisation. Adapted from Zijlmans et al., 2009  
 
(Edited) 
 
 
 
 
 
 
 
 
Role of gut hormones in glucose homeostasis 
 
 
 
A multimodal mechanism of glucose regulation has emerged following the discovery of 
several hormones released by the gut and elucidation of their impact on blood glucose 
concentrations. 
 
 
Incretin hormones: Glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide 
(GIP) are the principal incretin hormones produced by the enteric mucosa cells (L and K 
cells) following a meal. They stimulate insulin secretion and are responsible for the 
increase  in  plasma  insulin  response  to an  oral  glucose  load  in  comparison  to  an 
intravenous  glucose  load  (incretin  effect)  (Perley  et  al.,  1967).  GLP-1 also delays 
gastric emptying, inhibits glucagon secretion, promotes satiety and aids weight loss 
(Baggio et al., 2007).
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Ghrelin is secreted by the cells in the fundus of the human stomach and acts via 
growth hormone secretagogue receptor (GHSR) (Kojima et al., 1999). Ghrelin 
concentrations have been shown to increase prior to a meal and reduce following a 
meal (Ariyasu et al., 2001; Cummings et al., 2001). It is a potent stimulator of GH 
secretion (Takaya et al., 2000), increases secretion of ACTH, cortisol, epinephrine 
(Takaya et al., 2000; Nagaya et al., 2001), and increases appetite via action on the 
hypothalamus (Kamegai et al., 2001). Human studies have also shown a direct effect of 
ghrelin in inducing glycogenolysis following intravenous infusion of ghrelin (Broglio et 
al., 2001). 
 
 
Amylin is a neuroendocrine hormone, co-secreted with insulin by the pancreatic β-
cell. It enhances the actions of insulin by suppressing post-prandial glucagon 
secretion (Gedulin et al, 1997). Amylin also slows gastric emptying (Samsom et al., 
2000) and has been shown in animal models to reduce food intake and body weight 
(Bhavsar et al., 1998; Rushing et al., 2001; Rushing et al., 2000). 
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2 Metabolic adaptation to birth, fasting and ketone body 
production 
 
 
2.1  Introduction 
 
 
Newborns are vulnerable to hypoglycaemia due to the massive metabolic adaptation 
required to transition from a metabolically dependent fetus to an independent neonate. 
Maturity of the enzymes involved in glucose homeostasis, appropriate hormonal 
changes, adequate storage reserves, presence of alternate fuels are all important for a 
smooth transition to postnatal life (Ward et al.,  2005). 
 
 
Similarly children have a limited capacity to fast in comparison to adults and any 
maladaptation to fasting renders them susceptible to hypoglycaemia in times of 
metabolic stress such as illness or prolonged fasting (Zijlmans et al., 2009). 
 
2.2  Fetal glucose metabolism 
 
 
In utero the fetus is exposed to a continuous glucose supply via a carrier mediated 
facilitated diffusion across the placenta (Hay et al., 2006). The fetal glucose 
concentrations are a direct reflection of maternal glucose concentrations (Mitanchez et 
al., 2007). Under physiological conditions  the fetus  produces  only  minimal  amounts  
of  glucose  and  fetal  glucose homeostasis is characterised by high plasma insulin 
concentrations (which stimulates anabolism and glycogen deposition) and low glucagon 
concentrations. 
 
 
However, during prolonged reduced glucose supply, animal studies have shown the 
ability of the fetus to maintain glucose homeostasis by initiating glycogenolysis and 
gluconeogenesis at the expense of growth (Van Veen et al., 1987; Carver et al., 1997). 
The fetal brain adapts to chronic hypoglycaemia by modulating glucose transporters 
(increasing GLUT1 and decreasing GLUT3), to promote glucose uptake by the brain 
(Das et al., 1999). 
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2.3  Metabolic adaptation to birth 
 
 
Umbilical venous glucose concentration at birth (4.6 mmol/l range 3.7-5.5 mmol/l) is 
nearly 70% of maternal glucose concentration (Creery et al., 1953). The postnatal 
period is characterised by a fall in the blood glucose concentrations (1.3 -1.5 mmol/l) 
during the first 2 hours of life, that stabilises to 3-4 mmol/l by 3-72 hours of life (Tanzer 
et al., 1997; Hawdon et al., 1992; Srinivasan et al., 1986). The fall in blood glucose 
concentrations are well tolerated without any symptoms or long term dysfunction 
probably due to the presence of alternative fuels for the brain such as ketone bodies 
and lactate (Hawdon et al., 1992) and a compensatory increase in cerebral blood flow 
(Anwar & Vannucci et al., 1988). 
 
 
Following   birth   there   is   a   prominent   surge   in   catecholamine   and   glucagon 
concentrations (Girard et al., 1990). The catecholamine surge is secondary to increased 
fetal catecholamine secretion rather than maternal placental transfer (Padbury et al., 
1982). 
 
 
The surge in glucagon concentrations occur within minutes to hours of birth (Sperling et 
al., 1984). The rise in glucagon is coupled with the upregulation of glucagon receptors, 
fall in insulin concentration and downregulation of the insulin receptors. The insulin 
response to glucose also remains blunted for several days. The resultant decreased 
insulin: glucagon ratio decreases activity of glycogen synthase and stimulates glycogen 
phosphorylase thus inhibiting glycogen synthesis and promoting glycogenolysis 
(Sperling et al., 1984; Ktorza et al., 1985). 
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Glycogenolysis is the initial primary pathway of glucose production which is exhausted 
within a few hours; later contribution by gluconeogenesis is derived from lactate, 
pyruvate and alanine. The capacity for gluconeogeneis is not fully developed at birth. 
The rate limiting enzyme in gluconeogenesis, phosphoenolpyruvate carboxykinase 
(PEPCK) is activated by the reduced insulin: glucagon ratio and the infants are capable 
of gluconeogenesis by 4-6 hours of age, although actual maturation of the enzyme 
activity to adult levels can take up to 2 weeks (Girard et al., 1990; Girard et al., 
1986). Lipolysis and fatty acid oxidation are induced by the elevated concentrations of 
catecholamines, thyroid stimulating hormone (Marcus et al., 1988) and cortisol and 
decreased insulin concentrations. 
 
 
Alternate  fuels  such  as  ketone  bodies  and  lactate  are  extremely  valuable  in  the 
newborn period as they spare glucose for cerebral utilisation. Although hepatic 
ketogenesis is limited at birth, there is a significant increase during the first 24 hours 
following birth. High ketone body concentrations comparable to adult concentrations 
after several days of fasting are seen from 12 hours of life and continue to be high 
during the first 3 days of life (Hawdon et al., 1992; Bougneres et al., 1986). Enteral 
feeding also promotes ketogenesis by providing substrates other than glucose to the 
liver and the carnitine content of milk facilitates hepatic uptake and metabolism of fatty 
acids (Hawdon et al., 1992). 
 
 
Glucose transporters (GLUT) also play a key role in postnatal adaptation. During the 
immediate postnatal period there is a predominance of GLUT1 in all tissues. As GLUT1 
is a high affinity glucose transporter it increases tissue availability of glucose (Mena et 
al., 2001; Nualart et al., 1999). GLUT 1 gradually decreases after birth, and is replaced 
by specific isoforms in each tissue (Postic et al., 1994). 
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2.4  Metabolic adaptation to fasting 
 
 
In the fasted state glucose homeostasis is maintained by a combination of 
glycogenolysis, gluconeogenesis and lipolysis (Figure 3). The interplay between insulin 
and counterregulatory hormones cortisol, glucagon, epinephrine and GH is crucial for 
these metabolic pathways in the fed and fasted state. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Glucose 
Glycogen 
pyruvate 
Acetyl-CoA 
lactate 
alanine 
glycogenesis glycogenolysis 
gluconeogenesis 
Triglycerides 
Glycerol + NEFA 
β-oxidation 
Ketone bodies 
ketogenesis 
 
lipolysis 
 
Krebs 
cycle 
glycolysis 
Figure 3 Integration of carbohydrate, lipid and protein metabolism during fasting. The pathways 
active during fasting are highlighted in red. During the initial period of fasting, glycogenolysis 
maintains blood glucose concentrations, as fasting progresses gluconeogenesis and lipolysis 
play a greater role. Non- esterified fatty acids (NEFA) and ketone bodies generated following 
lipolysis act as alternate fuels for liver, skeletal and cardiac muscle and the brain (ketones only) 
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Glucagon facilitates glycogenolysis while insulin suppresses endogenous glucose 
production, enhances peripheral uptake of glucose, promotes glycogenesis and inhibits 
lipolysis and proteolysis. During the initial period of fasting, the fall in insulin 
concentrations and increase in glucagon concentrations promote glycogenolysis 
Catecholamines reduce peripheral glucose uptake, induce glycogenolysis, 
gluconeogenesis and lipolysis, while growth hormone and cortisol play a permissive 
role and regulate peripheral tissue sensitivity to insulin and glucagon 
 
 
The gluconeogenic amino acids are converted to pyruvate and enter the citric acid 
cycle. Hormone sensitive lipase, activated by glucagon, cortisol and epinephrine is an 
important step in mobilisation of fatty acids (Murray et al., 1996). Lipolysis also provides 
glycerol that can be utilised in gluconeogenesis (Jensen et al., 1987). Glycerol is 
transported to the liver and converted to glucose via glycerol-3- phosphate (Herrera et 
al., 2000). In the liver, β-oxidation of fatty acids results in production of ketone bodies 
that are released in to the circulation for peripheral uptake of sensitive tissues. 
 
 
 
 
 
2.5  Ketone body production 
 
 
Glucose is the major fuel for brain function but it can adapt to using ketone 
bodies, namely acetoacetate and 3-βhydroxybutyrate during starvation (Owen et al.,  
1967;  Patel et al., 1975). Thus the presence of ketone bodies during hypoglycaemia 
has a cerebroprotective effect. Ketone bodies are always present in the blood but 
increase as a   normal   physiological   response   during   exercise,   starvation, in the 
neonatal   period, pregnancy and high fat diet (Nordli, Jr. et al., 2001; Bonnefont et al., 
1990; Huttenlocher et al., 1976). 
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Ketogenesis begins with adipocyte lipolysis (breakdown of triglycerides into free fatty 
acids and glycerol) by hormone sensitive lipase (HSL). HSL induced lipolysis comes 
into play during fasting, stress and exercise. Under basal conditions non hormone 
dependent lipase ensures lipolysis. The free fatty acids travel to liver bound to albumin, 
to undergo β-oxidation to acetyl-CoA followed by synthesis of ketone bodies (Laffel et 
al., 1995). 
 
 
 
 
Figure 4  Ketone body production. Adipocyte lipolysis by hormone sensitive lipase (HSL), 
releases non-esterified fatty acids (NEFA). β-oxidation of fatty acids in hepatic mitochondria 
leads to generation of ketone bodies. Insulin inhibits HSL, while catecholamines, growth 
hormone (GH) and cortisol activate HSL
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Thus ketone bodies are derived from β-oxidation of fatty acids or from ketogenic amino 
acids such as leucine, lysine, and tryptophan in the liver (Mitchell et al., 1995). The key 
substrates for ketogenesis are medium and long chain fatty acids and to a minor extent 
ketogenic amino acids. β-oxidation of fatty acids in hepatic mitochondria result in 
production of 2 carbon unit acetyl-CoA. This is then converted into acetoacetate by 
covalent linkage of the two acetyl groups facilitated by  the  enzymes  thiolase,  3-
hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthase and HMG-CoA lyase. Acetoacetate 
can be further reduced to 3- βhydroxybutyrate by βhydroxybutyrate dehydrogenase 
(Figure 6). 
 
 
Acetoacetate and 3-βhydroxybutyrate are the principal  ketone  bodies.  Acetone is 
another ketone body that is produced in small quantities by spontaneous slow 
decarboxylation of acetoacetate. While acetoacetate and βhydroxybutyrate enter 
peripheral circulation to be utilised by sensitive tissues as energy source (Fukao et al., 
2004), acetone is exhaled. 
 
 
 
                   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acetyl-CoA + Acetyl-CoA 
Acetoacetyl-CoA 
HMG-CoA 
Acetoacetate 
Acetone β-hydroxybutyrate 
β-ketothiolase 
 
HMG-CoA lyase 
HMG-CoA 
synthase 
βhydroxybutyrate  dehydrogenase  
Figure 5 Ketogenesis. Acetyl-CoA is converted into acetoacetate by covalent linkage of the two 
acetyl groups facilitated by the enzymes thiolase, 3-hydroxy-3-methylglutaryl- CoA (HMG-CoA) 
synthase and HMG-CoA lyase. Acetoacetate can be further reduced to β-hydroxybutyrate by β-
hydroxybutyrate  dehydrogenase  or  decarboxylated  to acetone. 
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Regulation of ketogenesis  
 
          The key steps in the the regulation of ketogenesis (Laffel et al., 1999) are: 
 
1. Provision of substrate (FFA) for ketogenesis by lipolysis of triglycerides. 
 
Slavin  et  al  (Slavin  et  al.,  1990)  using  rat  adipocytes  were  able  to  show  that 
epinephrine, dexamethasone, GH and glucagon increase HSL activity and promote 
ketogenesis. They do so by phosphorylating HSL via cyclic AMP dependent protein 
kinase pathway (Yeaman et al., 1990). Insulin supresses HSL activity by HSL 
dephosphorylation (Shakur et al., 2001). 
 
In adult humans only catecholamines have been shown to cause lipolysis, mediated 
via β adrenoreceptors (Bjorntorp et al., 1977). In-vitro studies investigating the  effects  
of  various  hormones  on  human  adipocyte  cells,  has  shown  thyroid stimulating 
hormone to be the main mediator of lipolysis in the neonatal period. A gradual 
increase in the contribution of catecholamines to lipolysis was seen with increasing age 
in older children (Marcus et al., 1988). 
 
2. The next crucial step is the concentration of malonyl CoA within hepatocytes. Low 
concentrations of malonyl CoA promotes FFA entry into hepatic mitochondria, by 
inducing carnitine palmitoyl 1 transferase enzyme (CPT I). CPT1 is an enzyme that is 
necessary for transport of long-chain fatty acids into mitochondria for oxidation.  
 
Malonyl CoA is formed from acetyl CoA by the action of acetyl CoA carboxylase (ACc). 
Insulin activates (dephosphorylates) ACc, thus inhibiting FFA entry into mitochondria 
and glucagon deactivates ACc and promotes FFA entry into mitochondria. 
 
Harano et al (Harano et al., 1982)  were able to show that mitochondria isolated from 
adult rat hepatocytes, showed an increase in ketogenesis (50-55%), and an increase in 
Carnitine palmitoyl I (CPT I) activity by 25-50% under the influence of glucagon, while 
insulin suppressed CPT I activity by 34%
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.3. The final (rate limiting) step in ketogenesis is the action of HMG CoA synthase 
(mHS) that converts Acetoacetyl CoA to HMG CoA. Starvation, low insulin and 
ketogenic diet promote activity of HMG CoA synthase. 
 
 
 
Studies using tracer techniques to investigate adult human KB production and utilisation 
in vivo, has confirmed that insulin, epinephrine and thyroid hormone are the main 
mediators of ketone body homeostasis. These hormones not only affect ketogenesis by 
their effect on lipolysis but also influence intrahepatic ketogenesis (Keller et al., 1989) 
 
 
 
 
Figure 6 Regulation of ketogenesis. Ketogenesis is regulated at 3 levels (highlighted in red). 
Lipolysis by hormone sensitive lipase ensures availability of NEFA to the liver. The 
concentration of malonyl CoA in the hepatocytes influences transport of fatty acids into the 
hepatic mitochondria. The rate limiting enzyme in ketogenesis HMG CoA synthase is the final 
step of regulation. 
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3 Hypoglycaemia 
 
 
3.1   Definition of Hypoglycaemia 
 
 
There have been several approaches (based on clinical symptoms, epidemiological 
studies, threshold of counterregulatory response, neurophysiological impairment and 
neurodevelopmental outcome) to the definition of significant hypoglycaemia, but none 
satisfactory (Cornblath et al., 2000). 
 
 
The variability in perception of hypoglycaemia was highlighted by a survey of 178 
paediatricians and 36 textbooks, where definition of hypoglycaemia varied from <1 to 
< 4 mmol/l (Koh et al.,1988). There are several reasons contributing to the difficulty in 
defining significant hypoglycaemia which include the significance of symptomatic and 
asymptomatic hypoglycaemia, level of glycaemia associated with neurological 
impairment and the difficulty in quantifying duration of hypoglycaemia (Aynseley-green 
et al., 1996). 
 
 
Although the definition of hypoglycaemia remains controversial, defining significant 
hypoglycaemia in relation to brain function has been felt to be the most appropriate 
approach (Aynsley-Green et al., 1991). In accordance with that, Koh et al (Koh et al., 
1988) studied the effect of hypoglycaemia on neural function in 17 children (age 1 day - 
 
16 years). Abnormal brainstem evoked potentials (prolonged latencies and abnormal 
waveforms) were observed in 10/17 subjects when blood glucose concentration was 
below 2.6 mmol/l. In one child with blood glucose concentration of 1.9 mmol/l evoked 
potential was normal, that led to speculation about the protective effect of alternate 
cerebral fuels such as lactate and ketone bodies. 
35  
 
 
 
In the absence of a clear definition of significant hypoglycaemia, operational thresholds 
for intervention have been recommended (Cornblath et al., 2000) that merely provide 
guidance.  In  symptomatic  infants  intervention  is  recommended  if  blood  glucose  is 
< 2.5mmol/l, in asymptomatic infants intervention is suggested at a blood glucose 
concentration < 2.0 mmol/l, and intravenous glucose infusions at glucose concentration 
between 1.1-1.4 mmol/l. 
 
 
However, management at these suggested operational thresholds does not necessarily 
imply normal neurological outcome as the blood glucose concentration associated with 
brain injury is not known. A recent consensus workshop concluded that the evidence 
was still lacking to specify a range of glucose concentration that would define significant 
hypoglycaemia (Hay et al., 2009) 
 
 
 
3.2  Causes of Hypoglycaemia 
 
 
Hypoglycaemia is a biochemical diagnosis and can occur in a wide variety of conditions 
such as prematurity, intrauterine growth retardation, asphyxia, hypothermia, sepsis, 
infant of  diabetic mother, large for gestational age, polycythaemia, erythroblastosis 
foetalis, endocrine disorders (hyperinsulinism, hypopituitarism, cortisol deficiency, 
growth hormone deficiency), inborn errors of metabolism (defects in gluconeogenesis, 
defects  in  carnitine  metabolism,  defects  in  fatty  acid  oxidation),  insulin  producing 
tumours and insulin therapy for diabetes and ketotic hypoglycaemia in older children. 
 
 
In reference to the patient group recruited, only two causes of hypoglycaemia are 
discussed in detail below, namely hyperinsulinaemic hypoglycaemia (HH) and ketotic 
hypoglycaemia (KH). Children with HH have hypoglycaemia with complete lack of 
alternative cerebral fuels, whereas children with KH have hypoglycaemia with marked 
increase in alternative substrates such as ketone bodies (ketotic hypoglycaemia). This 
unique patient  cohort  is therefore ideal for undertaking  a study that will allow the 
assessment  of  the neuroprotective effect  of  ketone  bodies  in  hypoglycaemic  brain 
injury. 
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3.2.1 Hyperinsulinaemic Hypoglycaemia (HH) 
 
 
HH is a major cause of persistent and recurrent hypoglycaemia in the newborn period and 
in infancy due to dysregulated secretion of insulin (Aynseley-Green et al., 2000). 
 
 
Biochemically (Table 1) HH is characterised by inappropriately elevated insulin and C- 
peptide concentrations with low serum fatty acids and ketone bodies during the episode of 
hypoglycaemia. Importantly even a ‘normal’ (i.e detectable) insulin concentration in the 
presence of hypoglycaemia is inappropriate (Aynsley-Green et al., 2000). The presence of 
excess insulin results in an increased glucose requirement of more than 8 mg/kg/min 
(normal 4-6 mg/kg/min) to maintain normoglycaemia.   
 
 
 
 
 
 
 
 
 
Clinically HH may be transient or persistent. There are several causes of HH, it may be 
congenital (CHI - described in the next section), and it may coexist in high risk groups (like 
small for gestational age, hypoxic ischemic encephalopathy and maternal diabetes 
mellitus) or may occur associated with syndromes such as Beckwith - Wiedman, Kabuki, 
Costello, Usher and Trisomy 13. HH has also been reported in metabolic conditions 
such as congenital disorders of glycosylation type 1a/b/d and Tyrosinemia type 1 and 
also in association with dumping syndrome. 
Table 1 Diagnostic criterion for hyperinsulinemic hypoglycaemia 
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HH is a heterogeneous condition in terms of the age of onset, clinical presentation, 
duration, severity, molecular biology, histology and response to medical treatment 
(Hussain et al., 2007). 
 
 
The Incidence is 1 case per 40-50,000 in sporadic forms and as high as 1 per 2500 in 
familial forms (Glaser B et al. 2000). Early recognition and management is crucial to 
prevent brain injury (Menni et al., 2001; Meissner et al., 2003). 
 
 
In addition the glucagon and cortisol counter regulatory response has been shown to be 
blunted in these children, further exacerbating the hypoglycaemia. Due to the high risk of 
brain injury, it has been recommended that blood glucose concentrations less than 
3.5 mmol/l should be considered as hypoglycaemia (Hussain et al., 2007). 
 
 
 
Mechanism of insulin secretion 
 
Glucose is the key stimulus for insulin secretion. Within the pancreatic β-cell, glucose is 
converted to glucose-6-phosphate by the enzyme glucokinase that acts as a glucose 
sensor and couples the metabolism of glucose to insulin secretion (Figure 7). The ensuing 
glycolysis increases intracellular ATP/ADP ratio, that triggers closure of the adenosine 
triphosphate - sensitive potassium channels (KATP) spanning the β- cell membrane. This 
results  in  membrane  depolarization  and  influx  of  Ca2+   via  the  voltage  gated  Ca2+   
channels.  This influx of Ca2+   results in insulin exocytosis.  There are other KATP 
independent mechanisms of glucose stimulated insulin secretion (Gembal et al., 1992). 
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Figure 7 Illustration of mechanism of insulin secretion in β-cell of the pancreas. The β-cell 
adenosine triphosphate sensitive potassium channels (KATP) channel consists of 2 
essential protein subunits; Kir6.2, which is the pore-forming unit and belongs to the 
inwardly rectifying potassium channel family, and sulfonylurea receptor 1 (SUR1), which 
belongs to the ATP-binding cassette (ABC) transporter family. The channel is an octameric 
complex of four Kir6.2 and four SUR1 subunits. Glycolysis increases intracellular ATP/ADP 
ratio, which triggers closure of the KATP channels. This results  in  membrane  
depolarization  and  influx  of  Ca2+   via  the  voltage  gated  Ca2+ channels triggering 
insulin exocytosis. Figure reproduced with permission from Mohamed et al., 2012. 
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Molecular mechanisms of HH 
 
Mutations in seven different genes (ABCC8, KCNJ11, GLUD1, GCK, HADH, SLC16A1 
and HNF4A) have been implicated in the etiology of  congenital hyperinsulinism (CHI) 
 
 
ABCC8 and KCNJ11 encode for the ATP-sensitive potassium (K ATP) channel subunits 
SUR1 and Kir6.2 respectively in the pancreatic β-cells. Inactivating mutations (dominant 
and recessive) in these two genes are responsible for severe forms of CHI. 
 
 
Hyperinsulinism hyperammonaemia HI/HA is the second commonest cause of CHI. These 
children present with postprandial HH secondary to a protein meal (Stanley et al., 1988). 
Activating mutations in GLUD1 gene that encodes intramitochondrial glutamate 
dehydrogenase (GDH) is the underlying molecular mechanism. GDH causes oxidative 
deamination of glutamate to α-ketoglutarate and ammonia (Li et al., 2004). The  α- 
ketoglutarate via the citric acid cycle generates ATP that triggers closure of K  ATP 
channels, causing inappropriate insulin secretion. 
 
 
Activating mutations of the glucokinase (GCK) gene that encodes glucokinase enzyme can 
also cause CHI. Glucokinase via glycolysis generates ATP that triggers closure of K ATP   
channels, causing insulin secretion (Glaser et al., 1998). 
 
 
Loss of function mutations in Hydroxyacl-CoA dehydrogenase (HADH) gene is associated 
with CHI (Clayton et al., 2001). The exact molecular mechanism of HADH CHI is not 
known. Mutations in HNF4A gene (encoding transcription factor hepatocyte nuclear 4 α, 
HNF-4α) is responsible for CHI associated with macrosomia (Pearson et al., 2007). HNF-
4α is known to regulate several genes that influence glucose stimulated insulin 
secretion (Odom et al., 2004)
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Dominant mutations in the promoter region of SLC16A1 gene are associated with 
exercise-induced   HH   (Meissner   et   al.,   2005). SLC16A   gene   encodes   a 
monocaboxylate transporter (MCT 1) that enables movement of pyruvate into the 
mitochondria to enter the tricarboxylic acid cycle and generate energy. Dominant mutations 
result in overexpression of MCT 1 in β cells (Otonkoski et al., 2003). 
 
Histopathological forms of HH 
 
Histologically they may present as diffuse (increased nuclear size in all β cells) or focal 
(focal adenomatous hyperplasia confined to a single region) forms depending on the extent 
of pancreatic involvement. Management is medical (if responsive to diazoxide or 
octreotide) or surgical (subtotal pancreatectomy) in medically unresponsive children. 
The aim of the treatment is to prevent hypoglycaemia, while optimizing definitive 
management (either diet and medications or surgery). 
 
With the advent of 18F-DOPA-PET/CT scans to differentiate focal and diffuse lesions and 
rapid genetic sequencing and increased knowledge regarding genotype phenotype 
correlations, clinical management of children with HH has been revolutionized leading to 
improved care in these complex patients. 
 
 
 
3.2.2 Ketotic hypoglycaemia (KH) 
 
 
KH is the most common form of hypoglycaemia beyond infancy (Pershad et al., 1998). 
The pathophysiology remains unknown (Pagliara et al., 1972; Haymond et al., 1974) 
and children tend to manifest between 6 months to 7 years of age. 
 
 
These children are otherwise healthy but present with recurrent episodes of 
hypoglycaemia and ketonuria during an intercurrent illness or fasting. These children 
are believed to represent one end of the normal spectrum of age related adaptation to 
fasting (Stanley et al., 2006) 
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Diagnosis is confirmed when hypoglycaemia occurs in association with ketonemia/ 
ketonuria but without any evidence of metabolic or endocrine abnormalities, either 
during a spontaneous episode of hypoglycaemia or during a fasting tolerance test. 
Plasma ketone bodies in these children are significantly higher during hypoglycaemia 
when compared to controls (Bodamer et al., 2006). 
 
 
Prompt administration of oral or intravenous  glucose  reverses  the  hypoglycaemia. 
Seizures have been reported, but long term neurological impairment is rare (Colle et al., 
1964; Kogut et al., 1969), although follow up neurocognitive studies are lacking. Ketotic 
hypoglycaemia improves with age and disappears before adolescence (Stanley et al., 
2006). Management involves parental reassurance, avoidance of fasting, snack of complex 
carbohydrates before bedtime for slow release of sugar and glucose supplementation 
during illness. 
 
An assessment of glucose kinetics in fasting children with KH has shown low alanine 
concentrations (precursor for gluconeogenesis) and reduced endogenous glucose 
production indicating an imbalance between glucose production and uptake as the 
underlying mechanism of hypoglycaemia (Huidekoper et al.,  2008). 
 
 
 
With the advent of better diagnostic modalities, children previously labelled as ketotic 
hypoglycaemia have been subsequently diagnosed with hepatic glycogen synthase 
deficiency, acetoacetyl CoA thiolase deficiency and congenital disorders of glycosylation 
(Stanley et al., 2006). Hence it is important to be vigilant of any atypical features that 
may suggest an alternate diagnosis and impact on neurodevelopmental outcome. 
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3.3  Counterregulation of hypoglycaemia 
 
The brain depends predominantly on glucose for its metabolic needs and mechanisms are 
in place to detect hypoglycaemia and initiate counterregulatory measures to restore 
normoglycaemia. 
 
Glucose counterregulation results from an interaction of sensory input with complex neural 
networks resulting in behavioural and neuroendocrine and autonomic responses, the 
mechanisms of which are yet to be completely elucidated (Watts & Donovan et al., 2010) 
 
 
 
The  primary  glucose  sensors  are  hepatic  portal/mesenteric  vein  (peripheral)  and 
glucose   sensitive   neurons   within   parts   of   the   hindbrain   and   hypothalamus 
(venteromedial  hypothalamus)  (McCrimmon  et  al.,  2012).  The glucose sensitive 
neurons integrate the sensory input with other neural processes and trigger the 
counterregulatory response. 
 
 
Counterregulation involves an immediate reactive response (decreased plasma insulin and 
increased plasma glucagon and catecholamines) as well as a late adaptive response 
(increased cortisol and GH) that ensures adaptation of metabolic processes over longer 
period of time (Watts & Donovan et al., 2010). 
 
Recent studies have highlighted the importance of central KATP channels on glucose 
regulation. KATP channels in the β- cell play a crucial role in insulin secretion by coupling 
metabolic signals to electrical changes in resting membrane potential. KATP  channels 
have  been  demonstrated  in  different  regions of  the  animal  brain  especially  in  the 
hypothalamus (Ashford et al., 1988). Evans et al demonstrated impaired counterregulatory 
response to hypoglycaemia on closure of these channels (Evans et al., 2004). In children 
with congenital hyperinsulinism this is important as they can have mutations of KATP 
channels.
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The   reduction   of   Insulin   secretion   is   the   first   step   in   the   cascade   of   the 
counterregulatory  response  to  hypoglycaemia,  that  occurs  within  the  physiological 
range of glucose concentrations (4.6+/- 0.2mmol/l) (Sch wart z et a l. , 19 87; Mitrakou et 
al., 1991). Insulin suppression allows secretion of the other counterregulatory hormones  at  
glucose  concentrations  of  3.8mmol/l  prior  to  onset  of  adrenergic symptoms of 
hypoglycaemia at 3mmol/l. If hypoglycaemia continues neuroglycopenia (cognitive  
dysfunction)  occurs  by 2.7mmol/l,  followed  by  convulsions  and  coma  at 1.5mmol/l. 
 
 
 
Unlike glucagon and epinephrine, the effects of growth hormone and cortisol manifest only 
several hours after hypoglycaemia is corrected (Defeo et al., 1989). Growth Hormone and 
cortisol also promote lipolysis during hypoglycaemia (Defeo et al., 1989), thereby 
increasing the availability of gluconeogenic precursors and contributing to ketone body 
synthesis , that act as an alternative fuel for the brain during hypoglycaemia. 
 
 
 
 
Figure 8 Cascade of the counterregulatory response to hypoglycaemia. This figure 
shows the hierarchy of events when arterialised venous blood glucose concentrations 
decrease in adults. 
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4 Brain Energy Metabolism 
 
 
The brain develops rapidly during the first few years of life, attaining 90% of adult size 
by 5 years of age, however further modifications of gray and white matter and 
development of neural circuits for information processing continue till onset of adulthood 
(Tau & Peterson., 2010). Any problems in brain metabolism during this critical period of 
rapid growth can result in brain injury. 
 
 
4.1 Cerebral blood flow and metabolism 
 
 
The brain constitutes only 2% of body weight but consumes 20% of oxygen inspired 
and 15% of cardiac output and 25% of total body glucose utilisation (Sokoloff et al., 
1989). This reflects the complex processes of the brain that need to be sustained such 
as neuronal action potentials, protein synthesis, axoplasmic flow, neurotransmitter 
release, and maintenance of ionic homeostasis. 
 
 
Glucose is utilised for purposes beyond oxidation for brain metabolism, the glucose 
carbon is incorporated in lipids, proteins and glycogen and is a precursor for excitatory 
neurotransmitters like glutamate and aspartate and inhibitory neurotransmitters like 
gamma-amino butyric acid (GABA) (Sokoloff et al., 1989) 
 
 
Sokoloff  et  al  (Sokoloff  et  al.,  1977)  using  2- (14C) -  deoxyglucose (2DG)  enabled 
regional measurement of cerebral glucose utilisation by the brain in humans while 
previously only measurement of global brain glucose utilisation was possible. 
Incorporating this method, Chugani et al (Chugani et al., 1987, 1986, 1994) used PET 
(positron emission tomography)   with 18 fluoro-2-deoxyglucose   in  humans   and 
described cerebral glucose utilisation from birth to adulthood.
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These studies suggest that until 5 weeks of age, the sensorimotor cortex, thalamus, 
hippocampus, and brainstem show high utilisation of glucose. This was followed by 
marked increase in glucose utilisation in parietal, temporal and occipital cortices, basal 
ganglia and cerebellum by 3 months of age. By 8 months of age increased utilisation 
was seen in frontal cortex and association regions. This pattern of utilisation remained 
relatively stable with little change till 18 months of age. This evolution in the pattern of 
cerebral  glucose  utilisation  seem  to  be  linked  to  the  pattern  of  functional  and 
behavioural maturation of the brain (Chugani et al., 1989) 
 
 
The overall cerebral utilisation rate of glucose is low at birth, increases rapidly until 4 
years of age (twice the adult concentrations), followed by a plateau until 11 years of age 
and a gradual decline thereafter (Chugani et al., 1994). Studies in newborn dogs have 
shown increased cerebral blood flow (with regional variations) during hypoglycaemia, 
although regional utilisation of glucose remained unaltered except in occipital white 
matter (Mujsce et al., 1989). 
 
 
 
4.2 Glucose uptake and utilisation 
 
 
Glucose is taken up by the brain by an insulin independent carrier mediated facilitated 
diffusion, via glucose transporters (GLUT) (Lund et al., 1979; Partridge et al., 1983). 
These homologous carrier molecules transport substrates down a concentration 
gradient.  GLUT1 and GLUT3  have  been  established  as  the  principal  glucose 
transporters in the brain (Thorens et al., 1998). 
 
 
GLUT 1 is localised mainly within the brain endothelial cells and GLUT 3 in the neurons 
(Maher et al., 1994; Vannucci et al., 1997). The pattern of distribution and expression of 
these glucose transporters seems to be closely related to cerebral glucose utilisation. 
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In the rat and rabbit brain, GLUT1 and 3 expressions are low at birth in accordance with 
low rate of cerebral glucose utilisation, and then rapidly increase in the 2nd and 3rd 
postnatal week reflecting the increased cerebral glucose uptake crucial for the rapid 
synaptogeneis occurring during this period (Vannucci et al., 2000). 
 
 
The crucial role of glucose transporters is demonstrated by GLUT1 deficiency (De V et 
al., 1991), a condition that is characterized by low cerebrospinal glucose concentrations 
despite normal blood glucose concentrations and commonly associated with significant 
neurodevelopmental impairment, ataxia and seizures. 
 
 
On reaching the blood brain barrier glucose is transported into the brain interstitium via 
GLUT1. In the physiological state, glucose from the brain interstitium is taken up by the 
astrocytes and converted to lactate producing 2 mol of ATP. Lactate is then transported 
into the neurons and converted to pyruvate.  Pyruvate enters the citric acid cycle 
followed by oxidative phosphorylation resulting in 34 mol of ATP which is crucial to 
sustain synaptic activity (Magistretti et al., 1999). Thus astrocytes play a key role in 
linking synaptic activity to brain energy metabolism. 
 
 
4.3 Alternative fuels for cerebral metabolism 
 
 
Ketone bodies primarily acetoacetate and 3-βhydroxybutyrate are produced in the liver 
from beta oxidation of fatty acids. In certain metabolic conditions such as the fasted 
state (Owen et al., 1967; Haymond et al., 1982) and in breast fed neonates (Hawdon 
et al., 1992) there is an increased concentration of ketone bodies that can be utilised by 
the brain as an alternative fuel. This spares the breakdown of glycogen and skeletal  
muscle proteins to provide gluconeogenic substrates. 
 
 
Cerebral utilisation of ketone bodies is linearly dependent on the circulating 
concentration of  ketone  bodies  (Kraus  et  al.,  1974),  the  abundance  of  
monocarboxylic  acid transporters (MCT1) (Froberg et al., 2001; Gjedde et al., 1975) 
that determine the permeability of blood brain barrier to ketone bodies and also the 
maturity of relevant ketolytic enzymes (Middleton et al., 1973). 
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In suckling rats ketone bodies can provide more than 30% of cerebral energy 
requirement (Cremer et al., 1982). In hypoglycaemia secondary to hyperinsulinism, 
lipolysis and gluconeogenesis are inhibited, preventing the availability of ketone bodies, 
rendering the brain more susceptible to hypoglycaemic brain damage (Hussain et al., 
2007). 
 
 
 
Plecko et al studied oral supplementation of 3-βhydroxybutyrate (βohb) to two 6 month 
old infants with hyperinsulinaemic hypoglycaemia, and were able to demonstrate an 
increase in blood βohb concentration that was equivalent to concentrations seen 
following 16-24 hour fast and a comparable increase in CSF βohb and more importantly 
intracerebral uptake of βohb was confirmed by magnetic resonance spectroscopy. This 
provides  an  exciting  avenue  of  possible additional  neuroprotective  therapy  in  these  
patients (Plecko et al., 2002). 
 
 
Ketone body turnover is much higher in fasting children than adults (Bougneres et al., 
1986). However they are in very low concentrations in the human newborns prior to 
commencement of enteral feeding when the neonate is at a high risk of hypoglycaemia. 
KB concentrations in healthy term human infants progressively increase from 12 hours 
– 4 days of life and decline thereafter (Hawdon et al., 1992). 
 
 
During this period (1st day of life), possible alternative fuels in the form of lactate 
is present in high concentrations (Stanley et al., 1979; Hawdon et al., 1992) and in 
newborn dogs lactate has been shown to significantly contribute to cerebral energy 
metabolism during hypoglycaemia (Vannucci et al., 1981). 
 
 
Rodent studies have shown that enzymes that are crucial for ketogenesis such as 
carnitine palmitoyltransferase I and β-hydroxy-β-methylglutaryl–coenzyme A synthase, 
are not transcribed till 12 hours of age. Early introduction of enteral milk feeds are also 
important as they provide long chain fatty acids that initiate transcription of the genes 
encoding the beta oxidative enzymes (Pegorier et al., 1998). 
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Neuroprotective effects of ketone bodies have been demonstrated in certain conditions 
such as epilepsy, hypoxia, neurodegenerative disorders, and traumatic brain injury 
although knowledge regarding mechanisms of neuroprotection is still evolving (White & 
Venkatesh et al., 2011).   In   rodent   models   of   glutamate   excitotoxicity   (one   
possible mechanism of   hypoglycaemic brain injury), acetoacetate   infusion reduced 
neuronal damage and increased cellular ATP. 
 
 
Some of the other neuroprotective mechanisms postulated include protection against 
glutamate induced apoptosis/necrosis by decreasing free radical formation, increased 
glutathione peroxidase activity (Ziegler et al., 2003), conversion of excitatory 
neurotransmitter glutamate to inhibitory GABA (gamma amino butyric acid) (Gasior et 
al., 2006) and increased cerebral blood flow (Hasselbalch et al., 1996). In children 
ketogenic diets have been used in the treatment of epilepsy and although the exact 
mechanism is unknown a modulation of excitatory and inhibitory neurotransmitter 
balance has been thought to confer the neuroprotection (Hartman et al., 2007). 
 
 
Although the ketone bodies (KB) are available and the immature brain has the capacity 
to utilise them, their actual contribution to cerebral metabolism during hypoglycaemia in 
human newborns and older children is not known. In addition, glucose via glycolysis 
and its associated pathways is responsible for neurotransmitter homeostasis, defence 
against oxidative injury and maintaining redox equilibrium, that KB’s are unable to 
compensate for. 
 
 
Children with idiopathic ketotic hypoglycaemia are anecdotally believed to be 
neurologically normal suggesting a neuroprotective role of ketone bodies, but no 
supporting neuroimaging or neurodevelopmental data are available and existence of 
subtle learning difficulties cannot be excluded in the absence of reliable evidence. 
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5 Hypoglycaemia and the Brain 
 
 
There is insufficient understanding regarding the severity and duration of hypoglycaemia 
associated with brain injury. 
 
 
5.1 Pattern of Brain Injury reported in Hypoglycaemia 
 
 
Neuropathological studies following human neonatal hypoglycaemia have revealed 
neuronal necrosis in cerebral cortex (occipital more that frontal with temporal being 
least affected), hippocampus and basal ganglia (Anderson et al., 1967). 
 
 
A distinct pattern of cortical grey matter and subcortical white matter injury (bilateral and 
unilateral) in the occipital and parietal regions on neuroimaging is traditionally believed 
to be the outcome of neonatal hypoglycaemic brain injury (Yager et al., 2002). 
 
 
Alkalay et al (Alkalay et al., 2005) summarized the neuroimaging findings in 
hypoglycaemia  from  9  case  reports  involving  23  patients  with a differing  underlying 
etiology of hypoglycaemia. The median and range at age of clinical presentation was 30 
hours and 1-72 hours respectively. Most cases, 17 of 23 (74%) showed persistent 
abnormal neuroimaging studies and significant neurological sequelae. 
 
 
Changes were confined predominantly to the occipital (82%) and parietal lobes (29%). 
Periventricular deep white matter changes, cerebral cortical atrophy and ventricular 
dilation were described. Involvement of the globus pallidus in a patient with severe 
cortical injury and another with frontal white matter injury were also noted. A minority of 
the cases, 6/23 (26%), showed only transient brain oedema. 
 
 
Seizures as presenting symptom 12/17 (70%), motor and/or psycho-developmental 
delay 11/17 (65%), visual impairment 7/17 (41%) and microcephaly 6/17 (35%) were all 
noted as neurological outcomes. 
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Recently more diverse changes have been described as a consequence of 
hypoglycaemia. Burns et al (Burns et al., 2008) performed early (<6 weeks) MRI scans 
in 35 term infants with symptomatic hypoglycaemia and assessed their 
neurodevelopment at 18 months. Posterior pattern of brain injury was seen in 29%.  
94%  showed  white  matter  (WM)  injury  of  variable  extent  (global,  periventricular, 
posterior and anterior parasagittal) and 51% showed cortical injury (cortical abnormality 
either as cortical highlighting or loss of grey and white differentiation in areas of WM 
injury). They also noted haemorrhage and infarction in WM, not previously reported in 
hypoglycaemia. 
 
 
Involvement of basal ganglia and thalamus (BGT) was seen in 40% (4 patients had 
involvement of the posterior limb of the internal capsule (PLIC). Isolated cases with 
cerebellum and brainstem involvement were also present. It is possible that 
unrecognized comorbid conditions contributed to this varied presentation. At 18 
months cognitive impairment was more common than motor impairment.  9 patients  
showed  motor abnormalities (three  with  cerebral  palsy),  15  showed  mild  to 
moderate  cognitive  impairment,  12 developed seizures, 9 developed microcephaly 
and 8 developed visual impairment. 
 
 
Thus the pattern of brain injury following neonatal hypoglycaemia seems widespread, 
although a greater frequency of posterior cortical and subcortical WM injury is seen. 
 
 
The reason for occipital lobe involvement in hypoglycaemia is not clear. Postulated 
mechanisms include reduced regional cerebral glucose uptake during hypoglycaemia 
(Mujsce et al.,1989), a defect in expression of glucose transport proteins affecting 
glucose utilisation and increased synaptogenesis in the visual cortex during the 
neonatal period increasing susceptibility to hypoglycaemia (Alkalay et al., 2005; Filan et 
al., 2006). 
 
 
Neuroimaging   studies   in   children   following   neonatal   hypoglycaemia   has   been 
commonly performed in the acute period with short duration of follow up. Given the 
resilience of the immature brain to injury and its plasticity, neuroimaging studies 
performed beyond the acute phase with correlation to neurocognitive outcome, may be 
of greater prognostic value to patients. 
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5.2 Mechanism of Injury in hypoglycaemia 
 
 
The mechanism of cellular injury in hypoglycaemia is complex and poorly understood 
and not merely a result of energy failure. Animal studies have been crucial in providing 
an insight into the possible mechanisms involved in hypoglycaemic brain injury. 
Depletion of high energy phosphates, accumulation of excitotoxic amino acids, 
membrane breakdown, release of fatty acids, intracellular calcium influx and cell death 
have been noted in hypoglycemic bran injury (McGowan et al., 1999; Behar et al., 1985; 
Auer et al., 1986). 
 
 
An important mechanism implicated in brain damage is excitotoxic amino acid (EAA) 
injury. During hypoglycemia there is excess extracellular accumulation of excitatory 
amino acids such as glutamate and aspartate, due to release from the neurotransmitter 
pool and reduced reuptake by astrocytes and neurons (Butcher et al., 1987, Lipton et 
al., 1994). 
 
 
Although the exact mechanism by which EAA’s lead to brain injury is not known, they 
seem to mediate damage by excessive stimulation of N-methyl D aspartate A (NMDA) 
and non NMDA receptors that triggers a cascade of reactions (Morris et al., 1998). 
These include increased sodium and calcium influx, activation of proteases, lipases and 
superoxide generation leading to acute and chronic neuronal injury (Clarke et al., 1989). 
NMDA receptor antagonists have been shown to decrease hypoglycemia mediated cell 
injury  (Wieloch  et  al.,  1985)  furnishing  some  hope  as  a  possible  neuroprotective 
therapy. 
 
 
Glutamate receptors increase with the development of human brain (Lee et al., 1992) 
and are crucial for long term potentiation, a cellular mechanism that underlies learning 
and memory. McGowan et al (McGowan et al., 2002) demonstrated modification of 
glutamate binding sites of these receptors in newborn piglets. This might alter the 
function of how these receptors manipulate synaptic connections and result in 
irreversible change in brain structure and function. 
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In developing rat brain, hypoglycaemia can cause elevation of adenosine levels that 
activate A1 adenosine receptor and alter intracellular calcium concentrations resulting 
in neuronal damage (Turner et al., 2004). 
 
 
Yan et al (Yan et al., 2006) have shown that hypoglycaemia in newborn rats can affect 
oligodendrocyte precursor cell differentiation, maturation, migration and viability in vitro. 
Oligodendrocytes are cells that contribute to myelin formation in the central nervous 
system and form a pathophysiological basis for white matter injury following 
hypoglycaemia. 
 
 
Reactive oxygen species (superoxide and hydrogen peroxide) have been implicated in 
the pathogenesis of brain injury in hypoxic ischemic encephalopathy and 
neurodegenerative diseases (Traystman et al., 1996; Fachinetti et al., 1998; Lu et al., 
2000). McGowan et al (McGowan et al., 2006; Ballesteros et al., 2003) demonstrated a 
similar increase in free radical generation by mitochondria during insulin induced 
hypoglycemia in newborn piglets. 
 
 
These changes occurred within 2 hours of insulin induced hypoglycemia, implicating 
this as a possible early mechanism that initiates hypoglycemic brain injury. They 
postulate that the increase in mitochondrial reactive oxygen species is secondary to the 
imbalance between the normal oxidation potential in hypoglycemia and the decreased 
availability of reducing equivalents due to reduced glycolysis. 
 
 
Reactive oxygen species mediate injury by damage to mitochondrial membrane and 
fragmentation of DNA compromising the protein complexes of electron transport chain 
that leads to impairment of ATP synthesis. Intracellular calcium accumulation and 
apoptosis can also be triggered causing further damage. 
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5.3 Neurodevelopment in Hypoglycaemia 
 
 
 
There have been variable, even conflicting reports on the impact of hypoglycaemia on 
neurodevelopment. This has primarily resulted from the population group studied (ex 
preterm, infants with transient hypoglycaemia), underlying aetiology of hypoglycaemia 
(children with hyperinsulinism lack alternate fuels for the brain and are more 
vulnerable), difficulty in quantifying duration of hypoglycaemia, controversy regarding 
definition of hypoglycaemia, adequacy of follow up periods and the use of 
questionnaires or neurological examination to assess development as opposed to 
standardised tests. 
 
 
Brand et al (Brand et al., 2005) looked at 60 large for gestational age (LGA) children  
(non hyperinsulinaemic and non-diabetic parents) with transient hypoglycaemia defined 
as plasma glucose < 2.2mmol at 1 hour and < 2.5mmol beyond 1 hour on the first 
postnatal day and compared them to 15 normoglycaemic LGA children. No significant 
difference was found in the Denver developmental scale after a follow up period of 4 
years although reasoning IQ score was lower in the hypoglycaemic group. 64% of 
eligible patients were lost to follow up in this study. 
 
 
Boluyt (Boluyt et al., 2006) et al conducted a systematic review to assess 
neurodevelopmental outcomes after hypoglycaemia in the first week of life. They 
identified 18 studies, and classified 2 as high quality and 16 as low quality. They 
concluded based on quality, clinical and methodological heterogeneity of studies, that 
the effect of hypoglycaemia on neurodevelopmental outcome cannot be reliably 
estimated. 
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In a large study by Lucas et al (Lucas et al., 1988), 31 of 661 preterm infants with 
hypoglycaemia > 5 days, were found to have reduced mental and motor scores on 
Bayley developmental scales at 18 month follow up.  Neurodevelopmental impairment 
was 3.5 times greater in children with blood glucose < 2.6mmol/l for > 5 days. This 
study adjusted for other risk factors (eg: days of ventilation) associated with 
neurodevelopmental impairment. 
 
 
Cerebral palsy, epilepsy, microcephaly, visual impairment, motor deficits, apraxia, 
autism, learning difficulties, attention deficit hyperactivity disorder (ADHD) have all been 
reported following neonatal hypoglycaemia (Yalnizoglu et al., 2007; Kinnala et al., 1999; 
Creery, 1966; Haworth & McRae, 1967; Pildes et al., 1974; Murakami et al., 1999; 
Burns, 2008; Udani, 2009) 
 
 
Caraballo et al (Caraballo et al., 2004) described 15 patients with neonatal 
hypoglycaemia. Thirteen children had posterior cerebral injury on CT or MRI, 14 
developed occipital lobe epilepsy (focal > generalised), 12 suffered mild to moderate 
mental retardation and 2 had global severe developmental delay. Microcephaly (6 
patients) and visual disturbances (8 patients) were also described. 
 
 
Neurodevelopmental outcome reported at 2 years of age by Burns et al in children with 
a predominant pattern of global white matter injury on neuroimaging was cognitive 
impairment more than motor impairment. 
 
 
In addition, hypoglycaemia in the presence of co-morbid conditions such as sepsis, 
hypoxia and seizures that increase the cerebral glucose demand, has an additive effect 
on the resultant brain injury (Basu et al., 2009) 
55  
 
 
 
5.3.1 Neurodevelopment in HH 
 
 
In comparison to other forms of hypoglycaemia children with HH are at an increased 
risk of brain injury due to lack of alternate fuels (ketone bodies). Even transient forms of 
HH have been associated with significant neurological damage (Vercellino et al., 2011). 
Neonatal seizures and occipital brain injury have been reported following transient 
hyperinsulinaemic hypoglycaemia (IUGR and maternal diabetes mellitus) (Filan et al., 
2006). 
 
 
 
Al-Rabeeah (Al-Rabeeah et al., 1995) reported brain injury in 12/28 (42%) patients with 
HH, where late referrals were more likely to sustain brain injury. This was a highly 
consanguineous pedigree (70%) and brain injury was reported based on retrospective 
data   review.   It’s   not   clear   if   outcome   was   based   on   neuroimaging   or 
neurodevelopmental   examination.   Cresto et al  (Cresto   et   al.,   1998)   reported 
neurological abnormalities in 10/26 (38%) patients with HH. Motor difficulties, seizures, 
neuroimaging changes of diffuse cortical atrophy and low IQ were reported. 
 
 
Menni et al (Menni et al., 2001) looked at the outcome in 90 children with congenital 
hyperinsulinism. They collected data retrospectively and classified outcomes as mild 
(IQ> 80 or 1 minor disability), moderate (IQ 60-80, or 2 or more disability) and severe 
(IQ <60 or major disability or mental retardation). 26% of patients had psychomotor 
retardation - 7 with severe psychomotor retardation, 12 with intermediate psychomotor 
disability and 16 with epilepsy. Visual impairment was reported in 3 patients (1 blind, 2 
with strabismus) and deafness in 2 patients. 
 
 
They concluded that the main risk factors for adverse neurodevelopmental outcome 
were neonatal onset and surgically treated patients and reported no differences in 
developmental outcome between different disease types (focal and diffuse). It was a 
large study but the data was collected retrospectively and it is unclear if standardised 
measures were used to assess neurodevelopment. 
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Yet another large study (Meissner et al., 2003) looked at 114 children with persistent 
hyperinsulinaemic hypoglycaemia and found a high rate of psychomotor retardation 
(44%) and epilepsy (25%), with infancy onset disease as the main risk factor. 
 
 
Ludwig et al (Ludwig et al., 2011) assessed the neurological outcome of 20 children 
with HH (6 subtotal pancreactectomy), age range 7 months – 39 years in comparison to 
4 controls (9 months – 13 years). Although limited by the sample size and wide age 
range they reported a trend to motor and speech delay in 0-3 year old children and, 
better performance of non-verbal tasks in 2.5 -7 year old in the patient group. 33% 
(4/12) of patients also had behavioural problems (poor attention, increased aggression). 
 
 
 
Children with HI/HA syndrome, a type of hyperinsulinaemic hypoglycaemia, have 
increased frequency of generalised seizures (absence type), developmental delay and 
behaviour problems (Bahi-Buisson et al., 2008). This has been attributed to a 
combination   of   hypoglycaemic   brain   damage,   hyperammonaemia   and   
abnormal regulation of GDH in the brain. A genotype- phenotype correlation has been 
suggested with increased incidence of epilepsy noted in children with mutations in exon 
6 and 7 of GLUD1 gene (Kapoor et al., 2009; Bahi-Buisson et al., 2008). In a cohort of 
20 children with HI/HA, epilepsy was reported in 43% (Kapoor et al., 2009) 
 
 
Adverse neurodevelopmental outcome following hyperinsulinism has been attributed to 
 
– neonatal presentation, poor responsiveness to medical treatment, requirement of 
surgery, late diagnosis and possible influence of underlying molecular disorder 
contributing to hyperinsulinism. 
 
HH is associated with a high risk of neurodevelopmental impairment, yet few studies 
have examined neurodevelopment using standardized neuropsychological measures 
or in correlation with neuroimaging. Although KH is believed to be a benign condition, 
existence of subtle neurocognitive abnormalities has not been investigated and 
neuroimaging studies are not available. 
 
 
Thus a greater understanding of the impact of hypoglycaemia on neurodevelopment, in 
HH and KH children with correlation of neurodevelopment to imaging changes are 
required to provide a clear picture of the outcome and to enable recommendations for 
clinical practice. 
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6 Background and general aims of thesis 
 
 
6.1 Background to fasting studies 
 
Hypoglycaemia is a common problem encountered in clinical paediatric practice. Blood 
glucose concentrations are measured in virtually every child admitted to the hospital. As 
glucose is a major fuel for brain function, anything that leads to persistent and recurrent 
hypoglycaemia can cause brain damage, epilepsy, mental retardation and even sudden 
death (Siesjo et al., 1988). 
 
However, despite the commonality of hypoglycaemia, there is little consensus as to what 
constitutes a "safe" blood glucose concentration for normal brain function (Cornblath et 
al., 2000). 
 
There are many causes of hypoglycaemia in the childhood period ranging from the very 
severe hyperinsulinaemic hypoglycaemia (HH) to the mild fasting ketotic hypoglycaemia 
(KH). 
 
Children with HH exhibit hypoglycaemia with complete lack of alternative fuels such as 
ketone bodies, as the inappropriate insulin secretion inhibits lipolysis and ketogenesis. In 
contrast children with KH have hypoglycaemia with marked increase in alternative 
substrates. This unique patient cohort is therefore ideal for undertaking a study that will   
allow   the   assessment   of   the   neuroprotective   effect   of   ketone   bodies   in 
hypoglycaemic brain injury. 
 
The initial aims of the study were 
(a) To examine the relationship between low blood glucose concentrations and brain 
electrical activity  
(b) To determine if changes in intermediary metabolites (ketone bodies) and 
counterregulatory hormones, modulate the effect of low blood glucose on brain 
electrical activity  
(c) To investigate whether the generation of intermediary metabolites have a protective 
effect on brain electrical activity when blood glucose levels are low  
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(d) To investigate the relationship between structural brain abnormality and 
neuropsychological outcomes in children with KH and HH. 
 
Accordingly, those children undergoing fasting studies for suspected ketotic or 
hyperinsulinaemic hypoglycaemia was recruited to undergo simultaneous EEG 
(electroencephalography) recording of the brain. Electrical potentials associated with 
specific sensory, perceptual or motor events known as event related potentials (ERP) 
were also recorded. The ERP waveforms are embedded within the EEG recording and 
time locked averaging of the EEG signal were performed to study the response to 
event. The ERP waveform is a series of negative and positive waves that are classified 
as N1, P1, N2, P2 and so on, based on polarity (N=negative, P= positive) and their 
order of appearance. These waves reflect internal cognitive processing of the stimulus. 
 
In children who became hypoglycaemic during the fasting study, the aim was to assess 
the amplitude and latency of these waveforms before, during and after hypoglycaemia. 
As bloods were simultaneously collected at regular intervals for counterregulatory 
hormones and ketone bodies, any modulating effects of these on brain electrical 
activity during hypoglycaemia could be assessed. Children who were normoglycaemic 
at end of fast were utilised as control group.  
 
13 children (age range 1 month - 14 years) were recruited and underwent simultaneous 
fasting study and EEG/ERP recording. However this study had to be abandoned due to 
unresolvable methodological issues. As these experiments were conducted on the 
wards, interference from neighbouring electrical equipment (such as infusion pumps, 
monitors, mobile phones) led to poor EEG data quality.  
 
I performed the application, recording, processing and interpretation of data under 
supervision of Dr. Stewart Boyd (consultant neurophysiologist, GOSH). The time 
required to apply 26 scalp electrodes were nearly 2 hours per patient. These electrodes 
had to stay in place for 4 hours which was cumbersome for younger patients. Quite 
often electrodes had to be replaced due to artifacts from sweating or spontaneous 
displacement. 
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Thus patient compliance was a critical issue and particularly challenging in children 
less than 1 year of age. Artifacts due to movements, sweating and chewing further 
decreased the quality of data. Following artifact rejection only small numbers of events 
were available to average, and appropriate waveforms were not discernible to study 
the effects of hypoglycaemia. 
 
Although the EEG/ERP experiment was discontinued, the recruitment of fasting 
children continued to enable the study of rate and regulation of ketone body response 
during fasting in children. Thus the fasting studies included in this thesis comprise of 
children who demonstrated ketotic hypoglycaemia at the end of the fast or remained 
normoglycaemic during the fasting period.  
 
6.2 Background to neuroimaging and cognitive studies 
 
A pilot study of 17 children with hyperinsulinaemic hypoglycaemia in Great Ormond 
Street Hospital (GOSH) was conducted prior to this study. Specific cognitive domains 
such as IQ, memory and academic achievement were assessed with a battery of age 
appropriate tests. 11 males and 6 females were assessed with a mean age of 8.5 
years (range 6-13 years). 
 
Results demonstrated verbal IQ in the average range (mean 91.70 (range 73-114)), 
non verbal IQ in the average range (perceptual reasoning mean 93.88 (range 69-131)) 
and general memory score in the low average range (mean 81.62 (range 66-103)). 
 
Both the IQ and the memory scores showed a huge variability, however the presence 
of lower mean memory score relative to mean IQ score (10 point difference) was 
suggestive of selective memory impairment. The hippocampus is a key structure in the 
memory system and neuropathological studies of prolonged human neonatal 
hypoglycaemia have shown the hippocampus to be susceptible to hypoglycaemic brain 
injury (Auer et al., 1989). Hence further exploration of selective memory impairment by 
quantitative assessment of hippocampal volumes with correlation to memory indices 
was conducted.
62  
 
 
Based on recent evidence of predominant and widespread pattern of white matter injury 
rather than posterior (occipitoparietal lobe) cortical subcortical injury following neonatal 
hypoglycaemia (Burns et al., 2008) and the pilot study in children with HH children 
suggestive of cognitive impairment, it was proposed that HH group in addition would 
manifest white matter damage and related neurocognitive deficits  This was explored 
further by quantitative neuroimaging assessment of white matter (diffusion tensor 
imaging) with correlation to neurocognitive indices.  
 
 
Children with HH have profound energy deficiency (recurrent hypoglycaemia and lack of 
KB) that would render them more susceptible to brain injury and subsequent 
development of neucognitive deficits in comparison to KH group. In the absence of a 
normal healthy control group, children with KH were used as the control group in the 
neuroimaging and cognitive studies. 
 
 
6.3 Aims of the Thesis 
 
 
The aims of this thesis are 
 
 
 
1. To characterise the KB response and its regulation during fasting in children  
 
2. To assess and compare the structural brain abnormality and neurocognitive 
profile in children with hyperinsulinaemic hypoglycaemia (HH) and ketotic 
hypoglycaemia (KH). 
 
6.4 Ethical approval 
 
 
Ethical  approval  for  the  study  was  obtained  from  the  East  London  and  the  City 
Research Ethics committee. Consent forms, parent and children information 
leaflets were designed (appendix 1, 2, 3, 4) that were then approved by the ethical 
committee.
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Metabolic profiles in children with hypoglycaemia
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7 Biochemical changes during fasting studies 
 
 
This chapter outlines the biochemical changes during the fasting test in children with 
KH and a control group (children with suspected hypoglycaemia or previous history of 
hypoglycaemia, who were subsequently normoglycaemic on a fast) with an aim to 
investigate ketone body response between the two groups and factors regulating the 
response. As children with KH are believed to represent one end of the spectrum of 
normal healthy with limited fast tolerance, the KB concentrations and regulating factors 
were also analysed by grouping together the data from KH and control group. 
 
7.1  Introduction 
 
 
During fasting glycogenolysis, gluconeogenesis, fatty acid oxidation and ketone body 
formation are activated. Any defect along this pathway would lead to hypoglycaemia 
during the fast.  
 
 
In children, glucose homeostasis is maintained predominantly by the mobilisation of 
glycogen reserves in the initial 4- 8 hours of a fast; gluconeogenesis is initiated within 4- 
6 hours and plays a greater role in homeostasis by 10-12 hours of age and lipolysis and 
ketogenesis  begins  with  the  suppression  of  endogenous  insulin  production  and 
gradually  increases  as  glycogen  reserves  are  exhausted  (Haymond  et  al.,  1982; 
Pagliara et al., 1972). However the timing of these responses may vary with age, 
adequacy of glycogen reserves and gluconeogenic substrates and concomitant glucose 
concentrations (Ward et al., 1982). 
 
 
Children with ketotic hypoglycaemia are biochemically characterised by the presence of 
ketone bodies during hypoglycaemia. Despite several attempts the pathophysiological 
basis of KH remains elusive (Huidekoper et al., 2008; Bodamer et al., 2006) and ketosis 
is considered a consequence rather than a cause of the hypoglycaemia. 
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A greater KB response to fasting is seen in children in comparison to adults (Haymond 
et al., 1982). In particular, KB turnover rates during 8-10 hours of fasting in neonates 
and infants (12.8-26 micromol/kg/min) are comparable to adult rates after several 
days of fasting. Children with KH demonstrate greater KB concentrations in comparison 
to controls during 15-24 hour fasts (Chaussain et al., 1977; Saudubray et al., 1971; 
Bonnefont et al., 1990). The current utility of fasting studies apart from aiding diagnosis 
of underlying metabolic and hormonal disorders are to determine the safe fasting time in 
these children.  
 
The duration of current fasting studies are tailored to the age of the child (Morris et al., 
1996). While information regarding KB response in children are available after 
prolonged periods of fast (15-24 hours), it is not known if there is a variation in the 
pattern and regulation of KB response during physiological periods of fasting between 
KH and  healthy  children  and  the  relationship  of  counterregulatory  hormones  to  
KB response in children are not well reported. This knowledge would be crucial in 
interpreting the results of clinical fasting studies and increase understanding of the 
biochemical mechanisms underlying KH.  
 
3-βhydroxybutyrate was the circulating KB measured during this study and is used 
interchangeably with the word ‘ketone body (KB)’ throughout this thesis.  
 
 
7.2 Specific Aims 
 
 
To  determine the variation  in  the  magnitude  and  rate  of  ketone  body  
response  to  physiological periods of fasting  in KH group and the ‘control’ group. 
 
To investigate the factors influencing KB response during fasting in children. 
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7.3 Methods 
 
 
7.3.1 Patient recruitment 
 
All patients recruited into the study were referred to Great Ormond Street Hospital for 
investigation of hypoglycaemia during the period between March 2009 - March 2012. 
Great Ormond Street Hospital (GOSH) is a tertiary referral centre for the diagnosis and 
management of children with all forms of hypoglycaemia.The children requiring fasting 
studies were admitted to Kingfisher ward, a designated programmed investigation unit 
for performing controlled fasting investigations. 
 
 
Patient group 
 
Patients with the diagnosis of idiopathic ketotic hypoglycaemia (KH) defined as raised 
plasma NEFA and 3-βhydroxybutyrate at the time of hypoglycaemia during the fasting 
study and exclusion of other metabolic and endocrine causes of hypoglycaemia. 
 
Control group 
 
Children investigated for suspected or previous history of hypoglycaemia and found to 
be normoglycaemic on the fast test. 
 
Exclusion criteria 
 
Children with known endocrine (GH or cortisol deficiency) or metabolic causes of 
hypoglycaemia.
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7.3.2 The diagnostic fast 
 
 
The children admitted for the fasting studies had an intravenous cannula inserted 24 
hours before fasting. They underwent an initial 24 hour period of blood glucose profiling 
(2 hourly measurements) on a normal food and activity schedule to see if they had any 
spontaneous hypoglycaemia and to ensure normoglycaemia prior to fasting.  The 
children were then fasted.  
 
The length of the fast followed the protocol (Table 2) routinely used for fasting children in 
our programmed investigation unit by the endocrine and the metabolic team. The duration 
of the fast was determined by the age of child, with an aim to increase diagnostic yield 
and establish a maximum safe interval between meals while minimising the risks and 
discomfort associated with fasting tests (Morris et al., 1996). During the fast all oral and 
intravenous intake was withheld except sips of water. 
 
 
Table 2 Duration of the fast according to the age of the child 
 
 
Age Length of fast in hours 
0-6 months 6 
6-8 months 8 
8-12 months 12 
1-2 years 16 
2-8 years 18 
>8 years 20 
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During the fast blood glucose was measured hourly (bedside monitoring and in addition 
sample was sent to the laboratory) initially and half hourly if hypoglycaemia was 
anticipated. The fast was terminated 
 
If the blood glucose concentration was <3.0 mmol/l with or without symptoms of 
hypoglycaemia (nausea, vomiting, drowsiness, headaches, confusion, tremors, 
sweating) or 
 
At the end of the predetermined period of fast in the absence of hypoglycaemia 
 
 
A threshold of 3 mmol/l was chosen, as the normal fasting blood glucose concentrations 
in children range from 3.5 - 5.5 mmol/l and the counterregulatory hormonal responses 
are initiated by the time blood glucose concentrations reach 3 mmol/l. This threshold is 
also in agreement with published reports of clinical fasting investigation from other 
hospitals (Van Veen et al., 2011). 
 
Hypoglycaemia if present was corrected with intravenous fluids (1-2 ml of 10% dextrose 
bolus) or oral feeds if child was tolerating oral intake. All children were discharged only 
after normal food intake was established following the fast and normoglycaemia was 
maintained. 
 
Most of the hormones and intermediate metabolites were assessed as part of their 
initial clinical investigation plan. Bloods were taken for the measurement of the following 
(Table 3) 
 
Glucose, lactate, NEFA (non-esterified fatty acids), 3-βhydroxybutyrate,  GH, 
cortisol, insulin (beginning, middle and end of fast), Ammonia, plasma amino acids 
(at the beginning and end of fast) and plasma catecholamines  and serum glycerol 
(beginning, middle and end of fast) 
 
All samples were transported, for analysis to the biochemistry laboratory at Great 
Ormond Street Hospital. 
 
 
Acyl carnitine was measured on Guthrie card samples and urine sample was collected 
at end of fast for estimation of organic acids. Data from these 2 tests were not included 
as part of my study, although I checked them to detect any abnormalities.
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Table 3 Hormone and intermediary metabolites measured at the beginning and end of the fast 
or at the time of hypoglycaemia 
Hormone/Metabolite Volume of blood (mls) sample collection 
Glucose 0.2 fluoride 
Lactate 0.2 fluoride 
NEFA 0.5 lithium heparin 
3-βhydroxybutyrate 0.5 lithium heparin 
Insulin 0.5 clotted 
GH 0.5 clotted 
Cortisol 0.5 clotted 
Plasma amino acids 0.5 lithium heparin 
Ammonia 0.5 Special ‘NH3-free’ heparin 
Catecholamines 1 lithium heparin 
Glycerol 0.5 lithium heparin 
 
 
The blood sample for GH, cortisol, NEFA, 3-βhydroxybutyrate, and amino acids, were 
centrifuged, separated and stored at -200C until further analysis.  The samples for 
glucose, lactate, and insulin, ammonia were centrifuged, plasma/serum separated and 
analysed immediately. The sample for catecholamines was centrifuged, plasma 
separated and stored at -200C and transferred to the biochemistry laboratory at Royal 
Brompton Hospital for analysis. The sample for glycerol was precipitated with perchloric 
acid in the laboratory or by bedside, centrifuged, plasma separated, frozen to -200C and 
analysed within 2 weeks. 
 
 
 
7.3.3 Measurement of hormones and intermediary metabolites 
 
All hormones (except plasma catecholamines) and metabolites were measured in the 
Camelia Botnar biochemistry laboratory of Great Ormond Street Hospital and plasma 
catecholamines were measured at the biochemistry laboratory at Royal Brompton 
hospital. I learned the principles of measurement by spending time at the lab and 
observing the laboratory staff performing the procedures. 
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Measurement of serum insulin 
Serum insulin was measured by immunometric assay using the automated Immulite 
 
2500 analyser. The Immulite 2500 analyser performes automated chemiluminescent 
immunoassays. The assay utilises a solid-phase bead coated with monoclonal murine 
anti-insulin antibody, a liquid phase alkaline  phosphatase  conjugated  to  polyclonal 
sheep anti-insulin antibody and alkaline phosphatase conjugated to monoclonal murine 
anti-insulin antibody and a chemiluminescent substrate. 
 
 
The patient sample and the enzyme conjugate are incubated with the coated bead for 
60 minutes. The insulin in the sample forms an antibody sandwich complex, and the 
unbound patient sample and the enzyme conjugate are removed by centrifugal washes. 
The chemiluminescent  substrate  is  then  added  and  the  light  emission  detected  is 
proportional to the bound enzyme and antigen in the patient sample. 
 
 
The reportable range is 2- 300 mU/l with an analytical sensitivity of 2mU/l. This test for 
insulin has no cross-reactivity for c-peptide or glucagon and 8% cross reactivity for pro- 
insulin. The within run coefficient of variation was 3.7 -5.5%. 
 
 
 
Measurement of serum GH 
 
Serum GH was measured by a two-site chemiluminescent immunometric assay using 
the automated Immulite 2500 analyser. The patient sample is incubated with the solid 
phase (bead) coated with murine monoclonal anti-hGH antibody and reagent alkaline 
phosphatase conjugated to a rabbit anti-hGH polyclonal antibody. The GH in sample 
forms an antibody-sandwich complex. Unbound patient sample and enzyme conjugate 
are removed by a centrifugal wash.  The chemiluminescent substrate is then added and 
the light emission detected is proportional to the bound enzyme antigen in the patient 
sample. 
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Measurement of serum cortisol 
 
Serum cortisol was measured by a solid phase competitive chemiluminescent 
immunoassay, using the automated Immulite 2500 analyser. The assay utilises a 
solid-phase bead coated with polyclonal rabbit anti-cortisol antibody, a liquid phase 
alkaline phosphatase conjugated to cortisol and a chemiluminescent substrate. 
 
 
The patient sample and enzyme conjugate are incubated with the coated bead. The 
unlabelled cortisol in sample competes with the labelled cortisol for antibody binding 
sites. The chemiluminescent substrate is then added and the light emission detected is 
proportional  to  the  bound  enzyme  and  inversely  proportional  to  cortisol  in the  
patient sample. 
 
The measuring range is 28-1380 nmol/L with a detection limit of 5.5 nmol/l. The within 
run coefficient of variation was 5.1 – 7.4 %. The antibody is highly specific for cortisol, 
however there is a 62% cross reactivity with prednisolone. 
 
 
 
Measurement of 3-βhydroxybutyrate 
 
Plasma 3-βhydroxybutyrate was measured on the automated iLab 650 analyser. The 
method involves oxidation of 3-βhydroxybutyrate to acetoacetate by the enzyme 3- 
βhydroxybutyrate dehydrogenase. Alongside this oxidation reaction, cofactor NAD+ is 
reduced to NADH. There is a corresponding change in absorbance that is correlated 
directly to βhydroxybutyrate. 
 
 
3 β-hydroxybutyrate + NAD+                                                                               Acetoacetate+ H+ +NADH+ 
 
(3-βhydroxybutyrate dehydrogenase) 
The measuring range is: 0.05 – 3.2mmol/L 
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Measurement of Non Esterified Fatty Acids (NEFA) 
 
Plasma NEFA was measured on the automated iLab 650 analyser. In this enzymatic 
assay  NEFA  reacts  with  acyl  CoA  synthase  (ACS)  in  the  presence of  adenosine 
triphosphate (ATP), to form acyl CoA, adenosine monophosphate (AMP) and 
pyrophosphate  (PPi).  Acl  CoA  is  then  oxidised  by  acyl  CoA  oxidase  (ACOD)  to 
hydrogen peroxide (H2O2).   The hydrogen peroxide, in the presence of peroxidase 
(POD), yields a blue purple pigment by quantitative oxidation condensation with 3- 
methyl-N-ethyl-N (b-hydroxyethyl)-Aniline (MEHA) and 4-amino-antipyrine. The 
concentration of NEFA in the sample is calculated from the optical density measured at 
546 nm. 
 
 
 
 
NEFA + ATP +CoA                         (ACS)                               Acyl-CoA + AMP + PPi 
 
 
 
Acyl-CoA + O2                   (ACOD)                                  2, 3-trans-Enoyl-CoA + H2O2 
 
 
H202 + 4-amino-antipyrine + MEHA                            Blue purple pigment + H20 
 
 
The measuring range is: 0.01 – 4.0mmol/L 
 
 
 
 
Measurement of plasma lactate 
 
Plasma lactate was measured on the Kodak Vitrous 5600 analyser. 10 microlitres of the 
patient sample is deposited on multi-layered Vitros slide and evenly distributed.  Lactate 
in the sample is oxidised by lactate oxidase in the reagent layer, to pyruvate and 
hydrogen peroxide. The hydrogen peroxide generated oxidises the 4-aminoantipyrine, 
1, 7-dihydroxynapthalene dye system in a horseradish-peroxidase-catalysed reaction 
and results in a dye complex. The slide is incubated and the intensity of the dye 
complex is measured spectrophotometrically at 540 nm. 
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L – (+) – lactic acid + O2                                                     Pyruvate + H2O2 
 
lactate oxidase 
 
 
 
2 H2O2 + 4 aminoantipyrine + 1,7 dihydroxynapthalene                                 red dye 
peroxidase 
 
 
The reference range is between 0.7 – 2 mmol/L. The measuring range is 0.5 – 12.00 
mmol/L. 
 
 
 
Measurement of plasma ammonia 
 
Plasma ammonia was measured on the Kodak Vitrous 5600 analyser. 10 microlitres of 
patient sample is spread evenly on the Vitros slide. The Vitros slide contains the 
reactive ingredient bromophenol blue.  The reaction of ammonia with a specific 
indicator, bromophenol blue, produces a coloured (blue) dye. The absorbance of the 
dye produced is measured by reflectance spectrophotometry at 600 nm. 
 
 
Ammonia + bromophenol blue (ammonia indicator)                                       blue dye 
 
 
 
The measuring range is between 1.0 – 500 μmol/L. The sensitivity of the ammonia 
assay is 1.0 μmol/L. 
 
 
 
Measurement of plasma amino acids 
 
Plasma amino acids were measured by high performance liquid chromatography 
(HPLC). The analysis comprises of four different components. The first step is the 
removal of proteins by precipitation with 5-sulphosalicylic acid (5SSA) containing a 
specified quantity of internal standard, norleucine (NL) and 4-nitrophenylalanine (4NPA). 
The sample is then centrifuged, and a fraction of the supernatant containing amino 
acids is treated with phenylisothiocyanate (PITC), in the presence of methanol and 
triethylamine, resulting in a PITC derivative. 
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In the 3rd step, the PITC amino acid derivatives are separated by reversed phase 
partition liquid chromatography on a heated silica column, commencing with an acetate 
buffer pH 6.5 mobile phase, followed by an increasing gradient of organic solvent 
(acetonitrile, methanol). The eluting PITC amino acid derivatives are detected by their 
UV absorbance at a wavelength of 254nm. 
 
 
Electronically integrated detector peak areas are quantitated by using standard amino 
acid factors calculated from amino acid calibration standards. Before the amino acid 
concentrations are calculated, each chromatogram is inspected visually on the visual 
display monitor and the baseline manually adjusted where necessary. 
 
 
The detection limit ranges from1 µmol/l to 1500 µmol/l. The within batch coefficient of 
variation for the various amino acids range from 0.8-7.2%. 
 
 
 
Measurement of plasma glycerol 
 
Plasma  glycerol  is  measured  by  an  enzymatic  method  on  the  Roche  Cobas  Bio 
 
Analyser.The enzymatic reactions involved in the assay are as follows: 
 
 
 
Glycerol + ATP                                  glycerol-3-phosphate + ADP 
Glycerokinase 
 
Glycerol-3-phosphate + NAD                                 dihydroacetone phosphate + NADH + 
H+ 
 
G3PDH 
 
 
 
The associated increase in fluorescence emission of light at 450 nm, during the reaction 
caused by NADH when excited by light at 340 nm, can be directly correlated with the 
glycerol concentration. No reference ranges are available. The measuring range is 
between 0 – 700 μmol/L. The coefficient of variation in between batch samples is 
between 6-8%. This assay requires addition of a fixed amount of blood to perchloric 
acid precipitation tubes prior to analysis. 
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Measurement of plasma catecholamines 
 
Free catecholamines are detected in the plasma using high performance (pressure) 
liquid chromatography (HPLC) with electrochemical detection (HPLC-ECD), using an 
isocratic system. Extraction of catecholamines is achieved using alumina adsorption. 
Patient sample is injected by the autoinjector into the flow of mobile phase and onto the 
column (stationery phase). The sample passes on to the analytical column where 
separation of its components occurs due to a combination of the mobile phase and the 
column characteristics. 
 
 
The column eluate then passes through the detector where an electrochemical reaction 
occurs at the surface of a working electrode. This produces a current that is amplified 
and transmitted to the integrator. (The separated molecules require different electrode 
potential before they can be oxidised or reduced). The integrator monitors the ECD 
output and allows both qualitative and quantitative evaluation of the separation. 
 
 
The reference ranges are based on resting adult fasted samples (Plasma Adrenaline: 
 
0.10 – 0.80 nmol/L, Plasma Noradrenaline: 0.15 – 3.50 nmol/L) 
 
 
 
 
Measurement of plasma glucose 
 
Plasma glucose is measured on the Kodak Vitrous 5600 analyser. 10 microlitre of 
patient  sample  is  spread  evenly  on  a  multi-layered  (the  reagent  layer  containing 
glucose oxidase, peroxidase, dye precursors) Vitros slide. This results in an even 
penetration of solute molecules into the underlying reagent layer. Glucose in the patient 
sample is converted by glucose oxidase (GOD) to gluconate and hydrogen peroxide in 
the presence of oxygen. Hydrogen peroxide produced reacts with 4-aminophenazone 
and phenol in the presence of peroxidase (POD) to yield a coloured complex.   The 
intensity of the complex is measured at 505 nm and is proportional to glucose 
concentration. 
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Glucose +   02   + H2O                                 gluconate +  H202 
 
GOD 
 
 
2H202 + 4-aminophenazone + phenol                                   coloured complex + 4H2O 
POD 
 
The measuring range is 1.11 – 34.69 mmol/L. 
 
 
 
 
7.3.4 Statistical analysis 
 
 
As distribution of hormones and metabolites during fasting tests are skewed, non- 
parametric tests were used. All statistical analysis was performed on IBM SPSS version 
20. 
 
 
 
Samples at the beginning of the fast are denoted by suffix t = 0 or t0 and at the end of the 
fast by suffix t = e or te 
 
 
 
Within group analysis: Wilcoxon signed-rank test was used to detect significant 
differences between serum concentrations  at beginning (t0) and end of fast (te), within 
each group. Median, 10th and 90th percentile concentrations at the beginning and end 
of the fast were generated. 
 
 
Between group analysis: Mann Whitney-U was used to detect significant differences 
between 2 groups. 
 
 
Non parametric correlations (Spearman) were used to investigate the relationship 
between KB response and counterregulatory hormones. 
 
 
To estimate if rate of change of KB varied between 2 groups, the relationship between 
change in KB concentrations and fast duration was assessed using linear regression 
and subgroup (KH or control group) was entered into the regression model as a dummy 
variable to compare the difference in the slope of regression coefficient. 
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7.4 Results  
 
 
 
Patient characteristics 
 
 
Biochemical data were available for 30 children with ketotic hypoglycaemia and 74 
children from the control group. There was no significant difference in the baseline 
characteristics between the two groups (Table 4). 
 
 
The duration of fast was predetermined according to age, but shortened if 
hypoglycaemia occurred (Table 5). 
 
 
 
 Table 4 Comparison of the baseline characteristics between the control and the KH group 
Characteristics 
 
Ketotic 
hypoglycaemia 
Control group 
 
p value 
 
Number 30 74 
 
Gender (Male/Female) 18M/ 12F 43M/ 31F 0.859 
 
Birthweight in grams (mean 
(SD)) 
 
3054.4  (836.2) 
 
3136.03 (1016.9) 
 
0.604 
 
Gestational age in weeks 
(median, range) 
 
3.1 (0.36 -7.17) 
 
1.2 (0.08 – 16.00) 0.375 
 
Age at fast in years (median, 
range) 
 
 
-0.36 (-2.29 to 3.75) 
 
-0.17 (-2.10 to 2.32) 
 
0.133 
 
Height SDS (median, range) 
 
-0.59 (-2.42 to 2.00) -0.37 (-1.96 to 1.50) 0.799 
 
Weight SDS (median, range) 
 
-0.36 (-2.38 to 1.54) -0.36 (-2.40 to 3.24) 0.277 
 
 
             SD= Standard deviation, F= female, M= male, SDS= Standard deviation scores 
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Table 5 Duration of fast and distribution of patients 
Fast duration 
in hours 
Ketotic 
hypoglycaemia 
Control 
group 
4 2 0 
6 2 3 
8 3 17 
10 0 1 
11 1 0 
12 7 17 
14 1 2 
15 1 0 
16 3 11 
17 0 1 
18 8 16 
20 2 5 
24 0 1 
Total 30 74 
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         Figure 9 Distribution of the age at fast in the control and the KH group 
 
In the KH group 5 children were < 12 months of age, 24 children between 1-7 years of 
age and only 1 child > 7years of age. In the control group 32 children were <1 year of 
age, 28 children between 1-7 years of age and 14 children > 7 years of age. This is in 
accordance with the diagnosis of KH that presents after 6 months of life and resolves by 
7-10 years of life (Figure 9). 
 
Plasma glucose, lactate and serum insulin, cortisol and growth hormone 
concentrations during the fast  
There was a significant decrease (Table 6) in plasma glucose and serum insulin 
concentrations at the end of the fast, in both KH and the control group, and significant 
decrease in plasma lactate concentrations in control group. Serum cortisol and GH 
concentrations showed significant rise at end of the fast in both the groups. 
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Table 6 Concentrations of plasma glucose, lactate and serum GH, cortisol and insulin at 
the beginning (t=0) and at the end of the fast (t=e). Median values are presented, with 
10th and 90th percentile values in parenthesis.  
Hormones and 
 
metabolites 
      KH  
     group 
     t=0               
KH group 
 
t=e 
p 
 
value 
Control 
 
group t=0 
Control 
 
group t=e 
p 
 
value 
Plasma glucose 
 
mmol/l 
4.7 
 
(3.6-6.7) 
2.6 
 
(2.1-3.0) 
<0.001 5.0 
 
(4.2-6.1) 
3.9 
 
(3.3-4.5) 
<0.001 
Plasma lactate 
 
mmol/l 
1.2 
 
(0.8-1.9) 
1.1 
 
(0.8 -5.2) 
0.913 1.4 
 
(1-2.2) 
1.0 
 
(0.7-2.0) 
<0.001 
Serum insulin 
 
mU/L 
9.5 
 
(2-20.5) 
2.0 
 
(2.0) 
<0.001 14 
 
(2-42) 
2 
 
(2-4.5) 
<0.001 
Serum cortisol 
 
nmol/l 
113.5 
 
(41-403) 
484 
 
(207.6- 
 
892.7) 
<0.001 85 
 
(38-315) 
281 
 
(136-586) 
<0.001 
Serum growth 
 
hormone mcg/L 
1.0 (0.1- 
 
3.0) 
2.9 
 
    (0.28 –  
      11.4) 
0.013 0.5 
 
(0.1-3.6) 
1.9 
 
(0.2-5.2) 
<0.001 
 
 
 
 
Plasma amino acid concentrations during the fast 
 
Apart   from   leucine,   there   was   a   significant   decrease   in   plasma   amino   acid 
concentrations (glycine, valine, alanine, glutamine and lysine) in both KH and control 
group (Table 7) 
Plasma alanine concentrations at the beginning (p = 0.009) and end (p = 0.001) of fast 
are significantly lower in the KH group relative to control group. 
 Table 7 Plasma amino acid concentrations during the fast. Median values are presented, with 10th and 90th percentile 
values in parenthesis. 
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Plasma 
amino acids 
in µmol/l 
KH 
 t=0 
KH  
t= e 
p 
value 
Control 
 t=0 
Control  
t=e 
p  
value 
Glycine 
215 (170-
334) 
158 (102.8-
268.2) <0.001 
216.5 (157.8 -
347.3) 
197 (149.5 - 
264.5) <0.001 
Leucine 
129 (89-
205) 117 (89.4-166.4) 0.258 
127.5 (100-
185.5) 101 (76-121) <0.001 
Isoleucine 78 (35-121) 62 (42.8 - 86.6) 0.007 78 (52.3 - 108) 54 (39.5 - 63) <0.001 
Valine 
225 (142 - 
328) 203 (150.2 - 276) 0.013 
236.5 (175.8 - 
361.9) 
176.5 (143.5 -
229.5) <0.001 
Alanine 
331 (242-
438) 
157 (130.2 -
236.4) <0.001 
402 (282.1 - 
566.8) 223 (140 - 298) <0.001 
Glutamine 
577(439 - 
780) 
419 (334.4 - 
632.8) <0.001 
585.5 (469.1 - 
738.7) 514 (406 -663.5) <0.001 
Lysine 
171 (115 - 
277) 104 (69.6 -133.4) <0.001 
188.5 (133-
268.5) 130 (87-184) <0.001 
  
Plasma glycerol concentrations in the KH group. 
 
In children with ketotic hypoglycaemia, paired samples (beginning t=0 and end of fast 
t=e) were available only for 5 patients and end of fast concentration only for 1 patient. 
There was a significant (p=0.043) increase in glycerol concentrations at the end of the 
fast. The median concentration of glycerol at baseline was 60 μmol/L (range 30-94 
μmol/L), and median concentration at end of the fast was 151 μmol/L (range 120-179 
μmol/L). 
 
 
Plasma glycerol concentrations in the control group 
 
In the control group paired glycerol concentrations were available for 15 patients, 2 
patients  had  only  baseline  values  and  4  only  end  of  the  fast  values.  9 patients 
increased their glycerol concentrations during the fast, while 5 patients showed a 
decrease during the fast. No significant differences were found between the glycerol 
concentrations at the beginning (glycerol t = 0) and at the end of the fast (glycerol t = e) 
(p=0.460). 
 
 
The median glycerol concentration at the beginning of the fast was 50μmol/L (range 11- 
 
443  μmol/L)  and  the  median  glycerol  concentration  at  the  end  of  the  fast  was 
 
104 μmol/L (range 51-280 μmol/L). There was no significant difference in glycerol 
concentrations at the beginning (p = 0.762) or the end of the fast (p = 0.080) between 
KH and control group.  
 
        Table 8 Within and between group comparisons of glycerol concentrations during the fast 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patient type Glycerol mol/L 
t=0 (median, range) 
Glycerol mol/L 
t=e (median, range) 
p value 
(within 
groups) 
Ketotic hypoglycaemia 
n 
60 (30-94) 
         5 
151 (120-179) 
        6 
.043 
Controls 
n 
50 (11-443) 
         15 
104 (51-280) 
        15 
.460 
p value (between groups)  0.762  0.080  
 Plasma catecholamine concentrations during the fast (Table 9 and Figure 10) 
 
Catecholamine concentrations were available for 21 children in the KH group and 43 - 
 
47 children in the control group (t=0, n=43 and t=e, n=47). 
 
 
 
Within   group   analysis:   There   was   a   significant   increase   in   noradrenaline 
concentrations during the fast in both the KH (p = 0.009) and the control group (p = 
0.005). A significant increase in plasma adrenaline concentrations was observed only in 
the control group (p = 0.003). The baseline plasma adrenaline concentrations were 
elevated the KH group. 
 
 
Between group analysis: There was a significant increase (p =0.006) in the baseline 
plasma adrenaline concentration in the group with ketotic hypoglycaemia. No significant 
differences between groups were seen in plasma noradrenaline concentrations at the 
beginning and the end of the fast and plasma adrenaline concentrations at the end of 
the fast. 
 
 
Table 9 Catecholamine concentrations during the fast in KH and control group. Median 
values are presented, with 10th and 90th percentile values in parenthesis.  
 
  
KH group Control group 
Between 
group  p 
value 
Noradrenaline nmol/l t = 0 1.56 (0.67 - 2.66) 1.58 (0.93 - 2.55) 0.791 
Noradrenaline nmol/l t = e 2.00 (1.16 - 4.33) 1.80 (1.15 - 4.41) 0.947 
n 21 43 (t=0), 47 (t=e) 
 Within group p value 0.009 0.005 
 
    Adrenaline nmol/l t = 0 0.59 (0.30 - 0.76) 0.40 (0.11 - 0.72) 0.006 
Adrenaline nmol/l t = e 0.56 (0.13 - 3.1) 0.57 (0.22-1.62) 0.775 
n 21 43 (t=0), 47 (t=e) 
 Within group p value 0.185 0.003 
  
  
 
 
Figure 10 Comparison of noradrenaline and adrenaline concentrations during the fast 
between KH and control group. Noradrenaline concentrations show a significant increase 
following the fast in both, KH and control group. Adrenaline concentration rise significantly 
following the fast only in control group. In KH group, baseline concentrations are significantly 
elevated compared to control group. 
 
 
 
  
 
 
 
Free fatty acid (FFA) response during the fast (Table 10) 
 
 
 
Within group: There was a significant rise in FFA concentrations at the end of the fast, 
in both KH and control group. 
 
 
The FFA concentrations at the end of the fast in the KH group, was 0.91 mmol/l (0.70- 
 
1.43) in children <1 year (n=5) and 1.75 mmol/l (1.0-3.0) in children between 1-7 years 
of age (n=24). There was only one patient in the KH group between 7-16 years and 
hence not included in the analysis. 
In the KH group, the end of fast FFA concentrations were significantly (p = 0.015) 
 
greater in children 1-7 years of age compared to children <1 year of age. 
 
 
 
The FFA concentrations at the end of the fast in the control group, was 0.74 mmol/l 
(0.41 - 1.16) in children <1 year (n=32), 1.1 (0.67 - 1.88) mmol/l in children between 1-7 
yrs of age (n=28) and 0.82 mmol/l (0.44 -1.5) between 7-16 yrs of age (n=14). 
In the control group the end of fast FFA concentrations were significantly (p < 0.001) 
greater in 1-7 year old children compared to children <1 year of age and children 
between 7-16 years of age (p < 0.008). 
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Between group: The baseline and end of fast FFA concentrations were compared 
between the KH and the control group in children <1 year and between 1-7 years of age. 
In children between 1-7 yrs of age, the baseline (p = 0.045) and end of fast FFA (p = 
0.001) concentrations in KH children was significantly greater (p = 0.001) than control 
group. 
 
 
 
 
Table 10 Free fatty acid (FFA) response during the fast in KH and control group across 
the 3 age categories 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 na = not analysed 
 
 
 
 
 
 
 
 
FFA 
mmol/l 
KH t=0 KH t= e p 
value 
Control 
t=0 
Control t=e p 
value 
<1 yr 0.57  
(0.52 - 0.67) 
0.91 
(0.70-1.43) 
0.043 0.36  
(0.16 - 
1.45) 
0.74 
(0.41 -1.16) 
0.033 
n 5 5  32 32  
1-7 yr 0.48  
(0.19 - 0.98) 
1.75  
(1.0-3.0) 
<0.001 0.34  
(0.13 - 
0.69) 
1.1  
(0.67 - 1.88) 
<0.001 
n 24 24  28 28  
7-16 yrs 0.34 1.59 na 0.28  
(0.16 -
0.53) 
0.82  
(0.44 -1.5) 
0.001 
n 1 1  14 14  
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Ketone body changes during the fast and relationship to age (Table 11 and 
Figure 11) 
 
 
Ketone body response was considered in 3 age categories. 
 
The  age  categories  chosen  were  based  on  previous  studies  that  based  these 
classifications on time to hypoglycaemia (time to event analysis) (Van Veen et al., 
2011) or on observations indicating later onset of lipid mobilisation in children > 7 years 
of age (Bonnefont et al., 1990) and more specifically the clustering reflects the duration of 
fast tolerance expected in clinical practice based on our fasting protocol (Children <1 
year of age were fasted <12 hrs, while children between 1-7 years of age were fasted 
between 12-16 hrs and children between 7-16 years of age were fasted between 18-20 
hrs). 
 
Within group: There was a significant rise in KB concentrations at the end of the 
fast, in both KH and the control group. 
 
The KB concentrations at the end of the fast in the KH group, was 0.66 mmol/l (0.17 -
0.96) in children <1 year (n=5), 1.86 mmol/l (0.37 - 2.97) in children between 1-7 years of 
age (n=24). There was only one patient in KH group between 7-16 years and was not 
included in the analysis. In the KH group, the end of fast KB concentrations were 
significantly (p = 0.011) greater in children 1-7 years of age compared to children <1 year 
of age. 
 
The KB concentrations at the end of the fast in the control group, was 0.29 mmol/l (0.05 - 
0.97) in children <1 year (n=32), 0.79 mmol/l (0.19 -2.1) in children between 1-7 years of 
age (n=28) and 0.20 mmol/l (0.05 -0.8) between 7-16 years of age. 
 
In the control group the end of fast KB concentrations were significantly (p < 0.001) 
greater in 1-7 year olds compared to children <1 year old and children between 7-16 
years of age (p < 0.001). 
 
Between group: The baseline and end of fast KB concentrations were compared 
between KH and the control group in children <1 year and between 1-7 years. The 
end of fast KB concentrations in the KH children was significantly greater (p = 0.001) 
than the control group. 
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Figure 11 3-βhydroxybutyrate concentrations in KH and control group. Children between 1-7 
years of age showed a greater KB response compared children < 1year and >7 years of age, in 
KH and control group. 
 
 
Table 11 Ketone body (βohb) changes during the fast in KH and control group across the 3 
categories 
 
KH t=0 KH t= e p value Control t=0 Control t=e p value 
βohb  
mmol/l 
<1 yr 
0.15 
(0.05 - 0.55) 
0.66  
(0.17 - 0.96) 0.043 
0.05  
(0.05 - 0.27) 
0.29 
(0.05 - 0.97) <0.001 
n 5 5 
 
32 32 
 βohb  
mmol/l 
1-7 yr 
0.06 
(0.05 - 0.40) 
1.86  
(0.37 - 2.97) <0.001 
0.05 
(0.05 -0.14) 
0.79 
(0.19 - 2.1) <0.001 
n 24 24 
 
28 28 
 βohb  
mmol/l 
7-16 yrs 0.05 1.16 na 
0.05  
(0.05 -0.08) 
0.20  
(0.05 - 0.8) 0.002 
n 1 1 
 
14 14 
  
Βohb = 3-βhydroxybutyrate, na = not available  
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Comparison of the rate of change of KB concentrations between KH and 
control group 
 
The percentage of change in 3-βhydroxybutyrate concentrations at the end of the fast was 
computed using the following formula = (βohb te- βohb t0/ βohb t0) *100, where t=0 denotes 
beginning of fast and t =e denotes end of fast concentrations. 
 
Slope of the regression line, examining the effect of fast duration (predictor variable) on 
percentage change in 3-βhydroxybutyrate concentrations during fast (dependent variable) 
was compared between the KH and the control group (entered into the model as a dummy 
variable), yielded the regression equation Y = -392.1+ 172.6 (fast duration) -87 d1, where d1 
denotes control group as dummy variable (Figure 12Figure 12). Thus, for each hour of fast, 
the KH group showed an 87% increase in 3- βhydroxybutyrate concentrations in comparison 
to the control group. This difference in the rate of change was statistically significant (p 
<0.001). 
 
              
Figure 12 Comparison of the rate of change of KB concentrations between KH and the control 
group. The percentage increase of KB concentrations at the end of the fast was plotted 
against duration of the fast.  KH children (red line) demonstrated a greater (87%) rise per hour 
of fast compared to the control group (green). 
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Relationship between KB response and counterregulatory hormones 
 
a. Comparison between KH and control group 
 
 
 
A significant positive correlation was seen between cortisol and 3-βhydroxybutyrate 
concentrations at the end of the fast, in the KH (r = 0.441, p = 0.015) and control groups 
(r = 0.297, p = 0.015) (Figure 13). Cortisol concentrations at the end of the fast in KH 
group was significantly greater than the control group (median 484 nmol/l vs 281 nmol/l, 
p value <0.001) 
 
 
 
 
 
 
Figure 13 Relationship between cortisol and 3-βhydroxybutyrate concentrations in KH 
and control group. Positive correlation was seen (p = 0.015) in both groups. 
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In the control group there was a significant positive correlation (r = 0.435, p = 0.002) 
between 3-βhydroxybutyrate and plasma adrenaline concentrations at the end of the 
fast (Figure 14). KH group did not demonstrate any significant correlation (r = 0.271, p = 
0.235) between 3-βhydroxybutyrate and plasma adrenaline concentrations at the end of 
the fast (Figure 15).  
 
 
 
Figure 14 Relationship between 3-βhydroxybutyrate and adrenaline concentrations at 
the end of the fast in the control group 
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Figure 15 Relationship between 3-βhydroxybutyrate and adrenaline concentrations at 
the end of the fast in the KH group 
 
 
 
Table 12 Comparison of cortisol concentrations at the beginning (t=0) and end of the fast 
(t=e) between KH and control group 
 
Serum 
 
Cortisol 
KH group 
 
median (range) 
Control group 
 
median (range) 
p value 
 
 
t=0 nmol/l 
 
 
113.5 (36 -546) 
 
 
85 (28 - 538) 
 
 
0.236 
 
 
t=e nmol/l 
 
 
484 (198 -1018) 
 
 
281 (51 -884) 
 
 
<0.001 
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b. KH and control group as a continuum. 
 
 
In this section, the data from the KH and the control group was combined and 
analysed. As children with KH are considered to be at one end of the spectrum of 
normal children with limited fast tolerance and classification into the KH group or the 
control group was performed post data collection, based on glucose concentrations at 
the end of the fasting test, it was rationalised that a clear understanding of the factors 
influencing KB concentrations at the end of the fast would be obtained if the data from 
the two groups was considered as a continuum.  
 
Multiple regression analysis was performed with KB concentrations at the end of the 
fast as the dependent variable and age at fast, fast duration, BMI SDS and cortisol, 
glucose, adrenaline and growth hormone concentrations at the end of the fast as the 
independent or predictor variables. A significant model emerged (F 3, 56 = 16.74, p < 
0.0001.  Adjusted R square = .445). To correct for multiple testing, bonferroni correction 
was performed. This was performed using the formula, adjusted p value = α/n (where α 
is the commonly accepted significance level 0.05 and n is the number of predictors in 
the model). Thus a p value of <0.007 (0.05/7) was considered significant.  
Cortisol and glucose concentrations at the end of the fast emerged as the significant 
predictors of KB concentrations in this model. 
 
Table 13 Results of multiple regression analysis examining the relationship of 7 predictor 
variables on KB concentrations at the end of the fast 
Predictor variables Beta p value 
Cortisol 0.355 0.002 
Glucose -0.392 <0.001 
Adrenaline 0.205 0.042 
Growth hormone 0.048 0.629 
Age at fast 0.013 0.897 
Fast duration 0.076 0.463 
BMI SDS -0.193 0.063 
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7.5 Discussion 
 
 
Children with KH are believed to exist at one end of the normal gaussian distribution of 
healthy children with limited fast tolerance. The greater KB response in children with 
KH compared to the controls has been attributed to an earlier onset of lipolysis and 
ketogenesis during fasting, rather than a specific variation in KB response (Stanley et 
al., 2006). 
 
Studies comparing children with KH and controls have reported KB concentrations after 
similar prolonged durations (15-24 hours) of fasting regardless of age (Bodamer et al., 
2006, Haymond et al., 1982). 
 
In this study KH children were compared with the control children at equivalent stages 
of fasting determined by their age. The results revealed that children with KH have an 
increased rate of KB response (an 87%/hour increase) in comparison to the control 
group. This is a novel finding and indicates that the greater magnitude of KB response 
in KH children is secondary to a quantitative difference in the rate of KB response, 
rather than merely an earlier onset of ketogenesis. 
 
 
The mechanisms underlying the variation in the rate of response could be related to the 
cortisol concentrations during the fast. Cortisol concentrations were found to be a 
significant predictor of KB response at the end of the fast in both KH and control group. 
However KH children have significantly greater cortisol concentrations at the end of the 
fast compared to control population, suggesting that the increase in the rate of KB 
response in KH children is likely to be mediated by changes in cortisol concentrations. 
 
Glucose concentrations were lower in the KH group and were also shown to be a 
significant predictor of KB response at the end of the fast. However this is a well known 
response and our data is in accordance with the literature (Saudubray et al., 1981).
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KB body concentrations were positively correlated to NEFA concentrations at the end of 
the fast in both KH and control children; however NEFA concentrations were not 
positively correlated to cortisol concentrations in KH children. This may indicate that 
accelerated lipolysis as well as increased ketogenesis contributes to the variation in KB 
response in the KH group. 
 
 
Another consideration is that a combination of increased ketogenesis and reduced KB 
utilisation may lead to the increased KB concentration in the KH group. Once ketone 
bodies are formed they are transported to extrahepatic tissues such as the brain, 
kidney, heart and skeletal muscle where uptake is facilitated via monocarboxylate 
transporters (MCT1, 2 and 4) (Halestrap et al., 2004) for utilisation while 10-20% are 
excreted by the kidneys (Owen et al., 1969). 
 
In physiological ketotic states such as fasting, ketogenesis is proportional to ketone 
body utlisation and excretion (Balasse et al., 1989). This homeostasis is accomplished 
by the ability of KB to inhibit their own production through a negative feedback 
mechanism that is  mediated  by  the  antilipolytic  and  insulinotropic  actions  of  ketone  
bodies.  In pathological states KB production in excess to utilisation is invariably 
associated with ketoacidosis (such as diabetes mellitus and metabolic conditions 
secondary to ketolytic enzyme deficiencies). Ketoacidosis is not a feature of KH. Thus it 
may be safe to speculate that ketogenesis may play a greater part in the KB response 
to fast in KH although reduced capacity to utilise KB cannot be completely excluded. 
 
 
Regulation of the KB response in children 
 
 
 
In adult humans only adrenaline has been shown to effect lipolysis, mediated via β- 
adrenoreceptors (Bjorntorp et al., 1971). In-vitro tracer studies in children and adults, 
investigating the  effects  of  various  hormones  on  human  adipocyte  cells,  has  
shown  thyroid stimulating hormone an important mediator of lipolysis in the 
neonatal period. A gradual increase in the contribution of adrenaline to lipolysis was 
seen with increasing age in older children and adults (Marcus et al., 1988, Keller et al.,  
1989). 
 
 
 
91  
Adrenaline is believed to stimulate hormone-sensitive lipase mediated lipolysis, thereby 
increasing substrate (FFA) availability for ketogenesis. In this study cortisol 
concentration were found to be a significant predictor of KB response at the end of the 
fast when KH and control group were analysed as a continuum. When the two groups 
were compared, no significant relationship was seen between NEFA and cortisol 
concentrations at end of the fast in control or KH group and adrenaline was shown 
to be positively correlated to KB and NEFA concentrations at end of fast, only in the 
control group.  
 
 
This seems to suggest that in children undergoing a fast, adrenaline and cortisol 
concentrations play a role in regulating ketogenesis. While the role of adrenaline may 
be mediated by lipolysis, the role of cortisol may well be a direct effect on hepatic 
ketogenesis.  This is a novel finding as cortisol in vivo is not believed to play a 
significant role in lipolysis and ketogenesis as cortisol induced glucose increase is 
associated with an increase in insulin and subsequent inhibition of lipolysis.  Thus 
during fasting in children, with the background of suppressed insulin concentrations, 
cortisol may be an important regulator of ketogenesis. 
 
 
Plasma catecholamine concentrations during the fast and mechanism of ketotic 
hypoglycaemia 
 
 
Fasting was associated with a significant increase in noradrenaline concentrations in 
the control group and KH group and a significant increase in adrenaline concentrations 
in the control group. In children, fasting and hypoglycaemia are known to be associated 
with an increase in adrenaline concentrations (Jackson et al., 2004; Candito et al., 
1993).  
 
In children with KH, the baseline adrenaline concentrations were elevated compared to 
the control group and a further significant increase during the fast was not observed.  
The cause for the elevated adrenaline concentrations at baseline in the KH group is not 
clear as the demographic variables and the baseline concentrations of the various 
intermediary metabolites and counterregulatory hormones was not significantly different 
between groups. Increased physical or psychological stress can result in elevated 
adrenaline concentrations. Although these children were sampled at rest, contribution of 
psychological stress may be greater in children anticipating hypoglycaemia during the 
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fasting test. Stress or anxiety scores or dietary levels of sodium or caffeine that are 
known to augment plasma catecholamine concentrations were not recorded in this 
study. 
 
 
As adrenaline is an important mediator of lipolysis, increased adrenaline concentrations 
would be expected to result in increased lipolysis and increased NEFA and KB 
concentrations. Although KH group were characterised by brisk lipolysis and 
ketogenesis, adrenaline concentrations did not show a significant relationship with 
NEFA or KB concentrations at the end of the fast. It is likely that the rapid onset 
hypoglycaemia with resultant insulin suppression plays a greater role in promoting 
lipolysis with an additional contribution of cortisol to ketogenesis. 
 
A positive correlation between cortisol concentrations and KB concentrations at the end 
of  the  fast  in  the  KH  group  noted  in  this  study  may  lend  some  support  to  this 
hypothesis. No such relationship was observed between GH and KB concentrations. In 
addition glucagon is known to stimulate ketogenesis however this was not measured in 
this study. 
 
The observation of elevated adrenaline concentrations at baseline in the KH group, 
differ from the literature reports. Sizonenko et al (Sizonenko et al., 1973), infused 2-
deoxy-D-glucose (2-DG) to simulate hypoglycaemia and trigger counterreulatory 
response in 5 children with KH. In contrast to controls, infusion of 2-DG failed to elicit 
an increase in glucose concentrations. As hyperglycaemic response to 2-DG is 
especially dependent on intact adrenaline counterregulatory mechanism they 
concluded that children with KH have  defective adrenaline production. 
 
 
Koffler et al (Koffler et al., 1971) also reported defective urinary excretion of adrenaline 
in 5 children with KH following insulin induced hypoglycaemia or provocative ketogenic 
diet. However these 2 studies did not assess response to spontaneous hypoglycaemia 
or changes in plasma catecholamine concentrations.
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Huidekoper et al (Huidekoper et al., 2008) studied the rate of endogenous glucose 
production, glycogenolysis and gluconeogenesis following an overnight fast and at the 
end of fasting tolerance test in 12 children diagnosed with KH, of who 5 became 
hypoglycaemic   at   the   end   of   fast.   Compared   to   normoglycaemic   children, 
hypoglycaemic children had lower glucose production rates and lower rates of 
glycogenolysis without a compensatory increase in gluconeogenesis. As alanine 
concentrations were significantly lower at end of fast in the hypoglycaemic group, they 
concluded that reduced gluconeogenesis was secondary to reduced gluconeogenic 
precursors. 
 
 
Pagliara et al (Pagliara et al., 1972) have also reported reduced alanine concentrations 
in KH children that decrease further during fasting and alanine infusion during 
hypoglycaemia in these subjects restored normoglycaemia and caused resolution of 
symptoms. Significantly reduced plasma alanine concentration at the beginning and 
at the end of the fast in the KH group was also a feature of the fasting study in this 
thesis. 
 
 
Plasma glycerol changes during the fast 
 
 
 
During fasting, glycerol and fatty acids are released by lipolysis. Glycerol is then taken 
up by the liver and kidney and converted to glycerol 3-phosphate by glycerol kinase. 
Following further conversion to dihydroxyacetonephosphate and glyceraldehyde 3- 
phosphate, it can enter gluconeogenesis. 
 
 
In this study, there was a consistent increase in the serum glycerol concentrations in all 
the KH children during the fast. The increased response in KH group cannot be 
explained by lipolysis alone as, there was no evident correlation between glycerol and 
free fatty acid and ketone bodies. Thus the elevated glycerol concentrations could 
reflect a combination of increased lipolysis with decreased utilisation (gluconeogenesis) 
or additional contribution from other sources such as glycolysis (Jensen et al., 2001).
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There was difficulty in obtaining appropriate samples for glycerol measurement. The 
pre-analytical sample requires perchloric acid precipitation with a fixed amount of blood, 
to remove proteins in the patient sample. Addition of inappropriate quantities of blood 
can result in an imbalance of perchlorate and hydrogen ions, and can interfere with the 
analytical process, leading to falsely elevated glycerol concentrations. 
 
 
Due to the impact of the pre-analytical conditions on the estimated glycerol 
concentrations and the small sample size, the increased concentration in the KH group 
has to be interpreted with caution. Replication of this observation in a larger sample in a 
standardised manner would be required to confirm this finding. 
 
 
Limitations of the fasting study 
 
One of the  limitations of this study are the control group, that are not a true healthy 
normal population as they represent children who were referred with suspected 
hypoglycaemia or had previous history of hypoglycaemia that has resolved. However 
ethical  considerations  limit  the  recruitment  of  a  completely  healthy  population.  
 
The fasting tests were terminated on the basis of bedside glucose monitoring. However 
there was no discordance with the laboratory blood glucose concentrations. Another 
aspect was the unequal fasting times between different age groups. While the duration of 
fasting may have affected the concentrations of the various intermediary metabolites and 
counterregulatory hormones, the results were of clinical relevance due to its association 
with physiological fasting times and spontaneous hypoglycaemia. 
 
Previous studies have suggested that ketone body concentrations during fasting 
increases with decreasing age (Saudubray et al., 1981, Van Veen et al., 2011). In these 
studies children were fasted for similar time periods (15-24 hours) regardless of age 
and only one study looked at children less than 1 year of age (Van Veen et al., 2011). In 
our study children between 1-7 years of age had a greater response than children 
between 7-16 years of age. However children <1 year of age had an intermediate 
response. 
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This is consistent with the report by bonnefont et al (Bonnefont et al., 1990) who studied 
normal children in similar age categories however following a longer duration of fast (24 
hours). 
 
In contrast to previous studies, children younger than 1 year of age in this study did not 
demonstrate a greater KB response in comparison to older children. This could be 
attributed to the shorter duration of fast in this group. The length of the fasts in this 
study was predetermined by our diagnostic protocol (Morris et al., 1996) that was aimed 
at diagnosing hypoglycaemia and ascertaining fasting tolerance while minimising 
harmful complications. In clinical practice children <1 year of age will rarely be subjected 
to fasting tolerance tests longer than 12 hours. 
 
 
Assessment of glucagon concentrations were not performed in this study that may 
have provided additional information regarding the biochemical changes in KH children. 
 
 
7.6  Conclusion 
 
 
This study has generated novel information regarding the biochemical changes during 
 
KH and the relationship of counterregulatory hormones to KB response. 
 
 
 
Results of this study suggest that children with ketotic hypoglycaemia have a greater 
magnitude and rate of fasting ketone body response in comparison to control group. In 
both KH and control group, children between 1-7years of age, generated the greatest 
KB response in comparison to children <1 year and >7years of age, although the 
duration of fast was unequal between groups. Cortisol concentrations are a significant 
predictor of KB concentrations at the end of the fast. This suggests that cortisol 
regulates KB response during fast in children with a possible direct role of cortisol on 
hepatic ketogenesis. 
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Neuroimaging and cognitive profiles in children with 
hypoglycaemia 
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Patient characterisation 
A brief outline of the participants in the neurocognitive and imaging studies is presented 
below. 
Inclusion criteria: HH and KH children (as defined as per criteria given in 3.2.1 and 
3.2.2). Children between 5 – 16 years of age were recruited and the scans were 
performed without sedation or anaesthesia 
 
Exclusion criteria: Children with other additional metabolic and endocrine causes of 
hypoglycaemia, children with associated abnormalities that can increase risk of brain 
injury, such as diabetes, parental history of learning difficulties, and family history of 
epilepsy, hypoxia, cardiac problems, and syndromic forms of hyperinsulinism were 
excluded.   
Patient recruitment: All children with HH (n=24) were recruited from the endocrine 
clinics. Thirteen children had previously participated in a pilot study investigating 
neurocognitive function in GOSH. Results showed verbal IQ to be average (mean 91.70 
(range 73-114, SD 10.51)), perceptual reasoning was average (mean 93.88 (range 69-
131, SD 15.61)), working memory was low average (mean 88.70 (range 68-110, SD 
12.18), processing speed was low average (mean 86.95 (range 68-106, SD 11.19), 
general memory score was low average (mean 81.62 (range 66-103, SD 12.28)) and 
attention measures low average to average. As general memory scores were lower than 
the IQ scores, the possibility of injury to hippocampus was contemplated, that led to the 
investigaion of hippocampal volumes in the neuroimaging investigations.   
All children with KH were identified from metabolic and endocrine outpatient lists and 
invited to participate if >5 years of age. 
 
24 children with HH and 15 children with KH were recruited. 
 
3 children with HH were excluded from study (2 children had additional diagnosis of 
diabetes, 1 child’s parents refused consent as they did not agree with the results of the 
neurocognitive tests) 1 child with KH was excluded from study as there was a family 
history (maternal) of  learning difficulties that would complicate the interpretation of 
neuroimaging and neurocognitive data. 
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Therefore data from 21 children with HH and 14 children with KH were available 
for analysis 
 
The clinical details of the 21 children with HH are depicted in Table 16 and Table 
17. The clinical details of the 14 children with KH are shown in Table 18. 
 
Additional clinical characterisation of the HH group 
 
Nine children in HH group presented within 48 hrs of life, 7 presented beyond the 
neonatal period (0.16 -0.59 years) and 4 presented between 1-4 years of life. In 6 
children parents report a delay in diagnosis (0.15 -2.4 years). 
 
While most of the HH patients (n=15) were managed medically, 6 required surgical 
intervention (near total or subtotal pancreatectomy). Based on PET scan or 
histology reports post-surgery, 5 children were found to have focal lesions, 3 
diffuse and 1 atypical multifocal. Hyperinsulinism resolved in 8 patients (4 on 
medical treatment, 4 following surgery). 
 
 
Eleven children have a genetic diagnosis underlying their hyperinsulinism – 5 have 
mutations in ABCC8, 2 in KCNJ11, 2 in HADH and 2 in GLUD1). 5 children 
developed epilepsy (1 with HADH mutation and 2 with GLUD1 mutation). 1 child 
had infantile spasms treated with vigabatrine and lamotrigine; seizures have now 
evolved into focal epilepsy with secondary generalisation that is well controlled 
on levetiracetam. 
 
1 child with HADH mutation has absence seizures and generalised tonic clonic 
seizures treated with levetiracetam, 1 child with GLUD1 mutation has absence 
seizures responsive to lamotrigine and levetiracetam. Another child with GLUD1 
mutation also has generalised epilepsy treated with valproate. 1 child developed 
generalised seizures (treated with sodium valproate) after resolution of 
hyperinsulinism, following an episode of meningitis.
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Neurological examination and school support in HH and KH: Neurological 
findings were normal in all in the KH group and all but one (patient 4, Table 16 
had broad based gait that has improved over time) in the HH group. At the time of 
assessment all the children (HH and KH) were in mainstream schools although 3 
children in HH group (patient 2, 5 and 8 in Table 16) and 2 children in KH group 
(patient 2 and 7 in Table 18) require support with learning. However, as a result of 
the assessment findings, some children then became eligible for additional funding 
as evidence for subtle difficulties emerged. 
100  
 
8 Conventional Neuroimaging 
 
 
8.1 Introduction 
 
 
This chapter outlines the gross structural changes in the brain of HH and KH children, 
using conventional neuroradiological assessments (qualitative). Suceeding chapters will 
discuss the application of objective quantitative MR methods to analyse the 
hippocampus and the white matter. The quantitative approaches enable detection of 
subtle abnormalities that are not seen on conventional magnetic resonance imaging. 
The quantitative approaches also offer the possibility of correlating structural 
abnormality with neurocognitive functioning. 
 
 
 
8.2 Principles of MRI 
 
 
MRI signals of human tissues are predominantly from water and fat, which have 
abundant hydrogen atoms. The positively charged protons in hydrogen nuclei spin 
about their axis producing a small magnetic field. MRI is based on the interaction 
between an applied magnetic field and the magnetic spin properties of the hydrogen 
atoms in body tissues. 
 
 
In the absence of a magnetic field the spinning protons are randomly oriented. But in 
the presence of an external magnetic field (B0), the hydrogen protons predominantly 
align along the direction of the field, so that the net magnetisation vector is along the 
direction of the magnetic field. 
 
 
The protons in a magnetic field precess (oscillate) at a frequency that is proportional to 
the magnitude of the field. When a radiofrequency pulse (RF) is applied at the same 
frequency as the precessing protons, a phenomenon known as resonance occurs, 
whereby the magnetisation of the protons tilts towards the plane perpendicular to B0. A 
900 RF pulse flips the net magnetisation vector into the plane perpendicular to B0. 
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Once the RF pulse is switched off, the protons continue to precess for a while at their 
resonance frequency, producing a detectable MR signal, and they return to their original 
energy state along the direction of the magnetic field. 
 
 
The  return  of  magnetisation  to  its  original  equilibrium  can  be  described  by  two 
relaxation times T1 and T2.  T1 denotes the longitudinal relaxation or recovery along 
the direction of B0, while T2 denotes transverse relaxation or recovery perpendicular to 
B0. 
 
 
The T1 and T2 relaxation times vary between different tissues (T1 CSF> WM > GM, T2 
 
CSF>GM & WM) and also between diseased and normal tissues. Thus in T1-weighted 
images, fluids (CSF) appear dark, GM (water-based tissue) is grey and WM (fat-based) 
tissues are bright. T1-weighted images provide good contrast between different tissues 
and are known as ‘anatomy scans’. 
 
 
In  T2-weighted  images fluids  appear  bright,  while  WM  and  GM  appear  grey.  T2- 
weighted images are better for detecting pathology as abnormal collections of fluid 
(edema) appear brighter against normal tissue. 
 
 
The  predominant  pattern  of  brain  injury  in  hypoglycaemia  (of  varying  underlying 
etiology) is bilateral cortical and subcortical injury to occipito parietal lobes (Alkalay et 
al., 2005). More recently greater involvement of white matter has been described (Burns 
et al., 2008). Most MR studies report findings following neonatal hypoglycaemia. MR 
studies in childhood in HH are lacking and till date, there are no literature reports of MR 
studies in KH children. 
 
 
A more detailed discussion of MR findings in children with hypoglycaemia is given in 
chapter 5.1 
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8.3 Specific Aims : 
 
 
To evaluate the presence and pattern of brain injury in HH and KH. 
 
 
To ascertain if specific changes of hippocampus and white matter are discernible 
in children with HH or KH. 
 
It is envisaged that children with HH will have an increased frequency of brain 
injury in comparison to KH group. Increased likelihood of white matter injury is also 
expected. 
 
 
8.4 Methods: 
 
8.4.1 Participants: 
 
 
Scans from 21 children with HH and 14 children with KH were available for analysis. 
 
Patient characteristics are presented in Table 16, Table 17, Table 18 
 
 
8.4.2 Data acquisition 
 
 
All the children were scanned unsedated on a 1.5 T Siemans Avanto scanner. The scan 
time was a total of 35 mins. The imaging sequences obtained are described in Table 
14. Analysis of DTI and 3D FLASH data are described in chapter 10. 
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Table 14 Neuroimaging protocol 
Sequence TE (ms) TR (ms) Other 
T2 Axial 101 4920 25 slices, 4 mm thick 
T1 Coronal 13 561 25 slices, 4.5 mm thick 
T2 FLAIR Coronal 115 9060 26 slices, 4.5 mm thick 
T1 Sagittal 13 561 25 slices, 4 mm thick 
DWI 96 2700 19 slices, 5 mm thick 
3D FLASH 4.94 11 176 slices, 1 mm thick 
DTI 60 81 7300 Voxel size 2.5× 2.5× 2.5 mm 
FLASH= fast low angle shot, DWI = diffusion weighted imaging, FLAIR = fluid attenuated  
         inversion recovery, DTI = diffusion tensor imaging. 
        
8.4.3 Data analysis 
 
 
The T1- weighted (coronal and sagittal) and T2-weighted (coronal and axial) images 
were assessed by an experienced paediatric neuroradiologist, blind to disease 
diagnosis. All the anatomic features were examined for abnormalities in morphology 
and the presence of abnormal signal intensity. Special attention was paid to the 
hippocampus and white matter (WM). Any WM lesions were further classified as focal or 
diffuse. High signal intensity changes on T2-weighted images were described as focal 
lesions. Unilateral or global reduction of white matter with ventricular dilation was 
described as diffuse lesions. 
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Statistical analysis: Normality of data was determined using the Shapiro-Wilk test. If 
the distribution was normal, independent sample t tests were used for continuous 
variables and the Mann-Whitney U was used if the distribution was skewed. For 
categorical variables Chi-Square (χ2) tests were performed. 
 
 
 
8.5 Results 
 
 
Abnormal scans were observed in both HH and KH groups. 8/21 (38%) children in the 
HH group and 5/14 (35.7%) children in the KH group had abnormal scans. Accordingly, 
the incidence of abnormal scans between HH and KH patients was not significantly 
different (χ2= 3.71 df=2 p=0.156). Gross structural changes of the hippocampus and the 
white matter were noted in both groups (Table 15) 
 
 
Abnormalities of the hippocampus 
 
The hippocampus was affected more frequently in children with HH (28.5%) compared 
to KH (7%), however, this did not reach significance (χ2= 2.41, df= 1, p value= 0.121). 
Bilaterally reduced hippocampus (n=4) was more common than unilateral reduction 
(n=2) in HH, while only 1 patient in KH group had hippocampal involvement (bilateral). 
 
 
Abnormalities of white matter 
 
Focal WM lesions were reported in 3/21 (14%) with HH and 2/14 (14%) children with 
KH. The lesions were visible in the periventricular, peritrigonal and frontal regions in the 
HH group and peritrigonal and parietal regions in KH group.  
 
Diffuse WM lesions were seen in 7/21 (33%) in HH and 4/14 (28.5%) of the KH group. 
Mild global reduction of WM and unilateral (right) WM reduction were seen in both 
groups. Moderate and severe global WM reduction was seen only in HH group. 
 
 
Of the children with MRI abnormalities, the majority in HH group had involvement of 
hippocampus and white matter, while the majority in KH group had involvement of WM 
only.  
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Table 15 Gross MR changes in children with HH and KH 
 
 
 
 
 
 
 
 
 
 
 
 
Relationship between abnormal scans and clinical features 
 
The presence of an abnormal scan in children with HH, was not related to age at 
diagnosis (t= 0.33; p= 0.74), age at scan (t=1.64; p=0.11), birth weight (t=1.22, p=0.27), 
gestational age ( p= 0.238), presence of mutation (p=0.86), treatment type (p=0.60), 
histology (p=0.51), disease course (p=0.60), seizures at diagnosis (p=0.24), ongoing 
epilepsy (p=0.28) or delay in diagnosis (p=0.056) (Table 16,Table 17) 
In children with KH, the presence of an abnormal scan was not related to age at 
imaging, age at diagnosis, birth weight or gestational age (Table 18) 
 
 
Other abnormal findings 
 
1 child in HH group had mild cerebellar tonsillar descent, while 1 child in KH group had 
evidence of mild cerebellar atrophy. These were reported as incidental findings by the 
neuroradiologist. 
 
Abnormality on scan HH (n=21) KH (n=14) 
B/L small hippocampus 4 1 
Small Right hippocampus 1 0 
Small Left hippocampus 1 0 
 
 
FOCAL WM LESIONS 
  
Bilateral periventricular WM lesions 1 0 
Bilateral peritrigonal WM lesions 1 1 
Bilateral parietal WM lesions 0 1 
Right focal frontal WM lesion 1 0 
 
 
DIFFUSE WM LESIONS 
  
Mild global reduction in WM 4 2 
Moderate global reduction in WM 1 0 
Severe global reduction in WM 1 0 
Reduced WM right hemisphere 1 2 
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8.6 Discussion 
 
 
Incidence of abnormal scans in HH and KH 
 
In this study, abnormal MRI scans were noted in 38% of children in HH group and 
 
35.7% of the children in the KH group. There was no significant difference between 
groups in the incidence of abnormal scans, type or distribution of lesions. 
 
The incidence of abnormal scans in children with HH or KH is not well known. This 
study suggests that more than a quarter of children with HH or KH are likely to have 
radiological evidence of brain injury.This study did not contain children with gross motor 
abnormalities or visual impairment in the HH group. It is likely that inclusion of such 
children would be associated with a higher frequency of radiological abnormalities. 
 
It is important to note that a likely selection bias (parents with concerns about 
neurocognition in HH and KH group were more likely to participate) might have 
contributed to the high frquency of abnormal MRI scans in both groups. Observer bias is 
another likely contributor, and focus on hippocampus and WM could have increased the 
likelihood of detecting abnormalities in these regions. Ideally interobserver and 
intraobserver variability needs to be estimated, to determine the reliability of these 
results. However due to time restraints and clinical commitments, it was difficult to 
estimate the strength of the interobserver and intraobserver variability. Qualitative 
radiological reporting in this chapter will be followed by quantitative examination of the 
hippocampus and WM. If abnormalities of hippocampus and WM are detected in the 
quantitative methods, this will lend credence to the conclusions of the qualitative 
reporting. 
 
Contrary to traditional perception, this study found a high incidence of brain injury (BI) in 
children with KH. This seems to suggest that ketotic hypoglycaemia is not necessarily 
neuroprotective. Neverthless, due to the possibility of selection and observer bias, 
larger groups of KH children recruited from District General Hospitals need to be 
investigated, to confirm these findings. 
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It is important to note that KH is a diagnosis of exclusion and although the  KH  
children  in  this  group  have  a  typical  clinical  history,  they  might  represent children 
with subtle as yet undiagnosed metabolic defects that can contribute to these MRI 
findings. 
 
 
Pattern of abnormality on scan 
 
This is the only report of MR findings in a homogenous group of children with HH and 
KH. In this study specific attention was paid to the hippocampus and white matter that 
may have increased the likelihood of detecting abnormalities in these regions.  
 
 
Occipito-parietal cortical and subcortical involvement following neonatal hypoglycaemia 
has been supported by both MRI (Alkalay et al., 2005) and autopsy findings (Anderson 
et al., 1967) following neonatal hypoglycaemia. This typical pattern was not observed in 
our study group. It is likely that these reports, with similar results, reflect the type of 
patient’s selected (prolonged severe hypoglycaemia with seizures and encephalopathy 
in the neonatal period).  
 
 
The predominance of white matter injury noted in this study is consistent with the recent 
report by Burns et al (Burns et al., 2008). They looked at neurodevelopmental sequelae 
in 35 term neonates following symptomatic hypoglycaemia. MRI scans were performed 
within six weeks of life. The severity and duration of hypoglycaemia was not 
associated with specific distinguishing features on the MRI scan. They reported   
WM abnormalities in 94% of children (39% global, 36% periventricular), only 29% 
demonstrated a posterior pattern of brain injury. 
 
The etiology and duration of hypoglycaemia in the children participating in the Burns 
study was diverse (transient, prolonged, metabolic and endocrine). This complicates the 
determination of the contribution of the underlying etiology and its associated 
biochemical milieu on the susceptibility to hypoglycaemic brain injury. Involvement of 
basal ganglia and posterior limb of internal capsule, ischaemic and haemorrhagic 
lesions commonly seen in perinatal hypoxia and not previously described in 
hypoglycaemia have also been reported by Burns  et  al  (Burns  et  al.,  2008). As 43% 
of the children in the Burns study required minor or major resuscitation at birth. it 
questions the possibility of associated comorbid condition such as perinatal hypoxia 
contributing to the brain injury.
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Periventricular white matter (PVM) injury has been reported frequently in children born 
preterm and children with Hypoxic Ischaemic Encephalopathy (HIE). The PVM is a 
watershed zone (boundary of major arteries) and susceptible to pertubations in 
perfusion. Thus it is surprising that PVM injury is seen in 1 HH patient in this study. 
However, neuropathological reports by Anderson et al (Anderson et al.,1967) has 
described periventricular leucomalacia in one of the three infants who died following 
profound untreated neonatal hypoglycaemia. 
 
 
The underlying mechanisms causing PVM damage in premature and mature infant has 
been  attributed  to  ischaemia  alone  or  when  combined  with  inflammation,  which 
damages the premyelinating oligodendrocytes, by excitotoxic or free radical injury 
(Khwaja & Volpe et al., 2008). 
 
 
Co-morbid conditions 
 
 
 
Co- morbid conditions such as seizures and hypoxia can potentiate HBI (Basu et al., 
 
2009; Yager et al., 2002). Seizures at presentation are common in children with HH and 
KH. Three HH children with abnormal scans have ongoing epilepsy, while 2 HH children 
with normal scans have ongoing epilepsy. 1 child with a low birth weight (1800 g) had 
mild global reduction of white matter. Children born SGA are reported to have white 
matter reduction and corpus callosum thinning on conventional MRI (Skranes et al., 
2005), hence WM changes in these children cannot be attributed to hypoglycaemia 
alone. 
 
Clinical details were collected retrospectively in  this  study. Although none of the 
children in this study suffered from postnatal or perinatal hypoxia, sepsis was quite 
common in children admitted for prolonged duration and with central venous access.
109  
 
 
 
Relationship between mutations in HH children and abnormal scans 
 
 
 
HH is a genetically heterogeneous disorder. Apart from the hypoglycaemia and the lack 
of alternate fuels, there is a concern that the underlying genetic causes of 
hyperinsulinism, may contribute to neurodevelopmental impairment. 
 
 
This is certainly true of children with GLUD1 mutations, who are at a high risk of 
epilepsy and developmental delay (Bahi-Buisson et al., 2008) although MRI scans have 
been reported to be normal (Bahi-Buisson et al., 2008). The cause of brain injury has 
been attributed to a combination of recurrent hypoglycaemia, hyperammonemia and 
reduced   concentrations   of   neurotransmitters   glutamine   and   GABA   (gamma- 
aminobutyric acid) due to increased GDH activity in brain. 
\ 
 
In keeping with the literature, both children with GLUD1 mutations in this study have 
epilepsy (generalised). Serum ammonia concentrations in 1 patient was 133 and 150  
(patients 2 and 3 in Table 17) in another. Both these children display bilateral small 
hippocampus and global reduction of white matter. This study suggests that children 
with GLUD1 mutations are more likely to have widespread radiological evidence of brain 
injury. 
 
 
Several regions of the brain express high levels of Kir 6.2 mRNA (Dunn-Meynell et al., 
 
1998) and developmental delay, dyspraxia and epilepsy have been associated with 
 
KCNJ11 and  ABCC8 mutations in neonatal diabetes (Gloyn et al., 2006). 
 
 
In  this  study  2  children  with  KATP   channel  mutations  (1  KCNJ11,  1  ABCC8)  had 
abnormal MRI, while 4 children with KATP  channel mutations (1 KCNJ11, 3 ABCC8) 
have normal MRI. Thus the presence of KATP mutation did not increase the likelihood of 
abnormal scan in this study, although the the small sample size limits the interpretation 
of these findings.
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Relationship between abnormal scans and clinical features/presentation 
 
 
 
In children with HH, there is evidence suggesting poor neurodevelopmental outcome in 
children with neonatal onset (Menni et al., 2001; Steinkrauss et al., 2005) disease, 
persistence of hypoglycaemia beyond 35 days (Jack et al., 2003) and medically 
unresponsive patients requiring surgery (Steinkrauss et al., 2005). 
 
 
This study failed to find any significant  difference  in  the  clinical features  between 
children with abnormal and normal scans, in both HH and KH group , possibly due to 
sample size. 
 
 
Other abnormalities 
 
In this study 2 children were reported to have incidental findings. 1 HH child had mild 
tonsillar descent (no other abnormalities on scan) and 1 child with KH had cerebellar 
atrophy (small bilateral WM lesion in parietal region also noted). Neither of the 2 children 
have any gross neurological symptoms of concern. 
 
 
 
Mild descent of the cerebellar tonsils can be present without neurological symptoms. 
Kim et al (Kim et al., 2002) reviewed findings in 225 healthy children (age 1 month – 18 
years) participating in neuroimaging research and reported incidental findings in 21%. 
Tonsillar descent was seen in 1/225 patients. In this patient, the mild tonsillar descent 
may be an incidental finding, however in the absence of premorbid neuroimaging data, 
it is difficult to ascertain this with certainty. 
 
 
Hypoglycaemia is thought to spare the cerebellum (Auer et al., 1989). A greater 
concentration of vascular transport sites for glucose was thought to attribute to this 
resistance to hypoglycaemia. In addition, animal studies have shown unchanged or 
slightly  reduced  local  cerebral  glucose  utilisation  in  the  cerebellum  compared  to 
cerebral cortex, during severe hypoglycaemia (Abdul-Rahman et al., 1980).
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Burns et al (Burns et al., 2008) reported involvement of cerebellum in their cohort with 
neonatal hypoglycaemia, scanned < 6 weeks postnatal age. The main findings were 
increased signal intensity in one child and haemorrhage in another. The clinical features 
of this child are typical of any with KH and based on evidence mentioned above, it is 
debatable if the cerebellar atrophy in this child could be attributed to hypoglycaemia 
 
 
 
 
 
8.7  Conclusion 
 
 
Conventional MRI has shown abnormalities in both children with KH and HH suggestive 
of HBI. While children with HH are known to be at high risk of brain injury, this is a 
completely new and unexpected finding in children with KH. These findings question 
the perception that the presence of ketone bodies during hypoglycaemia confers 
protection against HBI. 
 
 
Furthermore, this study suggests that HBI is not restricted to the occipito parietal lobes. 
The focal and diffuse WM abnormalities found in this study are consistent with recent 
evidence of varied WM involvement following symptomatic neonatal hypoglycaemia. 
 
 
Succeeding chapters aim to probe further into the hippocampal and white matter 
abnormalities using quantitative MRI. 
  
 
 
 
Table 16 Comparison of clinical features in HH children with normal and abnormal scans 
Patient 
no 
Abnormality on neuroimaging Gender Age at 
scan in 
yrs 
Age at 
diagnosis 
in yrs 
Birthweight 
in grams 
Gestational 
age in 
weeks 
1 B/L small hipocampus. Small periventricular 
WM scars. Severe global reduction in WM 
M 7.9 0.04 4173 41 
2 B/L small hippocampus. B/L peritrigonal WM 
changes. Mild global reduction in WM 
F 7.31 0.37 3636 39 
3 B/L small hippocampus.Moderate global 
reduction in WM 
M 5.63 0.16 3960 40 
4 Bilaterally small hippocampus. Mild global 
reduction in WM 
M 7.46 0.25 4200 41 
5 Left small hippocampus. Small right frontal 
WM scars 
M 12.68 1.6 2860 36 
6 Mild global reduction in WM M 8.71 0.01 3880 36 
7 Mild global reduction in WM M 13.28 1 1800 32 
8 Small right hippocampus, reduced wm r 
hemisphere 
M 8.79 0.04 4290 40 
9 Normal F 9.89 0.59 4160 40 
10 Normal F 7.13 0.01 3990 40 
 11 Normal M 11 0.58 3500 42 
12 Normal M 14.13 0.26 3600 40 
13 Normal F 9.41 1 4500 41 
14 Normal F 8.18 0.36 3450 40 
15 Normal M 11.27 0.01 4602 40 
16 Normal F 7.22 0.01 4160 40 
17 Normal F 13.56 0.44 3100 38 
18 Normal M 10.08 0.01 6100 39 
19 Normal F 11.31 0.01 3000 40 
20 Normal M 14.04 4 3340 40 
21 Normal M 14.47 0.01 5100 41 
       
 HH with abnormal MR Mean 8.9 0.42 3599.8 40 
  SD 2.6 0.57 858.6  
 HH with normal MR Mean 10.8 0.56 4046.3 39.5 
  SD 2.5 1.1 876.2  
 Comparison between HH with normal and 
abnormal MR 
t test 1.64 0.33 1.12  
  p value 0.11 0.74 0.27 0.238 
 
 
 
 
  
 
 
Table 17 Continuation of comparison of clinical features in HH children with normal and abnormal scans 
Patient 
no 
Abnormality on MR 
Imaging 
Mutation Treatment Histology  Disease 
course 
seizures 
at 
diagnosis 
Ongoing 
epilepsy 
Delay in 
diagnosis 
1 B/L small hipocampus. 
Small periventricular 
WM scars. Severe 
global reduction in WM 
no Surg Focal resolved no no yes 
2 B/L small hippocampus. 
B/L peritrigonal WM 
changes. Mild global 
reduction in WM 
GLUD1 Med NK ongoing yes yes yes 
3 B/L small 
hippocampus.Moderate 
global reduction in WM 
GLUD1 Med NK ongoing no yes yes 
4 Bilaterally small 
hippocampus. Mild 
global reduction in WM 
no Med NK ongoing yes no yes 
5 Left small 
hippocampus. Small 
right frontal WM scars 
no Surg NK ongoing yes no no 
 6 Mild global reduction in 
WM 
KCNJ11 Surg Focal resolved no no no 
7 Mild global reduction in 
WM 
no Med NK resolved yes yes yes 
8 Small right 
hippocampus, reduced 
wm right hemisphere 
ABCC8 Med Focal resolved yes no no 
9 Normal no Med NK resolved yes no no 
10 Normal no Med NK ongoing yes yes no 
11 Normal no Med NK ongoing yes no no 
12 Normal ABCC8 Med Focal resolved no no yes 
13 Normal no Surg Diffuse resolved yes no no 
14 Normal HADH Med NK ongoing yes no no 
15 Normal KCNJ11 Surg Focal resolved no no no 
16 Normal ABCC8 Med NK resolved no no no 
17 Normal HADH Med NK ongoing no yes no 
18 Normal ABCC8 Med NK ongoing no no no 
19 Normal no Med NK ongoing no no no 
  
20 Normal no Med NK ongoing no no yes 
21 Normal ABCC8 Surg atypical ongoing no no no 
         
 ChiSquare 0.29 1.01 2.28 0.27 1.14 1.33 4.9 
 df 1 2 3 1 1 1 1 
 p value 0.86 0.6 0.51 0.6 0.28 0.24 0.056 
  
 
Table 18 Comparison of clinical features in KH children with normal and abnormal scans 
Patient 
no 
Abnormality on MR imaging Gender Age at 
scan 
Age at 
diagnosis 
(in yrs) 
Birth 
weight (in 
grams) 
disease 
course 
seizures at 
diagnosis 
1 Reduced WM right hemisphere M 12.08 1.92 3050 resolved no 
2 Mild global reduction in WM F 8.07 1.54 3818 resolved no 
3 Mild global reduction in WM. 
B/L small hippocampus. 
Peritrigonal WM lesions 
F 11.55 2.4 3946 resolved no 
4 Reduced WM right hemisphere M 10.4 1.19 2860 resolved no 
5 B/L parietal WM lesions. 
Cerebellar atrophy 
M 6.09 2.5 4270 resolved yes 
6 Normal M 8.75 1.6 3270 resolved no 
7 Normal F 6.04 1 2680 resolved yes 
8 Normal M 9.02 3 3493 ongoing no 
9 Normal M 5.2 1.36 4080 ongoing yes 
10 Normal M 8.5 1.54 1849 ongoing no 
11 Normal M 10.94 7 2700 ongoing no 
12 Normal M 7.53 2 3266 ongoing no 
13 Normal F 7.45 5 2840 ongoing no 
14 Normal F 11 2.5 4600 resolved no 
        
 KH with abnormal MR Mean 9.6 1.91 3588.8   
  SD 2.5 0.5 605.3   
 KH with normal MR Mean 8.2 2.7 3197.5   
   SD 1.9 1.9 814.2   
 Comparison between KH with 
normal and abnormal MR 
t test -1.13 0.94 -0.93   
   p value 0.28 0.36 0.36   
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Figure 16 Patient 1- T2- weighted MRI in transverse plane. Severe global WM reduction with 
ventricular dilation (arrow) 
 
 
 
 
 
 
Figure 17 Patient 2- T2-weighted MRI axial plane. B/L peritrigonal WM lesions (arrows) 
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Figure 18 Patient 3- T2- weighted MRI in transverse plane. Moderate global WM 
reduction. 
 
 
 
 
 
 
Figure 19 Patient 5 - FLAIR sequence coronal plane. Right frontal WM scar (arrow) 
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9 Neuropsychological profile of children with HH and KH 
 
 
This chapter describes the neuropsychological outcomes in children with HH and KH. A 
battery of age appropriate tests was used to assess cognitive domains such as 
intelligence, memory and attention. Academic attainment and motor skills were also 
assessed. Emotion and behaviour were assessed using standardised questionnaires. 
 
 
 
9.1  Introduction 
 
 
A detailed overview of the neurocognitive outcomes in hypoglycaemia and HH are 
presented in 5.3. A brief summary is presented below. 
 
 
In children with HH a high incidence of neurocognitive impairment has been reported as 
these children experience persistent and recurrent hypoglycaemic episodes. In addition 
the inappropriate secretion of insulin during hypoglycaemia, inhibits lipolysis and 
ketogenesis, depriving the brain of alternate fuels in the form of ketone bodies.Two 
large studies (n=90 and 114) have reported impaired neurodevelopment in 26-44% of 
patients with HH (Menni et al., 2001; Meissner et al., 2003). While developmental 
problems  such  as  cerebral  palsy,  epilepsy,  and  visual  disturbances  have  been 
commonly reported, it is not clear if subtle cognitive and motor deficits exist in the 
absence of overt neurological impairment. 
 
 
In contrast children with KH have alternate fuels (KB) during hypoglycaemia and are 
believed to be neurologically protected. However, reports of neurocognitive outcomes in 
children with ketotic hypoglycaemia are few and show conflicting results. Kogut et al 
(Kogut et al., 1969) reported an IQ <80 in three out of thirteen children with ketotic 
hypoglycaemia, while Colle et al (Colle et al., 1964) reported normal intellectual 
outcomes in 30 children described with ketotic hypoglycaemia. Some authors (Pershad 
et al., 1998) even suggest that an evidence of developmental delay would exclude the 
diagnosis of KH. 
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A more recent study by Daly et al (Daly et al., 2003), reported developmental delay in 
two of the twenty-four children described with KH. However these reports were based 
on retrospective review of case notes that can be susceptible to subjective bias and did 
not include or relate neurological outcome to neuroimaging findings. Thus, based on 
available evidence it is not clear if recurrent episodes of hypoglycaemia in children 
with KH can result in brain injury and subtle neurocognitive deficits. 
. 
 
 
9.2 Specific aims and predictions: 
 
 
To describe the neuropsychological outcomes in HH and KH. 
To ascertain if children with HH have impaired outcome relative to children with KH.  
 
It is expected that children with KH will perform similar to standard population and HH 
children will be impaired in some aspects of cognition such as IQ and  attention (Rother 
et al., 2001).  
 
 
9.3 Methods: 
9.3.1 Participants: 
 
 
Data was collected from 21 children with HH and 14 children with KH. One child (patient 
11, Table 16) in the HH group was included only in the analyses of IQ and academic 
attainment as memory and attention tests were not completed.  Another child (patient 2, 
Table 16) in HH group scored very low in all cognitive domains, and excluded from all 
analysis as an outlier. Finally data from 20 children with HH and 14 with KH were 
analysed.
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9.3.2 Neuropsychological protocols 
 
 
All  the  tests  were  administered  by  a  Clinical  Psychologist  or  by  an  Assistant 
Psychologist under supervision and scored in accordance with the appropriate test 
manual.  An overview of the assessments and questionnaires used  are  presented 
below. I have observed the performance of these assessments and understand the 
methodology and principles underlying them.  
A detailed description of the test components are presented in Table 36. 
 
 
 
1 – Intelligence 
 
Wechsler Intelligence Scale for Children- Fourth UK Edition (WISC-IV UK); (Wechsler 
et al., 2003) 
 
The Wechsler Intelligence Scale for Children – Fourth Edition (WISC-IV) is a 
standardised assessment of general cognitive ability for children between the ages of 6 
to 17 years old. The WISC-IV comprises 10 core subtests and 5 supplemental subtests, 
which measure different aspects of intellectual functioning, such as Verbal 
Comprehension, Perceptual Reasoning, Working Memory and Processing Speed. 
These subtests are marked using scaled scores, which allow a comparison of individual 
children against a large group of children of the same age. Administration time can 
range from 60 to 80 minutes. Only the 10 core subtests were administered. 
 
 
3 – Attention 
 
Tests of everyday attention in children (TEA-ch); (MANLY et al., 1998) 
 
This  test  provides  multidimensional  assessment  of  attention  in  children  aged  6-16 
years. It consists of 9 subtests, of which the initial 4 were administered (recommended 
as an inital screen for attention difficulties).   The subtests provide information on 
selective attention, sustained attention and attentional control/switching and take 
approximately 20 minutes to administer.
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4 – Memory 
 
The  Children’s  Memory  Scale  (CMS); (Cohen et al., 1997) 
 
This assessment is designed to evaluate learning and memory functioning in children 5 
to 16 years old. It specifically assesses three main areas involved in learning and 
memory; visual and verbal memory, immediate and delayed memory, and 
attention/concentration. It contains 6 core subtests and 4 supplemental subtests. Core 
subtests and one supplemental subtest (Word Pairs) were administered (time taken 40- 
45 minutes). 
 
 
 
5 – Academic Attainment 
 
Wechsler Individual Achievement Test – Second UK Edition (WIAT-II UK); (Wechsler 
et al., 2002) 
 
This assessment is a test of language, numerical and reading abilities for children aged 
 
4 to 16 years 11 months. Full administration time takes approximately 45 minutes for 
children aged 4 to 5 years old, and 90 minutes for children 6 to 11 years old. Four of 
nine subtests administered. These include Word Reading, Numerical Operations, 
Mathematical Reasoning and Spelling. 
 
 
6 – Motor 
 
Movement ABC -2 (MABC -2 ); (Henderson S & Sugden D et al., 1992) 
 
This assessment evaluates fine and gross motor skills. It contains 8 tasks that cover 3 
areas, namely manual dexterity, aiming and catching and balance, for children aged 3- 
16 years. Number of correct responses along with qualitative description of act noted. It 
requires 30 minutes to administer.
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7 – Emotional and Behavioural Function 
 
Strengths & Difficulties Questionnaire (SDQ); (Goodman et al., 1997) 
 
This 25-item questionnaire screens for emotional and behavioural problems in children. 
Items are grouped onto 5 sub-scales; prosocial, hyperactivity, emotional, conduct 
problems, and peer problems. This scale has parent, child and teacher versions. 
The information provided is used to predict the possibility of emotional, behavioural and 
concentration problems (for each diagnosis 3 possible predictions given – low risk, 
medium risk, high risk). Validity and reliability has been established and this instrument 
is a widely used clinical tool. Self-report measure is only used for children over 10 years 
old. This is a brief measure which takes 10 minutes to complete. 
 
The Paediatric Quality of Life Inventory (Peds-QL); (Varni et al., 2003) 
 
This 23-item questionnaire examines the health related quality of life of children and 
adolescents. The inventory comprises four core scales; physical functioning, emotional 
functioning, social functioning, school functioning. Psychosocial health summary score 
is then computed as a mean of emotional, social and school functioning scales and 
total scaled scores are derived from all four core scales. 
Scores range from 0-100. Higher scores indicate better quality of life. Parent reports are 
used for children 2 to 18 years old and the child/adolescent report covers 5 to 18 years 
of age. Validity and reliability have been established. It is estimated that the Peds-QL 
takes around 5 minutes to administer. 
 
 
Conners 3; (Conners et al., 2008) 
 
This is a 108-item multi-informant questionnaire with parent; teacher (6-18 years) and 
self- report (8-18 years) versions. It is a well validated tool used for identification of 
Attention- Deficit Hyperactivity Disorder (ADHD) and other related problems such as 
Oppositional Defiant Disorder (ODD) and Conduct Disorder (CD) that can impact on 
learning and behaviour. 
Global index score and separate scores for inattention, hyperactivity/impulsivity, 
learning problems, executive functioning, and aggression and peer relations can be 
calculated. Scores above 60 are considered high average and scores above 65 as 
elevated DSM-IV symptom counts can also be computed for ADHD, ODD and CD to 
see if child has enough symptoms of that disorder to consider a diagnosis. 
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Social Communication Questionnaire (SCQ); (Rutter, Bailey, & Lord et al., 2003) 
 
This 40-item questionnaire (requires yes or no responses) helps assess communication 
skills and social functioning. It is often used as an initial screen for autistic spectrum 
disorders (ASD). It is a parent report questionnaire, for children >4 years and requires 
10 minutes to complete. Scores range from 0-39. Validity and reliability have been 
established. Scores >15 are suggestive of social and communication disorders like 
ASD. 
 
 
9.3.3 Data Acquisition 
 
 
Overall, depending on the chronological age of the child, their developmental level, 
ability to attend and motivation factors, the full assessment battery could take 8-10 
hours. Often the assessment is broken down over a couple of sessions over 2 days to 
ensure the child is able to perform to the best of his or her ability. 
 
 
Thirteen  patients  with  HH  were  assessed  by  an  Assistant  Psychologist  under 
supervision (Jessica Jackson) and more recent data from 8 HH patients were collected 
as part of a clinical protocol for children with HH by the team’s Clinical Psychologist 
(Jemima Bullock). Patients with KH were assessed by 2 Assistant Psychologists under 
supervision (Lisa Walker and Holly Clisby).  The psychologists were not blinded to the  
underlying diagnosis. 
 
 
Data Analysis 
 
 
Statistical analysis: Normality of data was determined using Shapiro-Wilk test. If 
distribution was normal, independent sample t-tests were used for continuous variables, 
and Mann-Whitney U was used as a non-parametric test for ranked data. For 
contingency tables Chi-Square (χ2) tests or Fishers exact tests were performed.
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9.4 Results 
 
 
Baseline characteristics of patients 
 
No significant differences between groups were found in the baseline characteristics of 
age at test, birth weight, gestational age, gender, handedness or number of patients 
with seizures at diagnosis (Table 19). Children with HH presented (or were diagnosed) 
at a significantly younger age relative to KH group (0.16 vs 1.9 yrs). 
 
 
Table 19 Comparison of baseline characteristics between HH and KH groups 
Patient characteristics HH KH p-value 
Number  of patients 20 14  
Age at test in years (mean ± SEM) 9 (0.4) 8.8 (0.5) 0.802 
Age at diagnosis in years (mean) 0.16 1.9 <0.001 
Gender (Male/female) 13M/8F 9M/5F 1.000 
Birth weight in grams (mean ± SEM) 3876.2 (191.2) 3337.2 (199.7) 0.068 
Gestational age in weeks (median) 40 39 0.145 
Handedness (Right/Left) 16R/5L 11R/3L 1.000 
Seizures at diagnosis (patient no) 10 3 0.162 
 
 
 
There was no significant difference between socioeconomic status (p = 0.642, Fisher’s 
 
exact test (FET)) or maternal education (p = 0.609, FET) or paternal education (p = 
 
0.104, FET) between the HH and KH groups. 
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Psychological test scores 
 
Standard scores have a mean of 100 and a Standard deviation of 15. The scores are 
qualitatively interpreted according to Table 20. 
 
 
Table 20 Qualitative Interpretation of neurocognitive scores 
 
 
 
 
 
 
 
 
 
  
Intelligence 
 
 
Comparison of test scores of  patient groups with the standard population means 
The  mean  scores  in  the HH  group  differed  significantly  from  those  of  t he  
standard population mean on all the subtests of the intelligence scale. Performance 
in Verbal Comprehension (VC), Perceptual Reasoning (PR) and Working Memory 
(WM) was in the average range, and in the low average range in Processing Speed 
(PS) and Full Scale IQ (FSIQ) (see Table 21).  
The mean scores of KH group did not differ significantly from the standard population 
means 
 
Scores Classification 
130 and above Very Superior 
120–129 Superior 
110–119 High Average 
90–109 Average 
80–89 Low Average 
70–79 Borderline 
69 and below Extremely Low 
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Table 21 WISC IV: IQ and index scores in HH and KH 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Comparison between KH and HH groups: Perceptual reasoning (p = 0.006) and Full scale 
IQ (p = 0.026) was significantly lower in HH group relative to KH group (Table 22) 
 
 
 
 WISC IV Mean (Range) SEM test p value 
HH Verbal Comprehension 92.5 (75-119) 2.5 -3.0 0.007 
n=19 Perceptual Reasoning 91.9 (69-117) 2.7 -2.9 0.008 
 Working Memory 91.8 (68-116) 2.8 -2.9 0.009 
 Processing Speed 87.2 (59-115) 3.2 -3.8 0.001 
 Full Scale IQ 89.3 (70-112) 2.5 -4.1 0.001 
KH Verbal Comprehension 101.2 (73-130) 3.9 0.3 0.748 
n=14 Perceptual Reasoning 105.8 (88-127) 4 1.4 0.174 
 Working Memory 97.5 (62-126) 4.8 -0.5 0.614 
 Processing Speed 93.7 (68-121) 4.1 -1.5 0.156 
 Full Scale IQ 100.5 (77-127) 4.5 0.1 0.914 
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Figure 20 WISC IV: IQ and index scores in HH and KH. The scores are plotted along the y 
axis. The continuous horizontal reference line at score of 100 denotes the standard population 
mean and the interrupted horizontal reference line at scores 85 and 115 denote 1 standard 
deviation below and above the mean respectively. Full scale IQ and perceptual reasoning are 
significantly lower in the HH group. 
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Table 22 WISC- IV: Comparison between HH and KH 
WISC - IV HH (n=20).  
Mean 
 
(SEM) 
KH  (n=14) 
 
Mean (SEM) 
t test  
 
p  value  
 
Verbal 
 
Comprehension 
92.5(2.4) 101.2 (3.9) -1.9 0.056 
Perceptual 
 
Reasoning 
91.9 (2.7) 105.8 (4.0) -2.9 0.006 
Working Memory 91.8 (2.8) 97.5 (4.8) -1 0.289 
Processing Speed 87.2 (3.2) 93.7 (4.1) -1.2 0.221 
Full Scale IQ 89.3 (2.5) 100.5 (4.5) -2.3 0.028 
 
 
Academic attainment 
 
 
Comparison of test scores of patient groups with the standard population means The  
mean  scores  in  HH  group  differed  significantly  from  those  of  the  standard population 
mean on all the subtests of the academic attainment scale. Performance in word  reading  
was  in  the  average  range  and  numerical  operations,  mathematical reasoning and 
spelling were in the low average range. The mean scores in KH group did not differ 
significantly from the standard population means (Table 23).  
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 Table 23 WIAT II: Academic attainment in HH and KH 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SEM: Standard Error of Mean 
 
 
 
Group WIAT II Mean  SEM t test p value 
HH n=20 Word Reading 89 3.6 -2.3 0.028 
 Numerical Operations 86.8 2.4 -5.1 <0.001 
 Mathematical Reasoning 83.6 4 -3.6 0.004 
 Spelling standard 86 2.6 -4.4 <0.001 
 Mathematics Composite 83 4 -3.7 0.004 
KH n=14 Word Reading 101.7 4.1 0.4 0.674 
 Numerical Operations 99.7 4.8 -0.1 0.954 
 Mathematical Reasoning 100.1 4.3 0.0 0.974 
 Spelling standard 99.2 4.2 -0.1 0.857 
 Mathematics Composite 99.9 4.8 -0.0 0.989 
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Comparison between KH and HH:   Performance of HH group was impaired in all 
aspects of academic attainment in comparison to KH group (Table 24, Figure 21) 
 
 
 
Figure 21 WIAT II: Comparison of academic attainment between HH and KH. The scores are 
plotted along the y axis. The continuous horizontal reference line at score of 100 denotes the 
standard population mean and the interrupted horizontal reference line at scores 85 and 115 
denote 1 standard deviation below and above the mean respectively. HH group was impaired 
in all aspects of academic attainment in comparison to KH group. 
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Table 24 WIAT II: Comparison of academic attainment between HH and KH 
WIAT II HH (n=20). 
 
Mean (SEM) 
KH (n=14) 
 
Mean (SEM) 
t test 
 
HH vs KH 
p value 
 
HHvs KH 
Word Reading 89(3.6) 101.7 (4.1) -2.2 0.03 
Numerical Operations 86.8(2.4) 99.7 (4.8) -2.6 0.014 
Mathematical Reasoning 83.6(4) 100.1 (4.3) -2.7 0.01 
Spelling standard 86(2.6) 99 (4.2) -2.6 0.012 
Mathematics Composite 83 (4) 99(4.8) -2.5 0.016 
 
HH and KH group did not significantly differ in the discrepancy between their actual and 
predicted performance on WIAT based on their intellectual performance on WISC-IV.  
 
 
 
Table 25 Discrepancy between actual and predicted performance on WIAT 
Actual vs Predicted Group 
Word 
reading 
Numerical 
operations Spelling 
Significantly worse 
performance HH n=19 8 6 9 
 
KH n=14 3 4 3 
     Significantly better 
performance HH n=19 2 0 1 
 
KH n=14 5 2 3 
     Chi-square test χ² 3.3 2.7 3.3 
 
p value 0.241 0.215 0.494 
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Attention 
 
Comparison of test scores in patient groups with the standard population means: 
 HH children performed (Table 26) significantly worse in measures of sustained 
attention (score and sky search DT).  Time taken to complete sky search (tests selective 
attention) was significantly longer in HH and KH children. KH children required 
significantly longer time to complete creature counting task (tests attention 
control/switching). 
 
 
 
 
Table 26 TEA-Ch: Attention scores in HH and KH 
Group TEA-ch 
Subtests 
Standard 
scores 
Mean (range) SEM t p value 
HH 
n=19 
Sky Search  Total 
correct  
98.1 (65-130) 3.9 -0.4 0.646 
  Time  92.8 (70-115) 2.8 -2.4 0.025 
  Attention  96.5 (75-110) 2.4 -1.3 0.185 
 Score!   89.4 (60-125) 3.7 -2.8 0.011 
 Creature 
counting 
Total correct  92.1 (65-120) 4.2 -1.8 0.081 
  Time n=14 95.3 (80-120) 2.5 -1.8 0.09 
 Sky search DT  81.8 (55-125) 4.5 -4.0 0.001 
       
KH 
n=14 
Sky Search  Total 
correct  
107.5 (65-130) 4.6 1.6 0.133 
  Time  93.9 (80-115) 2.4 -2.4 0.029 
  Attention  95.7 (80-130) 3.4 -1.2 0.234 
 Score!  95 (80-125) 4.1 -1.2 0.247 
 Creature 
counting 
Total correct  100 (70-135) 4.0 0 1.000 
  Time n=13 91.5 (75-115) 3.1 -2.7 0.019 
 Sky search  DT  91.7 (55-120) 4.5 -1.8 0.095 
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Comparison between KH and HH: Performance of HH children was comparable to 
 
KH children in all measures of attention (Table 27, Figure 22) 
 
 
 
 
 
Figure 22 TEA-ch scores; Comparison between HH and KH. The scores are plotted 
along the y axis. The continuous horizontal reference line at score of 100 denotes the 
standard population mean and the interrupted horizontal reference line at scores 85 and 
115 denote 1 standard deviation below and above the mean respectively. Performance 
of HH group was comparable to the KH group. 
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Table 27 TEA-Ch scores: Comparison between HH and KH 
TEA-Ch 
 
Subtests 
Standard 
 
scores 
HH 
 
n=19 
KH 
 
n=14 
t test 
 
HHvsKH 
p value HH vs 
 
KH 
Sky Search Total correct 98.1 107.5 -1.5 0.136 
 Time per target 92.8 93.9 -0.2 0.797 
 Attention 96.5 95.7  0.2 0.835 
Score! Score! 89.4 95 -0.9 0.330 
Creature 
 
counting 
Total correct 92.1 100 -1.3 0.230 
 Timing n=14 95.3 91.5 -0.9 0.349 
Sky search DT SkySearch DT 81.8 91.7 -1.5 0.140 
 
 
Memory 
 
Comparison of test scores in patient groups with the standard population means: 
The mean scores for general memory and learning were significantly lower (although 
within the average range) than the reference mean in HH group. The mean scores for 
verbal immediate, general memory, learning index and delayed recognition were 
significantly better than the reference mean in KH children (Table 28). 
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Table 28 CMS: Children Memory Scale scores in HH and KH 
Group CMS Index scores Mean (Range) SEM t p value 
HH n=19 Visual Immediate 94.8 (69-122) 3.4 -1.5 0.147 
 Visual Delayed 97.5 (75-118) 2.5 -0.9 0.353 
 Verbal Immediate 94.9 (66-115) 3.0 -1.6 0.117 
 Verbal Delayed 97.2 (69-125) 3.5 -0.7 0.455 
 General Memory 93.1 (68-116) 3.1 -2.1 0.044 
 Attention/Concentration 99.2 (66-122) 4.0 -0.1 0.858 
 Learning index score 91.3 (60-125) 4.1 -2.1 0.049 
 Delayed Recognition 101.7 (60-131) 3.8  0.4 0.646 
KH n=14 Visual Immediate 106.3 (91-128) 3.0 2.0 0.059 
 Visual Delayed 104.5 (88-128) 3.1 1.4 0.172 
 Verbal Immediate 110.5 (72-131) 4.5 2.2 0.039 
 Verbal Delayed 108.7 (75-134) 4.5 1.8 0.081 
 General Memory 110.0 (77-131) 3.9 2.5 0.024 
 Attention/Concentration 99.3 (88-134) 8.2 -0.08 0.939 
 Learning index score 107.0 (85-125) 2.1 3.2 0.006 
 Delayed Recognition 109.1 (78-131) 3.4 2.6 0.021 
131  
 
Comparison  between  KH  and  HH:  Relative  to  KH  group, the HH  group  scored 
significantly lower  in  general  memory,  especially  visual  and  verbal  immediate  and 
verbal  delayed  memory.  Learning index, that reflects the ability  to  learn  based  on 
repetition, was also impaired in HH group (Table 29, Figure 23) 
 
 
 
Table 29 Children Memory scale scores: Comparison between HH and KH 
CMS Index scores HH n=19 KH n=14 T test p value 
Visual Immediate  94.8  106.3  -2.4 0.022 
Visual Delayed  97.5  104.5  -1.7 0.093 
Verbal Immediate  94.9  110.5  -2.9 0.006 
Verbal Delayed  97.2  108.7  -1.9 0.055 
General Memory  93.1  110.0  -3.3 0.002 
Attention/Concentration 99.2  99.3 -1.1 0.256 
Learning index score 91.3  107.0  -3.0 0.005 
Delayed Recognition  101.7 109.1 -1.3 0.182 
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Figure 23 Children Memory Scales: Comparison between HH and KH. Horizontal reference 
line at score of 100 denotes the standard population mean and the interrupted horizontal 
reference line at scores 85 and 115 denote 1 standard deviation below and above the mean 
respectively. HH  group  scored significantly lower  in  general  memory,  especially  visual  
and  verbal  immediate  and verbal  delayed  memory. 
Discrepancy between the actual CMS scores and predicted CMS (based on WISC-IV) scores 
was calculated using the WISC-IV technical report 5. The actual scores were then 
subtracted from predicted scores, to estimate the discrepancy. 
Negative scores indicate better performance than predicted and positive scores indicate 
worse performance than predicted. Discrepancy scores were computed for verbal immediate, 
verbal delayed and general memory. The frequency of these discrepancy scores in the test 
population and any statistical significance was calculated. 
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Results: The mean discrepancy scores for both children with HH and KH was not 
significantly different from the reference population (Table 30). However 4 children from 
the HH group (patients 4,7,10, 15 in Table 16) and 1 child from KH group (patient 2 
inTable 18) performed significantly worse than predicted (discrepancy scores 13 - 35 in 
4 HH patients and 19 in 1 KH child) 
 
 
Table 30 Discrepancy between predicted and actual CMS scores 
Predicted-Actual CMS scores Group Mean SEM 
Verbal Immediate HH 1.2 2.9 
 
KH -9.8 3.4 
    Verbal Delayed HH 1.2 3.3 
 
KH -7.7 3.5 
    General Memory HH 1.2 3.4 
 
KH -10.1 3.3 
 
 
 
Motor Skills 
 
 
Comparison between HH and KH group:  Children with HH scored significantly lower 
than  KH  children  in  the  tasks  of  manual  dexterity  (Table 31, Figure 24).  Manual 
dexterity tasks included placing pegs on a pegboard and drawing a trail. Total scores 
(sum of manual dexterity, aiming and catching and balance scores) were comparable 
between groups. 
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Table 31 Movement ABC-2 scores: Comparison between HH and KH 
Movement ABC Standard 
scores 
Group n Mean Std. Deviation p value 
Manual Dexterity HH 17 81.1 13.7  
 KH 13 95.3 16.1 0.015 
Aiming and Catching HH I 17 93.2 21.8  
 KH 14 87.5 12.5 0.392 
Balance HH 17 90 16.6  
 KH 14 97.8 12.6 0.158 
Total Test HH 17 84.1 18.2  
 KH 14 91.7 9.1 0.163 
 
 
 
 
 
Figure 24 Manual Dexterity scores: comparison between HH and KH. Children with HH 
scored significantly lower (p=0.015) than KH group in tasks of manual dexterity. 
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Emotion and Behaviour 
 
 
Social Communication questionnaire: The mean score in HH group was 5.3 (SD 2.5, 
range 0-9), and KH group was 4.5 (SD 3.5, range 1-12). No significant difference in 
mean scores between groups detected (t =0.7, df = 30, p = 0.484). 2 children in KH 
group had scores of 11 and 12. 
Conners-3: Both the parent and teacher reports indicate high average-elevated scores 
in inattention, learning and executive functioning in HH group relative to KH group 
(Table 32, Table 33). 
 
 
Table 32 Conner-3 Parent report 
DSM = Diagnostic and Statistic Manual, ADHD = Attention Deficit Hyperactivity Disorder
CONNER 3-Parent Tscore HH KH p-value 
Inattention  67.4 56.4 0.009 
Hyperactivity/Impulsivity  60.5 55.4 0.298 
Learning Problems  66.2 46.9 0.001 
Executive Fucntioning  60.7 47.6 0.014 
Aggression  55.9 50.5 0.204 
Peer Relations  56.2 50.0 0.242 
Conners 3 Global Index Total  64.1 56.9 0.149 
DSM-IV-TR ADHD Inattentive  63.8 53.6 0.021 
DSM-IV-TR ADHD 
Hyperactivity/Impulsivity  
60.3 55.5 0.346 
DSM-IV-TR Conduct Disorder  53.1 49.0 0.153 
DSM-IV-TR Oppositional 
Defiant Disorder  
56.4 53.1 0.451 
136  
 
Table 33 CONNERS 3 - Teacher's report 
CONNERS 3 - Teacher T score HH KH p value 
Inattention  62.4 52.2 0.046 
Hyperactivity/Impulsivity 56.5 56.0 0.955 
Learning Problems/Executive Functioning T score 62.9 51.3 0.030 
Aggression  59.7 56.1 0.617 
Peer Relations 59.4 51.0 0.226 
Conners 3 Global Index Total 64.1 55.1 0.193 
DSM-IV-TR ADHD Inattentive 63.1 50.2 0.020 
DSM-IV-TR ADHD Hyperactive-Impulsive 60.0 55.5 0.590 
DSM-IV-TR Conduct Disorder 53.0 48.7 0.227 
DSM-IV-TR Oppositional Defiant Disorder 62.7 56.8 0.413 
DSM = Diagnostic and Statistic Manual, ADHD = Attention Deficit Hyperactivity Disorder 
 
 
Strength and Difficulties Questionnaire: No significant difference between groups was 
identified in emotional, behavioural or hyperactivity problems.  
 
Table 34 Strength and Difficulties Questionnaire Diagnostic Predictions 
SDQ Diagnostic predictions HH KH p-value 
Any diagnosis (medium/high risk) 7M/6H 1M/2H 0.053 
Emotional Disorder (medium/high risk) 3M/3H 1M/1H 0.596 
Behavioural Disorder (medium/high risk) 3M/2H 0M/2H 0.460 
Hyperactivity (medium/high risk) 7M/1H 1M/1H 0.155 
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PedsQL - Impact on health related quality of life: Overall both HH and KH groups 
experience comparable quality of life. Parent rating of school functioning was significantly 
lower in HH group (Table 35) 
 
 
 
Table 35 PedsQL Paediatric Quality of Life: Parent and Child scores 
PEDS-QL Pediatric Quality of Life 
Inventory Scores 
Group Mean Std. 
Deviation 
p value 
Physical Functioning Child  HH 75.4 19.2  
 KH 69.7 21.3 0.424 
Emotional Functioning Child  HH 67.1 21.4  
 KH 60.3 19.6 0.363 
Social Functioning Child  HH 68.1 20.7  
 KH 75.7 24.2 0.343 
School Functioning Child  HH 52.8 25.9  
 KH 58.9 24.6 0.506 
Psychosocial Health Child  HH 62.8 19.6  
 KH 62.0 23.7 0.907 
Total Child  Score HH 66.9 17.5  
 KH 60.8 23.3 0.396 
Physical Functioning Parent  HH 78.3 13.8  
 KH 79.1 22.0 0.903 
Emotional Functioning Parent  HH 61.5 17.0  
 KH 71.9 19.4 0.122 
Social Functioning Parent  HH 76.8 19.3  
 KH 82.6 19.8 0.412 
School Functioning Parent  HH 53.6 17.1  
 KH 69.6 17.4 0.016 
Psychosocial Health Parent  HH 64.8 12.5  
 KH 68.0 21.7 0.604 
Total Parent  Score HH 68.4 12.3  
 KH 70.3 22.0 0.753 
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Relationship between neurocognitive scores and clinical features in HH group 
Neonatal  presentation,  presence  of  mutation  and  type  of  treatment  (medical  or 
surgical), was not related to lower IQ or memory or attention scores. However children 
with  parental  perception  of  delay  in  diagnosis  had  significantly  lower  perceptual 
reasoning scores on WISC-IV (81 vs 95, p = 0.005). Children with epilepsy also had 
lower p erceptual reasoning (76.6 vs 94.8, p = 0.005), IQ (76 vs 96, p = 0.044) and 
verbal immediate memory scores (82 vs 98, p=0.017) 
 
 
The relationship between cognitive profile and quantitative neuroimaging findings are 
described in chapter 10 
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9.5 Discussion 
 
 
Results of this study suggest that widespread cognitive and motor deficits exist in 
children with HH relative to the standard population, and to the KH group. Significant 
differences were noted in all domains assessed (IQ, memory, attention, and fine motor 
skills) and were reflected in the academic acheivement.  The performance of the KH 
children as a group was functionally equivalent to the standard population means, 
although large inter - individual variations exist. 
 
 
HH group 
 
 
 
Intelligence: Children with HH demonstrate an overall low average IQ (mean 89.3), 
relative to the standard population, with no discrepancy among index scores. Relative 
to KH group mean IQ was 10 points lower and perceptual reasoning component of IQ, 
was nearly 15 points lower. 
 
 
This is consistent with the report by Rother et al (Rother et al., 2001) of 8 children with 
HH, although no correlation with neuroimaging was available  in  this  group. They used 
WISC-III and reported low verbal comprehension (53-80) and perceptual organisation 
scores (50-83) in 4 of 8 children with HH that had undergone subtotal pancreatectomy 
within 2 months of diagnosis. Similar to the HH group they report a wide variation in the 
scores, with few children performing > 2SD below the mean. 
 
 
In this study, the diffuse white matter reduction detected by conventional 
neuroradiological assessment (discussed in chapter 8) may explain the overall low 
average IQ in the HH group, as white matter volume is considered to be one of the 
neuroanatomical correlates of intelligence. In healthy adults greater full scale IQ scores 
were positively associated with grey matter and white matter volumes (Narr et al., 
2007). 
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Total white matter volume was found to be the major determinant of IQ in adolescents 
born preterm (Northam et al., 2011). A study of 79 adolescents born preterm (<32 
weeks gestation) in comparison to 30 controls born term, showed WM reduction in the 
preterm group that accounted for 70% variance in the IQ scores. 
 
 
Increased white matter volume may indicate an increase in the number of axons and 
degree of myelination, contributing to increased efficiency of interneuronal 
communication, reflected in the IQ scores. However objective quantitative assessments 
of white matter would be required to confirm this and will be explored in a subsequent 
chapter on diffusion tensor imaging. 
 
 
Attention:  3  aspects  of  attention  were  assessed  in  this  study,  namely  selective 
attention (sky search), sustained attention (score! and sky search DT) and attention 
control/switching (creature counting). 
 
 
HH children show impairment of sustained attention but sparing of selective attention 
and attention control.  Sustained  attention  is  the  ability  to  maintain  a  particular 
processing  function  over  time.  Score!  tests sustained  auditory  attention  while  sky 
search DT tests sustained divided attention (children have to attend to 2 tasks at 
the same time). 
 
 
This is consistent with a report by Rust et al (Rust et al., 2008) on young children with 
HH, suggesting impaired sustained attention and suggests selective damage to 
neuroanatomical networks that subserve different attentional processes. 
 
 
Functional neuroimaging studies in healthy adults, has shown right frontal activation 
using measures similar to Score! (Lewin et al., 1996). Children with ADHD, assessed 
using TEA-Ch have shown impaired sustained attention and attention control with 
sparing of selective attention (Manly et al., 2001) and neuroimaging studies of ADHD 
children, have shown a delay in cortical maturation especially in the prefontal region 
that subserves attention and motor planning (Shaw et al., 2007). Based on the above it 
is reasonable to speculate that injury to the frontal regions of the brain in HH children 
may explain the finding of impaired sustained attention. 
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The presence of focal and diffuse white matter lesions (including frontal regions) on 
conventional radiological assessments in the HH group lends some support to this 
hypothesis. However these lesions were not specific or greater in the frontal regions 
and does not fully explain the pattern of attention impairment. Specific studies 
investigating cortical thickness and the characteristics of specific white matter tracts 
(tractography) in the frontal region that subserve attention (such as the frontostriatal 
network) would be required to confirm this hypothesis. 
 
 
2 other aspects of attention were assessed in this study, namely selective attention (sky 
search), and attention control/switching (creature counting). 
 
The time taken to complete the sky search task (selective attention) was significantly 
prolonged in both HH and KH groups. This reflects the way both groups approach the 
task. According to clinical observation both groups were cautious in performing this 
task, sacrificing speed for accuracy, thus taking a longer time than normal. Alternatively 
this could reflect impairments in processing speed or manual dexterity. 
 
 
KH children took significantly longer time to complete creature counting task correctly. 
Although time taken by HH children does not seem to differ relative to reference, it is 
important to note that nearly 5 children struggled to produce correct responses in the 
creature counting task and they were not included in timing analysis. It’s also important 
to note the normative data for TEA-Ch is derived from australian children and any 
difference in the study group may reflect cultural influences. 
 
 
Memory: Children with HH scored significantly lower in general memory, relative to 
standard population (7 points lower). This discrepancy was greater when compared to 
KH group (HH group 17 points lower). Learning index that reflects ability to improve 
scores with repetition was also impaired in HH group. 
 
 
Although memory scores were impaired in HH, there was no discrepancy as a group 
between memory score predictions based on IQ and the actual memory scores to 
suggest specific memory impairment.
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However 4 HH children showed a discrepancy of 13-35 from their predicted general 
memory scores. While 2 of these children were noted to have normal scans, 1 was 
reported to have bilateral hippocampal and diffuse white matter reduction and another 
was reported to have only white matter reduction on conventional neuroradiological 
assessment. 
 
 
The pattern of memory deficit was also inconsistent between these children. 1 child had 
impaired visual immediate memory (69), 2 children had impaired visual (75, 78) and 
verbal delayed memory (69, 85), and 1 child had impaired visual and verbal immdiate 
score (66). 
 
In children with childhood onset amnesia, bilateral hippocampal pathology is associated 
with  impaired  delayed  memory  (verbal  and  visual)  with  intact  performance  on 
immediate memory measures (Gadian et al., 2000; Vargha-Khadem et al., 1997). 
 
 
Unilateral lesions in the MTL circuit can result in impaired verbal memory in left sided 
lesions and deficits in nonverbal memory in right sided lesions (Milner et al., 1971). In 
16 healthy adults, using event related fMRI, Rosazza et al (Rosazza et al., 2008) were 
able to demonstrate left lateralised activation (of hippocampus and parahippocampus) 
with words and right lateralised activation with faces. Thus based on neuroimaging 
findings some prediction can be made regarding pattern of memory deficit. 
 
 
However the lack of a specific pattern of memory impairment and a combination of 
normal and abnormal scans on conventional neuroradiological assessments make it 
difficult to conclusively establish or exclude memory impairment in this group. 
Further exploration utilising quantitative assessment of hippocampal volumes and 
relationship to memory indices are discussed in chapter 10. 
 
 
Academic attainment: Children with HH underperformed (12 -16 points lower) in all 3 
academic  areas  assessed  (reading,  mathematics  and  spelling),  relative  to  the 
standard population and the KH group. This seems consistent with their overall low 
average IQ. 
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Motor skills: The MABC-2 is a screening tool used to assess motor impairment. It has 
been particularly useful in detecting developmental coordination disorders (Mon- 
Williams et al., 1994), and is increasingly used in children, without any gross 
neurological abnormality to detect subtle movement problems (Webb et al.,   2012). 
 
 
In  this  study,  although  the  total  MABC  scores  were  comparable  between  groups, 
children with HH (relative to KH) performed significantly poorly in skills of manual 
dexterity. Outcome reports in children with HH have documented gross motor (Meissner 
et al., 2003; Menni et al., 2001), and coordination difficulties (Cresto et al., 1998; Mazor- 
Aronovitch et al., 2007; Meissner et al., 2003). Mazor-Aronovitch et al (Mazor-
Aronovitch et  al.,  2007)  reported  motor  coordination  difficulties  as  the  most  
prevalent  motor problem, although improvement was noted by school age. 
 
 
Deficits in white matter microstructural integrity of the corpus callosum, 
corticospinal tract,  anterior  corona  radiata  and  internal  capsule  have  all  been  
associated  with impaired performance on MABC-2.  
 
 
Emotion and behaviour 
 
Several studies have reported emotional and behavioural problems in children with 
hypoglycaemia. 
 
High scores on Achenbach Child Behaviour checklist suggestive of aggression or 
oppositionality was reported by Rother et al (Rother et al., 2001). Bahi-Buisson et al 
(Bahi-Buisson et al., 2008) have reported mild behavioural problems (social withdrawal, 
attention difficulties) in children with HIHA syndrome. 
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In contrast Mazor-Aronovitch et al (Mazor-Aronovitch et al., 2007) compared 21 children 
with medically treated HH with sibling controls and found no increased susceptibility to 
behavioural problems in HH group. However, the outcome was based on telephone or 
personal interview with parents that can underestimate the presence of any emotional 
or behavioural difficulties. In addition, this study consisted of only medically treated 
patients who may represent a milder group with regard to disease severity 
 
 
Elevated scores for inattention were obtained from both parent and teacher reports in 
HH children, using Conners-3. Along with their poor performance in sustained attention 
tests on TEA-Ch, this strongly suggests attention difficulties in children with HH in this 
study. 
 
 
In this study poor communication skills suggestive of autism were not seen in either HH 
or KH group. Overall perceived health related quality of life did not differ between 
groups 
 
 
Relationship between neurocognitive scores and clinical features in HH group 
 
 
 
In children with HH, the evidence suggests, poor neurodevelopmental outcome in 
children with neonatal onset (Menni et al., 2005) disease, persistence of hypoglycaemia 
beyond 35 days (Jack et al., 2003) and medically unresponsive patients requiring 
surgery (Menni et al., 2001; Steinkrauss et al., 2005). 
 
 
In  this  study  impaired  cognitive  outcomes  were  not  related  to  neonatal  onset  or 
medically unresponsive diasease, possibly owing to small numbers. However presence 
of delay in diagnosis and epilepsy were associated with impaired outcomes. This is 
consistent with evidence  suggesting  co- morbid  conditions  such  as  seizures,  and 
hypoxia can potentiate HBI (Basu et al., 2009; Das, 2009; Yager, 2002) 
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The widespread cognitive deficits in HH children in this study cannot be fully explained 
by the current neuroimaging findings. Within the HH group, there are inter-individual 
variations, with some children performing well below the mean scores. This variation 
could be due to the marked clinical heterogeneity of this disorder, duration and severity 
of hypoglycaemia in each individual. However the contribution of additional factors such 
as  presence  of  epilepsy,  seizures  at  diagnosis,  infection, genetic  mechanisms  
(increased likelihood of impairment in children with GLUD1 mutations), age at injury, 
may all have influenced the outcome. 
 
 
KH group 
 
 
 
Overall the performance of the KH children as a group is consistent with the clinical 
observation, that these children are functionally unimpaired. 
 
 
However, 4 children in KH group (age 7.45-11.5 years), scored FSIQ in the borderline 
(77, 79- patient 3 and 14 in Table 18) and low average range (81, 84 - patient 12 and 
13 in Table 18). Discrepancy in the index scores were also noted in these children. 3 
scored lower in processing speed (PS) and working memory (WM) relative to verbal 
comprehension (VC) and perceptual reasoning (PR), while 1 scored lower in VC and 
PS relative to WM and PR.  
 
 
Apart from one child (patient 13, Table 18) that presented at 5 years of age with irritable 
behaviour inbetween meals, the clinical features documented in the other 3 children are 
typical of KH and do not account for the neurological compromise. The 2 children that 
performed in the borderline range had additional MRI features of mild global white 
matter reduction and 1 in addition had bilateral hippocampal volume reduction. 
 
 
White matter reduction was also seen in 2 additional children without IQ impairment 
(patient 1 and 4 in Table 18). However, IQ impairment in the KH group was not 
restricted to children with abnormal scans. Although the neuroradiologist was blinded 
to patient diagnosis, reporting of scans involved specific inspection of white matter and 
may have lead to a bias in the perception white matter compromise. However the 
association of low IQ in some of them tends to indicate neurological impairment in 
those children with KH. 
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Further quantitative investigation of white matter structural integrity and hippocampal 
volumes are required comparing KH group to a healthy paediatric population to 
corroborate these findings. 
 
 
 
9.6 Conclusion 
 
 
A comprehensive assessment of IQ, memory, attention, academic attainment, motor 
skills, and emotion and behaviour was conducted in HH and KH children. Overall 
assessments indicate widespread cognitive and motor deficits, academic 
underachievement and behaviour difficulties in the HH group. 
 
 
Specific differences observed between HH and KH group, include impaired PR and 
FSIQ scores, general memory (consistent with low IQ) and learning index scores in HH 
group. Academic performance in reading, spelling and mathematics was impaired in HH 
group. In  addition,  HH  group showed  impaired  sustained  attention  scores  relative  
to  test standard population. Furthermore, performance of HH group was impaired in 
tasks of manual dexterity relative to KH group. Presence of epilepsy and delay in 
diagnosis was associated with impaired performance in PR score in the HH group. 
 
 
Neuroimaging studies have revealed white matter lesions in children with HH (discussed 
in chapter 8). This may partly explain the widespread neurocognitive deficits noted in 
this group.  Further exploration utilising quantitative assessments of neuroimaging 
studies are discussed in chapter 10. 
 
 
Although children with KH are used in this study as a control group, the unexpected 
finding  of  impaired  cognitive  performance  in  some  children  and  the  presence  of 
abnormal neuroimaging scans may indicate that KH can result in brain injury and 
warrants further research. 
  
 
 
 
 
 
Table 36 Description of psychometric assessments 
Neurocognitive 
Tests 
Index scores Subtests Description of subtests 
WISC IV Verbal 
Comprehension 
Similarities 2 related (as objects or concepts) words are presented and 
child needs to describe similarity, ex: How are cat and mouse 
alike 
  Vocabulary Name pictures  presented in a stimulus book and define 
words read aloud by examiner 
  Comprehension Child questioned on general principles and social situations 
    
 Perceptual 
Reasoning 
Block Design Child needs to recreate a displayed design with red and 
white bricks (time limited) 
  Picture 
Concepts 
2 or 3 rows of pictures displayed and child needs to select 
one from each row with a common theme 
    
 
 
 
 
Working 
Memory 
Digit Span A series of numbers are read aloud by examiner and child 
repeats it in the same order heard or in the reverse order 
when prompted 
  Letter-Number 
Seq 
Intermixed numbers and letters read aloud by examiner and 
childs needs to recall numbers in ascending and letters in 
alphabetical order 
    
  Processing 
Speed 
Coding A key of shapes with symbols inside are provided and child 
needs to copy the symbol into a corresponding shape (time 
limited) 
  Symbol Search A target group of symbols are given and the child need to 
specify if a corresponding search group has any matching 
target group symbols 
    
WIAT II Reading Word Reading Child is asked to read aloud from a list of familiar words. 
Accuracy and speed of response are noted 
    
 Mathematics Numerical 
operations 
Child is asked to recognise and reproduced dictated 
numerals and solve written maths problems involving 
addition, subtraction,multiplication and division 
  Mathematical 
reasoning 
Maths problems are presented verbally and non-verbally to 
evaluate reasoning skills 
    
 Written 
language 
Spelling Child is asked to write dictated letters and words 
    
TEA-ch Sky Search selective 
attention 
An A3 paper with randomly distributed craft pairs provided. 
Task required children to circle identical pairs quickly. An 
attention score was also derived that removed the influence 
of motor speed on this test. 
    
 Score sustained 
attention 
Children were asked to silently count the number of tones 
produced by a media player in a trial and announce them at 
the end of the trial. Number of trials with correct responses 
recorded (total 10 trials) 
     
 Creature 
counting 
attentional 
control/switching 
A map of creatures are displayed and children are expected 
to count and switch to count up or down based on cues. 
Correct responses and timing noted 
    
 Sky Search DT sustained 
attention 
This is a combination of sky search and score. Children were 
expected to circle identical crafts while observing the number 
of tones in each trial 
    
CMS Dot locations  3 array of dots presented, after a distractor array, children 
need to reproduce the original array. Tested again after 30 
min delay 
    
 Stories  Children are read 2 stories and asked to repeat as much as 
they remember immediately and again after 30 mins. The 
child is aslo asked yes or no questions about the story. 
    
 Faces  A list of faces presented in series, following this child asked 
to recall if a series of presented faces are from the initial list. 
Repeated after 30 min delay 
    
 Word pairs  The child is provided with a list of word pairs. 3 trials where 
examiner prompts child with one of the words in a pair. After 
trials child asked to remember as many word pairs as 
possible. After 30 mins child asked to recollect word pairs 
again with prompts.Finally examiner reads word pairs and 
child asked to indentify if they were present in original list 
    
  Numbers  series of numbers presented and child asked to repeat them 
forward and backward 
    
 Sequences  Tests mental capacity for verbal manipulation of data in a 
sequence. For example recollecting months in a year 
backwards or alternating counting numbers with alphabets 
    
MABC-2 Manual dexterity  This is assessed by asking child to place pegs in a pegboard 
using preferred hand and non preferred hand, threading lace 
(or ‘placing coins in a slot’, this task varied depending on the 
age of the child) and drawing a trail 
    
 Aiming and 
catching 
 This includes catching with 2 hands and throwing a beanbag 
onto a mat at a specified distance  
    
 Balance  This includes balancing on best leg and the other leg, 
walking heel to toe and hoping on mats on best leg followed 
by the other leg 
 
 
 
 
 
  
 
 
 
 
 
 
10 Quantitative MRI studies 
 
10.1 Hippocampal Volumetry 
 
10.1.1 Introduction 
 
 
The hippocampus is a component of the medial temporal lobe and plays an important 
role in learning and memory (Eichenbaum et al., 1997). Structurally the hippocampus 
contains the cornu ammonis subfields CA1-4, subiculum and the dentate gyrus. The 
medial temporal lobe-cortical circuit contains the hippocampus, parahippocampal cortex, 
mammillary bodies, medial thalamus and the prefrontal cortex. This complex 
interconnected neural network forms the neuroanatomical basis of declarative (explicit) 
memory. 
 
 
Neuropathological studies of prolonged human neonatal hypoglycaemia have shown 
the hippocampus to be susceptible to hypoglycaemic brain injury (Auer et al., 1989). 
The dentate gyrus is especially vulnerable to damage following prolonged 
hypoglycaemia. Hypoglycaemic coma associated with electrocerebral silence, in adult 
animal studies has been shown to selectively damage cerebral cortices, hippocampus 
and striatum, with dense necrosis in the dentate gyrus of the hippocampus (Auer 
et al., 1984). 
 
 
 
Recurrent severe hypoglycaemia in the setting of diabetes has also been shown to 
affect the hippocampus.  Hershey et al (Hershey et al., 2010) have described 
hippocampal volumes in young individuals (7-17 years) with type 1 diabetes. Children 
with increased episodes of severe hypoglycaemia were found to have significantly 
larger hippocampal volumes. This contrasts with most studies, where hippocampal 
volume reduction is implicated in pathology and associated with impaired memory. The 
authors speculated that the increased hippocampal volumes could be secondary to 
reactive neurogenesis or disruption of normal developmental pruning. 
  
Diffusion-weighted imaging in a diabetic adult following hypoglycaemia coma has 
demonstrated bilateral high intensity signal in the hippocampi and associated 
anterograde amnesia for 2 months (Ko et al., 2008). 
 
 
Decreased hippocampal volumes have been reported in children with temporal lobe 
epilepsy, preterm children with low birth weight and children with hypoxic-ischaemic 
injury (HIE)  (Isaacs  et  al.,  2000;  Gadian  et  al.,  2000).  Reduction of hippocampal 
volumes in these groups of children has been associated with significantly reduced 
performance on memory scales. A specific impairment of episodic memory (memory for 
events of personal significance) with relative preservation of semantic memory (memory 
for general knowledge and facts) has been described in some of these children. This 
condition has been termed developmental amnesia (Gadian et al., 2000). 
 
 
Isaacs et al compared 2 groups of children with reduced hippocampal volumes (preterm 
with low birth weight, children with developmental amnesia secondary to HIE) to 
ascertain the degree of hippocampal atrophy associated with developmental amnesia 
(Isaacs et al., 2003).  They concluded that a 20-30% bilateral reduction of hippocampal 
volume is necessary for manifestation of developmental amnesia. 
 
 
Unpublished data from a group of 17 children with HH from GOSH described general 
memory scores in the low average range (mean 81.62, range 66-103, SD 12.28). As 
the hippocampus is one of the key structures in the memory system and is susceptible 
to hypoglycaemia, we decided to investigate these further using quantitative methods to 
ascertain hippocampal volume.  The relationship between hippocampal volume and 
memory was also examined 
 
 
Quantitative assessment of hippocampal volumes (HV) includes manual and automated 
methods. Manual hippocampal volumetry is considered the gold standard method to 
assess HV (Tae et al., 2008), although it is labour intensive and relies on rater 
experience. The ability to discern and define the boundaries of the hippocampus is a 
crucial determinant of hippocampal volume accuracy. This greatly depends on the 
expertise of the rater and other technical aspects of neuroimaging, such as image 
resolution of scanner, acquisition parameters and slice orientation. 
  
 
 
10.1.2 Specific Aims 
 
 
To  investigate  if  children  with  HH  have  reduced  hippocampal  
volumes  in comparison to children with KH 
 
To investigate the relationship between hippocampal volumes and memory indices 
 
 
 
 
10.1.3 Methods 
 
10.1.3.1 Participants 
21 children with HH and 14 children with KH underwent MRI scans. 1 child in 
HH group (Patient 10 in Table 16) did not complete the 3D FLASH sequence 
required to assess HV, hence data from 20 children in HH group and 14 
children in KH group were included in hippocampal volumetry analysis. 
 
10.1.3.2 Image Acquisition 
Fast  low  angle  shot  (FLASH)  three-dimensional  MRI  scans  were  acquired  on  a 
Siemens 1.5T avanto scanner. The 3D FLASH parameters were: repetition time, TR = 
11 ms; echo time, TE = 4.94 ms; flip angle = 15°; matrix size 224*256; and 176 slices 
with a slice thickness of 1 mm. The scan time was 5.34 minutes. 
 
10.1.3.3 Image processing and analysis 
The hippocampal volumes were measured by Professor David Gadian, blind to patient 
diagnosis. After acquisition, the dataset was transferred to a PC, and analysed using 
MEDx, version 3.3 (Sensor Systems Inc., VA). The data were reformatted in the tilted 
coronal plane perpendicular to the long axis of the hippocampus. Each hippocampal 
slice, 1 mm in thickness, was then manually traced. Manual tracing was guided by 
anatomical references (H.M.Duvernoy., 1991). 
 The volume was then derived from the summed slices. Intracranial volume was 
calculated from the sagittal images. A random slice and every 10th slice after that was 
systematically measured and the volume calculated by summation of the slices. The 
hippocampal volumes then were corrected for intracranial volume and presented in the 
corrected form (Gadian et al., 2000; Van Paesschen et al., 1997). I learnt the principles 
of the HV measurement technique and performed HV measurements on some control 
samples, under the supervision of Prof Gadian to gain a better understanding of the 
methodology involved and its complexity. 
 
 
10.1.3.4  Statistical tests 
The distribution of hippocampal volumes was analysed using the Shapiro-Wilk test. As 
the distribution of the right hippocampal volume was skewed in the HH group, non- 
parametric statistical tests were performed. Differences between groups (unrelated 
samples) were assessed using the Mann-Whitney U test. Within group difference 
between sides (related samples) was assessed using the Wilcoxon signed rank test. 
Partial correlation was used to examine the relationship between hippocampal volumes 
and memory indices controlling for age. Intra-rater intraclass coefficient of variation was 
calculated for right and left hippocampal volumes and intracranial volume. All statistical 
analysis was performed in IBM SPSS version 20. 
 10.1.4 Results 
 
 
 
Baseline characteristics 
 
 
The groups did not exhibit significant differences in baseline characteristics. 
 
 
 
Table 37 Baseline characteristics of HH and KH group in hippocampal volumetry 
analysis 
Patient characteristics HH KH p-value 
Number  of patients (no) 20 14  
Age at scan in yrs (mean ± SEM) 10.3 (2.6) 8.7 (2.1) 0.073 
Gender (Male/female) 13M/7F 9M/5F 0.960 
Gestational age in weeks 39.3 38.7 0.420 
Birth weight in grams (mean ± SEM) 3870.5 (898.7) 3337.2 (747.4) 0.069 
Handedness (Right/Left) 15R/5L 11R/3L 1.000 
Height sds (median) -0.06 (0.8) -0.05 (0.6) 0.703 
Weight  sds (median) 0.09 -0.17 0.287 
Seizures at diagnosis (patient no) 9 3 0.270 
 
 
No significant difference in maternal education (p=0.597, FET) or socioeconomic status 
 
(p=0.677, FET) was seen between groups. 
 
 
 
Comparison of hippocampal volumes between HH and KH (Table 38, Figure 25) 
 
The intrarater intraclass correlation coefficient (ICC) was calculated from volumetry data 
of 20 patients (KH and HH), that were assessed 1 week apart. The ICC was 0.908 for 
right hippocampus, 0.929 for left hippocampus and 0.996 for intracranial volumes. 
  
Between groups: No significant differences in hippocampal volumes were seen in the 
right (p = 0.959) or left (p = 0.877) hippocampus between the KH and HH groups. 
Within groups:  The left   hippocampus was   significantly smaller   than  the  right 
hippocampus in both HH (p = 0.023) and KH (p = 0.002) children. 
 
 
 
 
 
Figure 25 Comparison of hippocampal volumes (HV) between HH and KH. The HV in cu 
mm is plotted along the y axis. There was no significant difference in HV between HH and 
KH group. 
 
 
Table 38 Comparison of hippocampal volumes (HV) between HH and KH 
Hippocampus 
 
Volume 
KH 
 
(n=20) 
HH 
 
(n=14) 
Mann-Whitney U  
(KH  vs HH) p- 
value 
Right (median) mm3 3035.19 3138.36 0.959 
Left (median) mm3 2887.09 2887.22 0.877 
Wilcoxon signed rank test  
(right vs left) p-value 
0.002 0.023  
 Percentage hippocampal volume reduction relative to the mean hippocampal 
volumes of the KH group 
 
 
The mean right (3068.76 mm3) and left hippocampal volumes (2905.55 mm3) were 
calculated for the KH group. For each individual in the KH and HH groups, the 
hippocampal volumes were compared with the mean hippocampal volumes of the KH 
group. The differences were expressed as a percentage hippocampal volume 
reduction (Table 39), negative values indicating a larger hippocampal volume relative to 
the KH group mean, and positive values indicating a smaller hippocampal volume 
relative to the KH group mean. 
 
 
In the KH children, the percentage difference ranged from 10.1% to -15.0% for the right 
hippocampus and 13.0% to -17.4% for the left hippocampus. In the HH children, the 
percentage difference ranged from 34.3% to 21.2% for the right hippocampus and 
33.1% to 27.2% for the left hippocampus. 3 children in the HH group (patient 1, 3 and 
 
4) have > 20-25% reduction in bilateral hippocampal volumes. Of these only patient 4 
showed a significant discrepancy between general memory score achieved and 
predicted by IQ (13 points) and more specifically delayed memory was impaired (verbal 
and visual). 
 
 
Of these 3 children (patient 1: 7.9 yr old male, patient 4: 7.46 yr old male, patient 3: 
 
5.63 yr old male). One patient was diagnosed within 2 weeks of life, while the other 2 
were diagnosed in the 2nd month of life. Parents report a delay in diagnosis in all 3 
patients with symptom manifestations within 48 hrs of life.   All 3 were born at term 
with birth weights ranging between 3960 – 4173 g. Co-morbid conditions such as 
hypoxia and seizures at diagnosis were not present; however patient 3 has a specific 
type of HH known as HIHA and has developed generalised epilepsy. 
 
 
Patient 3 has a mutation in the GLUD1 gene that results in hyperinsulinism associated 
with hyperammonemia (HIHA). The other 2 do not have mutations in any of the genes 
associated with hyperinsulinism.   Patient 1 is cured following surgical resection of a 
focal lesion in tail of pancreas, while the other 2 are managed medically (diazoxide 
responsive). All 3 children are neurologically normal, although patient 4 had broad 
based gait at a younger age that has improved with time. 
 Conventional MRI in these 3 children was also abnormal. All 3 showed varying degrees 
(patient 1 – severe, patient 3 – moderate, patient 4 – mild) of global white matter 
reduction. 
 
  
Table 39 Hippocampal volumes and percentage reduction in comparison to mean 
hippocampal volume of KH group. Highlighted in bold are children with >20% reduction 
in bilateral hippocampal volume. 
Group 
Patient 
no Right HPV Left HPV 
Right % 
difference 
Left % 
difference 
HH 
(n=20) 1 2094.88 1944.88  31.74 33.06 
 
2 3112.64 2902.64 -1.43 0.10 
 
3 2014.86 2042.86  34.34 29.69 
 
4 2028.50 2278.50  33.90 21.58 
 
5 3326.04 3043.04 -8.38 -4.73 
 
6 2783.16 2604.16  9.31 10.37 
 
7 2739.28 2463.28 10.74 15.22 
 
8 2726.16 2558.16 11.16 11.96 
 
9 3193.78 3032.78 -4.07 -4.38 
 
11 3281.36 2614.36 -6.93 10.02 
 
12 3718.39 3530.89 -21.17 -21.52 
 
13 2452.80 2871.80  20.07  1.16 
 
14 3474.29 3017.29 -13.21 -3.85 
 
15 3164.08 2850.08 -3.11  1.91 
 
16 3013.01 3032.51  1.82 -4.37 
 
17 3464.80 3697.30 -12.91 -27.25 
 
18 3265.64 3059.64 -6.42 -5.3 
 
19 3199.94 3017.94 -4.27 -3.87 
 
20 3388.10 3063.10 -10.41 -5.42 
 
21 3109.04 2845.04 -1.31  2.08 
            
KH 
(n=14) 1 2788.84 2609.84  9.12  10.18 
 
2 2788.42 2526.42  9.14  13.05 
 
3 3038.91 2697.41  0.97  7.16 
 
4 3304.23 3255.23 -7.67 -12.03 
 
5 3189.22 2935.22 -3.93 -1.02 
 
6 3530.10 3283.10 -15.03 -12.99 
 
7 3212.00 2969.00 -4.67 -2.18 
  
 
 
 
 
 
 
In the KH group one child (patient 1, 12 yr old male), with bilateral hippocampal volume 
reduction of 9-10% did not display any memory impairment.  However another child 
(patient 2, 8yr old female) with bilateral hippocampal volume reduction of 9-13%, had an 
IQ- memory discrepancy of 19 points. Verbal memory (immediate (72) and delayed (75) 
was more impaired than visual memory (immediate and delayed (both 94)) in this child 
 
 
Patient 1 attends mainstream school without any support, although parents note that 
he is a little bit behind his peers, while Patient 2 attends mainstream school with 
support for learning. Academic attainment was normal in both children. Conventional 
MRI in both these children was also abnormal, patient 1 had white matter reduction 
in the right hemisphere and patient 2 had mild global white matter reduction and. Full 
scale IQ assessed  using WISC-IV  was 105 in patient 1 and 89  in  patient  2  (impaired  
perceptual  reasoning  and working memory). 
 
 
These  2  children  did  not  display any differences  with  regards  to  clinical  features, 
disease onset was in the 2nd year of life in both (22 months in patient 1 and 18 months 
in patient 2) and seizures at onset was not present in either child. 
 
8 3384.14 3412.14 -10.28 -17.44 
 
9 2925.06 2712.06  4.68  6.66 
 
10 2805.77 2858.77  8.57  1.61 
 
11 2989.42 2915.42  2.59 -0.34 
 
12 2844.34 2784.34  7.31  4.17 
 
13 3130.82 2987.82 -2.02 -2.83 
 
14 3031.47 2730.97  1.22  6.01 
  
Concurrence between hippocampal volumetry and conventional MRI 
 
 
 
In all 3 HH patients with >20-25% bilateral hippocampal volume reduction, the 
conventional MRI report concurred. In 2 children with hippocampal volume equivalent 
or greater (HH patient 5 and KH patient 3) than mean KH hippocampal volume, 
conventional MRI reported an asymmetrical decrease in hippocampal volume. In 1 HH 
child with 11% bilateral reduction in hippocampal volume (patient 8), conventional MRI 
reported an asymmetrical change in hippocampus and in 1 HH child (patient 2) with 
asymmetrical reduction in hippocampal volume; conventional MRI reported bilaterally 
small hippocampi. 
 
 
 
Table 40 Hippocampal volumes in children with abnormal hippocampus report on 
conventional neuroimaging 
Type 
Patient 
no 
Hippocampus 
on conventional 
MRI Rt HPV Lt HPV 
Right % 
difference 
Left % 
difference 
HH 1 Bilateral small  2094.88 1944.88 31.74 33.06 
 
2 Bilateral small  3112.64 2902.64 -1.43 0.10 
 
3 Bilateral small  2014.86 2042.86 34.34 29.69 
 
4 Bilateral small  2028.5 2278.5 33.9 21.58 
 
5 Left small 3326.04 3043.04 -8.38 -4.73 
 
8 Right small 2726.16 2558.16 11.16 11.96 
       KH 3 Bilateral small  3038.91 2697.41 0.97 7.16 
 
 
 
 Relationship between hippocampal volumes and memory indices 
 
 
 
The relationship between hippocampal volumes and memory indices such as visual 
immediate memory, verbal immediate memory, visual delayed memory, verbal delayed 
memory, general memory and delayed recognition scores were analysed using partial 
correlations, controlling for age at scan. 
 
 
No significant relationship was seen between memory indices and the hippocampal 
volumes in the HH group. 
 
 
In the KH group significant strong positive correlations were seen between corrected 
left hippocampal volume and verbal immediate memory, verbal delayed memory and 
delayed recognition, while strong significant positive correlations were seen between 
corrected right hippocampal volume and verbal immediate memory (Table 41). 
 
 
Table 41 Relationship between hippocampal volumes and memory indices in KH group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hippocampus Children memory scale partial correlation r p-value 
Left Delayed recognition 0.641 0.025 
 
Verbal delayed memory 0.729 0.007 
 
Verbal immediate memory 0.667 0.018 
    Right Delayed recognition 0.544 0.068 
 
Verbal delayed memory 0.558 0.059 
 
Verbal immediate memory 0.592 0.043 
 Relationship between age and hippocampal volumes (Figure 26, Figure 27) 
 
There is a significant positive correlation between age at imaging and right (r =0.628, 
p = .003) and left (r = 0.570, p=0.009) hippocampal volumes in children with HH. No 
such relationship was seen in children with KH (right hippocampus r =-.082, p = 0.780. 
left hippocampus r = -0.064, p = 0.827).  
 
 
 
Figure 26 Relationship between age and corrected left hippocampal volume in children 
with HH and KH 
 
 
 
Figure 27 Relationship between age and corrected right hippocampal volume in children 
with HH and KH 
  
 
 
10.1.5 Discussion: 
 
 
In this study, using manual hippocampal volumetry, group differences in hippocampal 
volumes have not been demonstrated between HH and KH group. 
 
 
However, 3 patients (all males) in HH group had bilateral volume reduction of more than 
 
20- 25%. Although these children were among the youngest in the HH group, similar 
volumes were not seen in age matched children within HH group or in the KH group, 
suggesting that the reduction may reflect actual hippocampal volume loss. In one child 
(patient 4, HH group) memory indices showed low general memory scores, especially 
verbal and visual delayed memory and the discrepancy between actual and predicted 
memory scores was 13 points. The other 2 children (patient 1 and 3) did not 
manifest specific memory impairments. 
 
 
Hippocampus dependent memory functions mature around 5-7 years of age in humans, 
and deficits associated with hippocampal damage sustained early in life, are known to 
emerge later in childhood (Bachevalier et al., 2005; Gadian et al., 2000). Thus it will be 
important to re-evaluate these children at a later age (10-12 years), with specific focus 
on hippocampus-dependent memory functioning, to understand the impact of the 
hippocampal damage. 
 
 
Following hypoxic ischaemic encephalopathy, bilateral hippocampal volume reduction 
of 40% (29%-55%), in comparison to age matched controls, has been associated with 
specific   memory   impairments,   such   as   impairment   of   episodic   memory   with 
preservation of semantic memory (Isaacs et al., 2003). The maximal hippocampal 
reduction in our HH group was lower 20-25%, and may explain the lack of similar 
memory impairment as reported by Isaacs et al (Isaacs et al., 2003) 
  
 
 
Everyday memory problems and semantic memory (vocabulary, information and 
comprehension subtests in WISC-IV) were not assessed in this study, and they need to 
be ascertained in order to gain a complete understanding of the impact of severe 
hippocampal volume reduction on memory. 
 
 
 
This study suggests that HH is associated with a risk of severe bilateral hippocampal 
reduction, although the clinical or functional impact of the damage and features that 
increase susceptibility to injury needs to be investigated further. The impact of KH on 
hippocampal volumes is less clear. One child in the KH group (patient 2) had bilateral 
reduction of hippocampal volumes, albeit to a lesser degree (9-13%) and this child also 
displayed impaired verbal memory 
 
 
Conventional MRI concurred with hippocampal volumetry in only 3 patients. Studies in 
adults with temporal lobe epilepsy (Cendes et al., 1993; Jack et al., 1990) have 
shown volumetric studies to be more sensitive than conventional MRI in ascertaining 
hippocampal pathology. Cendes et al (Cendes et al., 1993) have shown 92% 
concordance between volumetric and EEG in lateralising epileptogenic areas in TLE in 
adults, in comparison to a concordance of 56% between qualitative visual assessment 
of MRI and EEG. Qualitative assessment of hippocampal pathology can be affected by 
several factors such as image orientation; slice thickness and type of sequences used 
(spin echo T2 and Fluid Attenuation Inversion Recovery sequence enable better 
detection of pathology). 
  
 
 
In KH children, no relationship was demonstrated between hippocampal volume and 
age.  This  is  consistent  with  longitudinal  MRI  studies  of  hippocampal  volumes  in 
children, that indicate a stable hippocampal volume between the ages of 4 – 25 yrs 
(Gogtay et al., 2006). In contrast HH children show a strong positive correlation of 
bilateral hippocampal volumes with age. However, exclusion of the 3 younger children 
with severe bilateral reduction in hippocampal volume renders this relationship 
insignificant (right hippocampus vs age r = 0.398, p = 0.113 and left hippocampus vs 
age r = 0.323, p = 0.205). 
 
 
In the KH group, left hippocampal volumes correlated with verbal memory. This is in 
accordance with the study by Frisk et al (Frisk et al., 1990), where adults with left 
hippocampal resection showed impairment in long term maintenance of verbal 
information. No such correlation was noted in the HH group. An explanation for this 
could be the significant age discrepancy between neurocognitive assessment and age 
at neuroimaging in this group. 13 children with HH had previously participated in a pilot 
project investigating neurocognition, so the neurocognitive data from these patients 
predate the neuroimaging acquisition by 1.5-3.3 years. 
 
 
Thus  it  is  difficult  to  conclude  with  certainity  if  children  with  HH  and  KH  have 
hippocampal  involvement  or  a  specific  memory  impairment.  It is likely that  some 
children may be affected, and a larger study would be required to discern the risk 
factors associated with such an involvement. 
 
 
An important limitation of note in this study is the lack of healthy population. This may 
underestimate the effect of HH on the hippocampus. 
  
 
 
 
 
10.1.6  Conclusion 
 
 
Hippocampal volumetry has not shown any significant group differences between HH 
and KH children. The absence of specific memory impairment as a group on 
neurocognitive assessment also supports this finding. 
 
 
However, increased risk of  hippocampal  injury following  HH  cannot  be  completely 
excluded, as 3 children in the HH group have severe bilateral reduction of hippocampal 
volumes ( > 20%), and 3 children with IQ- memory discrepancy also had significantly 
lower hippocampal volumes.  
 
Hippocampal injury in children with KH also cannot be excluded as 1 child in the KH 
 
group had 9-13% reduction in hippocampal volume and an IQ-memory discrepancy of 
 
19 points. 
 
 
 
However, additional white matter injury in both groups (seen in conventional MRI) may 
have contributed to the cognitive deficit. 
  
 
 
 
 
 
 
10.2 Diffusion tensor imaging 
 
 
 
10.2.1 Introduction 
 
 
Diffusion tensor imaging is a unique MRI technology to assess white matter 
microstructure by utilising the properties of water diffusion in brain tissue. Water 
molecules within the body tissue are in a state of constant random motion (Brownian 
movement). The magnitude and direction of diffusion of water molecules within the 
brain can be used to understand the integrity of the underlying structure (Basser et 
al., 2002; Le Bihan et al., 1986). 
 
 
Water   diffusion   is   uniform   and   equal   in   all   directions   (isotropic   diffusion 
Figure 28) when cellular barriers are not coherently organised as in the grey matter or 
when no barriers are present as in cerebrospinal fluid. 
 
 
 
 
 
 
 
                                                                                
                                                                      Figure 28 Isotropic diffusion 
 
 
 
 
 
The white matter (WM) in contrast, is coherently organised due to axons, with a 
cylindrical structure that is bundled into tracts, with additional cellular barriers in the 
form of the myelin sheath. Thus in WM water diffusion is greater along one direction 
 (parallel  to  tract),  but  restricted  perpendicular  to  the  tract,  resulting  in  anisotropic 
diffusion ( Figure 29) (Le Bihan et al., 2001). 
 
 
 
 
 
 
 
 
 
                                              
                                            Figure 29 Anisotropic diffusion 
 
 
 
The diffusion within each voxel of the brain image is described mathematically by a 
diffusion tensor that has magnitude and direction. To best characterise the diffusion 
tensor in each voxel, DWI is obtained by applying diffusion gradients in at least 6 non- 
collinear directions (Le Bihan et al., 2001) 
 
 
The diffusion tensor is expressed by 3 eigenvectors (V1-V3) and their respective 3 
eigenvalues (λ 1-3). The eigenvalues represent the magnitude of diffusion in each of 
the 3 dimensions and the eigenvectors represent the orientation of the 3 eigenvalues. In 
isotropic diffusion all eigenvalues are equal. In anisotropic diffusion the principal 
eigenvalue λ 1 is greater than λ 2 and λ 3. 
 
 
An MRI voxel can also contain crossing fibre tracts that produce a more complex 
pattern of diffusion. This is usually characterised by 2 eigenvalues that are larger than 
the third (λ 1= λ 2 > λ 3) 
 
 
The degree of anisotropic diffusion is summarised by a quantitative measure known as 
fractional anisotropy (FA), which reflects how strongly structured the underlying white 
matter is. In very coherent structures like WM tracts the FA value approaches unity and 
in less coherent structures such as CSF and grey matter the FA value approaches 0. 
  
 
 
Three other indices of significance, obtained from DTI are mean diffusivity, radial 
diffusivity (λ radial) and axial diffusivity (λ axial). Mean diffusivity (MD) is an indicator of the 
total amount of diffusion in a given voxel, irrespective of the direction of diffusion. Axial 
diffusivity, quantifies diffusion in the principal direction of diffusion and radial diffusivity 
quantifies diffusion perpendicular to the principal direction of diffusion. (Pierpaoli et al., 
1996). Thus changes in one or both (λ radial, λ axial) could underlie changes in FA and MD. 
 
 
The two most commonly used DTI parameters in neuroimaging research are FA and 
MD (Pierpaoli et al., 1996). Diffusion within WM is influenced by density of axons, axonal 
diameter and integrity and degree of myelination. 
 
 
Longitudinal quantitative MRI studies in paediatric and adults populations have revealed 
a linear increase in white matter volume until 20 yrs of age (Giedd et al., 1999a). DTI 
studies of white matter development in healthy paediatric populations have shown 
increased FA and decreased MD values with increasing age and maturity (Schmithorst 
et al., 2002) (Cascio et al.,  2007). Thus, increased diffusion within the WM, indicated 
by low FA levels, reflect underdeveloped or compromised  WM  (Beaulieu  et   al., 
2002; Cascio et al., 2007). 
 
In a healthy paediatric population, Schmithorst et al have demonstrated that FA 
correlates positively and MD negatively with full scale IQ and reduced FA levels has 
been shown to correlate with neurocognitive and emotional and behavioural dysfunction 
in children with prematurity (van Kooij et al., 2012), diabetes (Kodl et al., 2008) and 
autism (Ameis et al., 2011), amongst several other conditions.  
 
Thus DTI enables detection of subtle WM changes, unrecognised by conventional 
neuroimaging and can be used to investigate the relationship between structural deficit 
and neurocognitive impairment. 
  
 
 
Children with HH are at a high risk of motor and neurocognitive development (Menni et 
al., 2001). Unpublished data from a pilot study of HH children (n=17) from our centre, 
highlighted cognitive deficits in the form of low average memory and attention scores 
and average IQ scores. As white matter involvement has been implicated in cognitive 
impairments in children with hypoglycaemia (Burns et al., 2008), we hypothesised that 
children with HH and cognitive deficits may have underlying white matter damage. 
 
 
 
10.2.2 Specific Aims 
 
 
To detect if children with HH have white matter microstructural abnormalities/deficits 
 
(reflected by reduced FA) in comparison to children with KH  
 
To detect if FA values correlate to neurocognitive measures 
 
10.2.3 Method 
10.2.3.1 Participants 
 
 
HH group: 21 children recruited into study. One child with gross structural abnormality 
(patient 1, Table 16) was excluded to prevent alignment issues in group analysis and 5 
children >13yrs (patients 7,12,17, 20 and 21 in Table 16) were excluded to perform 
age matched comparison with KH group. Thus, 15 children were included in the 
TBSS (Tract Based Spatial Statistics) analysis. 
 
KH group: 15 children recruited into study. DTI images were not completed for 2: 
patients 2 and 3 inTable 18 (due to compliance with scanning and motion) and 1 patient 
excluded from study as parent has learning difficulties. Thus, 12 children were included 
in TBSS analysis. 
 10.2.3.2 Image acquisition 
 
 
All the children were scanned unsedated on a 1.5 T Siemans Avanto MRI system. DTI 
 
was obtained using diffusion-weighted spin-echo echoplanar imaging sequence (TR 
 
7300 ms, TE 81 ms, field of view 240 mm, and acquisition matrix 96x96). 60 slices of 
 
2.5 mm thickness and zero gaps were collected encompassing the whole brain. Data 
was collected in 60 non-collinear directions, by applying diffusion gradients at b=1000 s 
mm-2. Four non- diffusion weighted datasets (b=0) were also collected in an interleaved 
fashion during the sequence. Final image resolution was 2.5×2.5×2.5 mm. 
Images were then transferred to a separate workstation for processing. The processing 
and statistical analysis of the data is outlined below. 
 
 
 
10.2.3.3 Image processing and analysis 
 
Diffusion-weighted images were processed using tools from the Functional Magnetic 
Resonance Imaging of the Brain Software Library (FSL; www.fmrib.ox.ac.uk/fsl). Initial 
processing of data involved inspection for movement artefacts, removal of eddy-current 
induced distortions and brain extraction by skull stripping. The diffusion tensor model 
was then fitted in each voxel and FA, MD, λ radial and λ axial maps were generated. 
 
 
FA maps were then processed using Tract-based spatial statistics (TBSS), part of FSL 
(Smith et al. 2004). TBSS is an automated, observer independent, statistical approach 
to compare diffusion tensor imaging data between groups (Smith et al., 2006). 
 
In TBSS, the FA image of each subject is non-linearly aligned to a common space. A 
group mean FA map is created and thinned to form a group mean FA skeleton by 
projecting the FA data of all subjects onto it. A projection step that searches for the 
point  of  maximal  FA  perpendicular  to  the  FA  skeleton  ensures  that  the  FA 
measurements projected are from the centre of each individual’s white matter tract. This 
is a crucial step in TBSS that overcomes alignment issues faced by other automated 
whole brain voxel-wise comparison methods such as voxel-based morphometry (VBM).
 The FA threshold is then set > 0.20 to ensure inclusion of major central white matter 
tracts in the analysis and exclusion of grey matter and peripheral white matter tracts 
that may be highly variable between subjects.  This is followed by voxel-by-voxel 
analysis between groups, of mean FA WM skeleton, which is fully corrected for multiple 
comparisons across space. Similar transformations were applied to MD, λ radial and λ axial 
maps. 
 
 
All preprocessing of images were performed by myself and the final TBSS analysis and 
extraction of DTI indices were performed by Dr.Kiran Seunarine (Institute of Child 
Health). 
 
 
 
Statistical analysis 
 
Analysis of covariance was used to compare the DTI indices between groups, using 
age and gender, (that influence brain development and myelination) as covariates. The 
relationship between cognitive measures and DTI indices (FA, MD, λ radial, λ axial) was 
investigated using partial correlations, controlling for age at scan and gender. 
  
 
 
 
 
10.2.4 Results 
 
 
 
Baseline characteristics 
 
DTI data from 15 children with HH and 12 children with KH were compared using 
 
TBSS.  
 
As  children  in  the  KH  group  were  <13  years,  in  order  to  perform  an  age  
matched comparison, children >13 years were excluded from HH group. 
 
Baseline characteristics are summarised in Table 42.  
 
 
Table 42 Baseline characteristics of HH and KH group in TBSS analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The mean age of presentation in the HH group is significantly lower than the mean age 
of presentation in the KH group, which is consistent with underlying diagnosis. 
Birthweight is also significantly different between groups, primarily due to an increase in 
weight of hyperinsulinaemic patients. Although the KH group has a significantly lower 
birth weight, this is clinically within normal limits. 
Patient characteristics HH  KH  p-value 
Number  of patients (no) 15 12 
 Age at scan in yrs (mean ± SEM) 9 (0.5) 8.5 (0.6) 0.549 
Age at neuroimaging in yrs (mean± 
SEM) 8.2 (0.4) 8.5 (0.6) 0.673 
Age at diagnosis in yrs (mean ± SEM) 0.32 2.5 <0.0001 
Gender (Male/female) 8M/7F 9M/3F 0.424 
Birth weight in grams (mean ± SEM) 
4019.2 
(197.5) 
3246.2 
(222.9) 0.016 
Handedness (Right/Left) 10R/5L 9R/3L 0.696 
Height SDS (median) 0.08 -0.24 0.674 
Weight SDS (median) 0.37 -0.19 0.14 
Seizures at diagnosis (patient no) 9 3 0.121 
  
No significant difference in maternal education (p=0.692, FET) or socioeconomic status 
 
(p=1.000, FET) was found between groups.  
 
 
 
Results of TBSS analysis (Table 43 ) 
 
 
 
Global White Matter: WM skeleton mean FA, MD, λ radial and λ axial   values were 
compared (ANCOVA) between groups, controlling for age and gender. Results indicate 
significantly lower FA (p = 0.018, Figure 30) and greater λ radial (0.022, Figure 32) in HH 
group, relative to KH group. This suggests that decrease in FA is secondary to increase 
in radial diffusivity. Mean diffusivity (p = 0.070, Figure 31) and axial diffusivity (p= 0.77) 
were not significantly different between groups.  
 
 
 
 
 
Figure 30 Comparison of WM skeleton fractional anisotropy between HH and KH group 
  
 
 
 
 
Figure 31 Comparison of WM skeleton mean diffusivity between HH and KH 
 
 
 
 
 
 
 
 
Figure 32 Comparison of WM skeleton radial diffusivity between HH and KH 
 Regional WM: Results of TBSS comparing HH and age- matched KH groups are 
shown in Figure 33. The mean FA skeleton is overlaid on mean FA image. Green areas 
denote regions with no significant differences in FA values between HH and KH, areas 
of red and yellow denote significantly lower FA values in HH group. 
Significantly low FA values (p=0.05) were seen in genu, splenium and body of corpus 
callosum in the HH group. 
 
 
 
 
 
Figure 33 Results of TBSS analysis comparing fractional anisotropy (FA) between HH and 
KH group. Green areas denote regions with no significant differences in FA values between 
HH and KH, areas of red and yellow denote significantly lower FA values in HH group. 
Significantly low FA values (p=0.05) were seen in genu, splenium and body of corpus 
callosum in HH group. 
 Corpus Callosum (CC): FA values were significantly lower in CC (p = 0.022), 
especially in genu (p = 0.021) and splenium (p = 0.043). Radial diffusivity was 
significantly higher in CC (p = 0.018), including body (p = 0.041), genu (p = 0.035) and 
splenium (p = 0.053). Mean Diffusivity was significantly greater in CC (p = 0.050) and 
body of CC (p = 0.039) (Table 43). 
 
 
 
 
Table 43 Comparison of DTI indices between HH and KH group 
DTI indices Type Mean p-value 
Mean Fractional Anisotropy of WM skeleton HH 
0.405760 
 
 KH 
0.418433 
0.018 
Mean Diffusivity of WM skeleton HH 
0.000800 
 
 KH 
0.000793 
0.07 
Mean Radial Diffusivity (RAD) of WM 
skeleton 
HH 
0.000610 
 
 KH 
0.000596 
0.022 
Mean Axial Diffusivity (AD) of WM skeleton HH 
0.001182 
 
 KH 
0.001186 
0.77 
Corpus Callosum FA HH 
0.676470 
 
 KH 
0.699510 
0.022 
Body of Corpus Callosum FA HH 
0.639028 
 
 KH 
0.660683 
0.081 
Genu of Corpus Callosum FA HH 
0.686601 
 
 KH 
0.718064 
0.021 
Splenium of Corpus Callosum FA HH 
0.718047 
 
 KH 
0.736817 
0.043 
Corpus Callosum AD HH 
0.001611 
 
 KH 
0.001617 
0.729 
Body of Corpus Callosum AD HH 
0.001626 
 
 KH 
0.001623 
0.363 
Genu of Corpus Callosum AD HH 
0.001591 
 
 KH 
0.001598 
0.786 
Splenium of Corpus Callosum AD HH 
0.001607 
 
  KH 
0.001624 
0.681 
Corpus Callosum RAD HH 
0.000438 
 
 KH 
0.000406 
0.018 
Body of Corpus Callosum RAD HH 
0.000491 
 
 KH 
0.000458 
0.041 
Genu of Corpus Callosum RAD HH 
0.000419 
 
 KH 
0.000374 
0.035 
Splenium of Corpus Callosum RAD HH 
0.000384 
 
 KH 
0.000362 
0.053 
Corpus Callosum MD HH 
0.000829 
 
 KH 
0.000810 
0.05 
Body of Corpus Callosum MD HH 
0.000869 
 
 KH 
0.000846 
0.039 
Genu of Corpus Callosum MD HH 
0.000810 
 
 KH 
0.000782 
0.106 
Splenium of Corpus Callosum MD HH 
0.000792 
 
 KH 
0.000783 
0.253 
 
 
 
Relationship between DTI indices and cognitive function: In children with HH mean 
WM FA correlated significantly with full scale IQ (r = 0.586, p = 0.035) and perceptual 
reasoning index (r = 0.691, p = 0.009). FA values of body of corpus callosum also 
correlated positively to full scale IQ (r = 0.675, p = 0.011). 
  
Figure 34 Relationship between mean fractional anisotropy and perceptual reasoning 
index in HH group 
 
 
 
 
Figure 35 Relationship between mean fractional anisotropy and full scale IQ in HH 
  
 
 
 
 
 
 
Figure 36 Relationship between body of corpus callosum fractional anisotropy and full 
scale IQ in HH group 
 
 
10.2.5 Discussion 
 
 
In this study FA, MD, axial and radial diffusivity were estimated for the whole brain in 
HH and KH patients and TBSS was used to look for significant differences in WM 
between groups 
 
 
Results of this study suggest that white matter microstructural deficits exist in children 
with HH. Relative to to the KH group, significant differences were noted in whole white 
matter skeleton and more specifically in genu, splenium and body of corpus callosum. 
FA  values  (WM  skeleton  and  body  of  corpus  callosum)  positively  correlated  to 
perceptual reasoning and full scale IQ measures in the HH group, suggesting white 
matter deficits in HH partly underlie these cognitive impairments. 
 Global WM: To date, no DTI studies investigating white matter changes in HH have 
been performed in children. The global reduction of WM suggested by the decreased 
FA of WM skeleton corresponds with the conventional MRI report of reduced white 
matter in 33% of HH children described in an earlier chapter (chapter 8). 
 
 
This global reduction of WM is consistent with the report by Burns et al (Burns et al., 
2008), describing a predominant white matter involvement in early MRI scans (< 6 
weeks) of children with symptomatic hypoglycaemia that was associated with impaired 
neurocognitive development at 18-24 months of age. This study as an extension has 
shown predominant WM deficit following HH, persisting in late scans that correlated to 
neurocognitive measures. 
 
 
A comprehensive assessment of the neurocognitive profile of the HH and KH group 
(described in chapter 9), has highlighted significantly impaired perceptual reasoning 
and full scale IQ scores in children with HH. The positive correlation of PR and FSIQ 
scores with mean FA in this study, suggests that impaired white matter structural 
integrity most likely underlies the IQ impairment. 
 
 
The KH group in this study also has a high incidence of white matter abnormalities on 
conventional neuroimaging (28.5%, chapter 8). This probably underestimates the white 
matter differences detected by TBSS. It’s likely that larger differences may have been 
detected if HH group had been compared to healthy controls. 
 
 
White matter is composed of glial cells (microglia, radial glia, astrocytes and 
oligodendrocytes) and myelinated axons. The axons are organised into projection 
(between brain and spinal cord), association (between different regions within a 
hemisphere) and commissural (between right and left hemispheres) fibres that enable 
communication between different neuronal cortical  regions.  These pathways are a 
crucial component of the complex integrated neural networks that underlie various 
cognitive processes. 
  
Human and animal studies have indicated, a peak period of synaptogenesis during 
the last trimester and first postnatal year of life (De Graaf-Peters et al., 2006), and both 
synapse formation and elimination continues on during childhood and adolescence. 
 
 
MRI studies of human brain development have shown that myelination begins as early 
as 29 weeks of gestation (Inder et al., 2000), and occurs in a predefined spatial and 
temporal sequence with most tracts myelinated by early childhood, although some 
tracts (eg: arcuate fasciculus and corpus callosum) can continue to myelinate through 
adolescence (Lenroot & Giedd et al., 2006; Pujol et al., 1993). 
 
 
Thus it is reasonable to speculate that recurrent episodes of HH during this crucial 
period, maybe detrimental to this process and affect white matter structure and function. 
 
 
Rivkees et al (Yan & Rivkees et al., 2006) have shown that hypoglycemia in newborn 
rats can affect oligodendrocyte precursor cell differentiation, maturation, migration and 
viability in vitro.  Oligodendrocytes  are  cells  that  contribute  to  myelin  formation  in  
the  central nervous system. This may be one of the pathogenetic mechanisms of 
white matter injury in HH. Excitotoxic mechanisms and free radical generation can also 
cause injury to glia, myelin and axons and cause cytoskeletal degradation of these 
structures (Stys et al., 2004) 
 
 
 
Regional  WM:  This study  has  identified the  CC  as  particularly  vulnerable  to  
injury  in children with HH. 
 
The CC is a major WM tract connecting the cerebral hemispheres. It connects 
homologous regions between the right and left hemispheres. Thus fibres within the 
anterior part of CC, the genu, are mostly derived from the frontal lobes, while the fibres 
in the posterior CC, the splenium are derived from the temporal and occipital cortices. 
  
 
 
Quantitative MRI studies in children and adults has shown that the corpus callosum 
continues to mature (fiber redirection, myelination and pruning) into adulthood, with 
maximal growth during childhood and adolescence (Pujol et al., 1993) and with more 
marked changes occurring in the splenium (Giedd et al., 1999) 
 
 
Diffusion weighted imaging in adults with hypoglycaemic encephalopathy, has 
demonstrated restricted diffusion in the splenium of the corpus callosum and posterior 
limb of internal capsule, in the acute phase (Atay et al., 2012). Diffusion weighted 
imaging in neonatal hypoglycaemia has shown restricted diffusion in OP lobes and 
splenium  of  the corpus callosum  in the acute phase and  increased diffusion on  
DWI  and atrophy of these regions on conventional imaging in chronic phase (Kim et al., 
2006) 
 
 
Thus the vulnerability of the  CC to HH demonstrated in this study is consistent with 
case reports of diffusion weighted imaging in adults and neonates with hypoglycaemia 
Children in this study were specifically chosen above 5 yrs of age, to allow for maximal 
myelination (Nakagawa et al., 1998) and brain growth (Lenroot & Giedd et al.,  2006). 
 
 
Of  the  6  children  in  the HH  group  that  were  excluded,  2  had  abnormal  scans  on 
conventional  neuroimaging.  One had bilateral hippocampal  volume  reduction  and 
severe global reduction of white matter and one had mild global reduction of WM. Of 
the 3 children with KH excluded from the analysis, 2 had abnormal scans on 
conventional neuroimaging, one had bilateral hippocampal volume reduction and mild 
global reduction of white matter and one had mild global reduction of WM. As the 
distribution of WM involvement was equivalent in groups, it’s unlikely that exclusion of 
these subjects has adversely influenced outcome. 
  
 
 
 
 
10.2.6  Conclusion 
 
 
In this study, TBSS analysis of DTI, comparing HH to KH has shown white matter 
microstructural deficits in the HH group (significantly reduced diffusion anisotropy). 
The corpus callosum, especially the genu and splenium are highlighted as specific white 
matter regions vulnerable to injury in HH. Mean FA in the WM skeleton in the HH group 
correlated positively with IQ and perceptual reasoning, indicating that structural white 
matter deficits may underlie the neurocognitive impairment relative to the KH group. 
This study indicates that WM is sensitive to hypoglycaemic brain injury and could result 
in impaired neurocognition. 
 
 
This is a novel finding in HH and consistent with the recent evidence of a predominant 
pattern of white matter injury on conventional neuroimaging associated with impaired 
neurocognition following symptomatic neonatal hypoglycaemia (Burns et al., 2008). 
  
 
 
 
 
11 General Discussion 
 
 
This chapter summarises the findings of this study and relates the findings to the current 
knowledge regarding pathophysiological and biochemical mechanisms of the 
underlying disease.   Areas requiring future research are also highlighted. 
 
 
 
11.1 Review of neuropsychological and neuroimaging findings and 
their implications for HH group 
 
 
White matter pathology and relation to cognitive indices 
 
 
 
In the HH group  (n=21)  conventional  neuroradiological  assessments  (chapter  8) 
revealed abnormal scans in 8/21 children. Diffuse white matter lesions and reduced 
hippocampus were the predominant pattern of brain injury along with some focal white 
matter lesions. The presence of diffuse white matter injury was corroborated by 
significantly low fractional anisotropy values in the mean white matter skeleton and 
corpus callosum analysed using novel quantitative MRI techniques (chapter 10). 
Consistent with the presence of diffuse white matter injury, neuropsychological tests 
(chapter 9) revealed widespread neurocognitive deficits in the domains of intelligence 
(perceptual reasoning), memory, attention (sustained attention) and manual dexterity  A 
clear relationship between IQ scores and DTI indices, suggests that white matter 
structural deficits partly explain the neurocognitive  deficits  noted  in the  HH group. 
However despite the reports of reduced hipppocampal volumes on conventional 
neuroradiological assessments, hippocampal volumetry did not reveal any significant 
differences in comparison to children with KH. 
 
 
Cognitive profiles with correlation to quantitative and qualitative neuroradiological 
measurements have not been reported previously in HH children. The widespread 
neurocognitive deficits are consistent with the knowledge that HH children are at a 
higher risk of brain injury compared to other forms of hypoglycaemia. 
  
 
 
Bilateral parieto-occipital cortical and subcortical injury is considered the hallmark of 
hypoglycaemic brain injury in children (Alkalay et al., 2005). The patients with this 
pattern of brain injury reported in the literature are invariably neonates with prolonged 
severe hypoglycaemia associated with seizures or coma. The predominat pattern of 
global WM injury reported in this thesis most likely reflects the pattern of injury following 
recurrent ongoing moderate hypoglycaemia although some of these children have also 
experienced severe hypoglycaemia during the neonatal period.  Burns et al (Burns et 
al., 2008) found a similar pattern of predominant WM injury and cognitive impairment 
following symptomatic neonatal hypoglycaemia. A high incidence of seizures at 
diagnosis, ongoing epilepsy and prematurity were all noted in the HH group that could 
have potentiated the hypoglycaemic brain injury, however these features are common 
in children with HH. 
 
 
In accordance with the hypothesis of increased white matter vulnerability to 
hypoglycaemia and higher risk of injury in HH group, this study has clearly established 
the presence of white matter microstructural deficits in children with HH utilising 
qualitative and quantitative MRI techniques with correlation to cognitive indices. 
 
 
Hippocampal pathology and memory indices 
 
 
 
This study was unable to conclusively establish the presence of hippocampal damage 
or a specific memory impairment in children with HH. 
 
 
The absence of significant differences in hippocampal volumes (hippocampal volumetry 
studies) between HH and KH group may be explained by the presence of hippocampal 
pathology in the KH group as suggested by the conventional neuroradiological 
assessments. Thus the ability to detect a significant change in HV was limited by 
comparison with a group that has also experienced hypoglycaemia and may have 
consequently developed hippocampal damage. Comparison with a healthy paediatric 
population would be required to establish the presence of hippocampal damage in 
either group. 
  
 
 
However memory scores were significantly lower in HH group relative to the KH group 
(mean general memory scores HH vs KH 93 vs 110) but the results of this study failed 
to show any correlation between memory impairments in HH group and HV. Thus it is 
difficult to attribute the memory impairment to hippocampal pathology. A likely 
explanation would be that injury to MTL-cortical system (and not specifically the 
hippocampus)   underlies   this   memory   impairment.   Injury   to   cortical   structures 
subserving memory other than the hippocampus, such as the parahippocampal cortex 
may contribute to the memory impairment and were not explored in this study. 
 
 
Another explanation for the low memory scores could be the relationship between 
intelligence and memory functioning. Concurrent administration of WISC-IV and CMS to 
126 children aged 6-16 yrs have demonstrated low to high correlations (0.21 to 0.74) 
between the WISC-IV composite and CMS index scores. These correlations have been 
utilised to predict memory scores based on intellectual functioning (Drozdick et al., 
2008). In this study, HH children, as a group did not demonstrate a disassociation 
between the predicted and achieved memory scores. Thus the memory impairments in 
HH may just be a reflection of their intellectual functioning. 
 
 
Four children with HH achieved lower memory scores than predicted by 13-35 points. 
Thus some children seem to exhibit a specific memory impairment (disassociation 
between IQ and memory functioning). These children had lower left hippocampal 
volumes relative to children with IQ-memory discrepancy of <13 points, implicating 
hippocampal pathology as a cause of specific memory impairment in this group. 
Nonethless contribution  from  other  regions  subserving  memory  (medial  temporal 
cortical circuit) cannot be excluded. 
  
 
 
Three children in HH group demonstrated a bilateral reduction (21-35%) in hippocampal 
volume. Surprisingly apart from 1 child, specific memory impairment was not seen in the 
other two children. As hippocampus- dependent memory functions mature by 9-10 
years (Bachevalier et al., 2005), these children may manifest impairments at a later 
date. 
 
 
 
The findings of this study have important implications for the interpretation of 
neuroimaging findings in children with HH and counseling regarding neurocognitive 
prognosis.   It is recommended that children with HH undergo comprehensive 
neurocognitive   assessment at various key stages of  development  to ascertain  the 
pattern of cognitive impairment and to implement targeted strategies that will optimise 
neurocognitive outcomes. 
 
 
 
 
 
11.2 Review of biochemical, neuropsychological and neuroimaging 
findings and their implications for KH group 
 
 
Fasting studies 
 
 
 
The KB response in children with KH is qualitatively and quantitatively different from 
control children. A novel finding is the increased rate of KB response in KH group (87% 
increase/hour) in comparison to controls, within the physiological limits of fasting 
tolerance. 
 
 
The ability of the brain to utilise KB as an alternate fuel during fast depends on the 
concentration of KB in the blood, permeability of the blood brain barrier to KB 
transport and the activity of ketolytic enzymes (Morrisl et al., 2005). 
  
 
 
Owen et al (Owen  ., 1967) demonstrated an increase in KB concentrations to 5.8 - 9.7 
mmol/l following a 5-6 week fast in 3 obese adults and cerebral vascular catheterisation, 
at the end of the fast demonstrated that KB had replaced glucose as the predominant 
fuel for metabolism. Measurement of cerebral arteriovenous difference of ketone bodies 
in children anasthetized for elective surgery (n=70, age 11-15 years) has demostrated a 
cerebral uptake of KB greater than adults after comparable periods of fasting 
(Settergren et al., 1980) 
 
 
 
It is well known that ketonemia following a fast is greater and earlier in children 
compared to adults (Haymond et al., 1982). The greater cerebral metabolic demand 
and larger brain/body surface ratio in children in comparison to adults is thought to 
necessitate such a response to spare glucose while maintaining cerebral metabolism. 
 
 
Thus the significantly increased magnitude and rate of KB response in KH children in 
this study relative to the control group is an indirect evidence of greater KB utilisation by 
the brain. 
 
 
This study also suggests that KH group have an altered epinephrine response to 
fasting.  The baseline adrenaline conentrations were elevated. Children are diagnosed 
with KH after exclusion of metabolic or endocrine causes of hypoglycaemia; however 
adrenaline concentrations during fasting are not routinely measured.  The role of 
adrenaline in fasting metabolism in children and its response in KH needs to be 
explored further before the findings of this study can be extrapolated to the general 
population. 
 
Studies investigating glucose kinetics in children with KH need to incorporate 
measurement of hormones (including adrenaline and glucagon) and gluconeogenic 
substrates to substantiate these findings. 
 
Cortisol concentrations were found to be a significant predictor of KB concentrations 
at the end of the fast, with poor correlation to NEFA concentrations at the end of the 
fast. This suggests that cortisol regulates KB response during a fast in children with a 
possible direct role of cortisol on hepatic ketogenesis. 
  
As adult reports of KH do not exist, follow up of the KH children to understand the 
nature of this epinephrine resonse (transient or persistent) and the mechanism of 
symptom resolution (increased gluconeogenic substrates or behavioural modification) 
may further the knowledge regarding the underlying mechanisms of KH 
 
 
Neuroimaging studies and neurocognitive outcomes in KH 
 
 
 
The presence of hippocampal pathology and focal and diffuse white matter lesions on 
conventional neuroradiological assessments in children with KH was unexpected. Five 
of 14 children had abnormal scans. Bilateral reduction of hippocampus was seen in one 
child who had additional focal and diffuse WM lesions, 1 child had focal WM lesion and 
3 chidren had diffuse WM lesions. The clinical phenotype of KH children with abnormal 
scans was no different from the children with normal scans with respect to age at 
diagnosis, gestational age, birthweight and presence of seizures at diagnosis 
 
 
The similarity of findings in HH and KH group suggest that changes may reflect injury 
due to hypoglycaemia. As a healthy control group was not studied in parallel, the 
occurrence of these lesions in the general population is not known. However the 
presence of associated neurocognitive impairment in two of these children with 
abnormal scans (Full scale IQ 77 (patient 3, Table 18) and 89 (patient 2, Table 18) 
suggest that these lesions may represent true injury as a consequence of 
hypoglycaemia. In addition 3 other children with normal scans had IQ scores (IQ 79-
84: patient 12, 13 and 14 in Table 18) below 1 SD (i.e < 85). The above observations 
challenge the perception that ketotic hypoglycaemia is not associated with neurological 
injury and subsequent functional impairment. 
 
 
Although children with KH have recurrent episodes of hypoglycaemia, they do not tend 
to be prolonged or as frequent as in children with HH. In addition fasting tests have 
shown that these children have higher concentration of KB during the entire catabolic 
state even prior to the episode of hypoglycaemia. Thus the evidence of neurological 
injury and impairment despite the presence of alternate fuels is surprising. 
  
 
 
As premorbid cognitive and neuroimaging data are not available for this group, it is 
difficult to conclude with certainity that the impairment is a consequence of 
hypoglycaemia.  However  in  the  absence  of  any  other  associated  pathology  and 
similarity of findings to HH group it is highly likely that these impairments indicate 
hypoglycaemic brain injury. These finding would also support inconsistent reports in the 
literature regarding neurological impairment in KH. 
 
 
 
The presence of injury in this group also questions the ability of  KB to  act  as  a 
neuroprotective fuel in the absence of glucose. The mechanism of injury and role of KB 
is discussed in the following section. 
 
 
At present children with KH do not undergo routine neurodevelopmental follow up. 
While the  findings of this study need to be interpreted with caution in the absence of 
comparison to a normal healthy population, it is recommended that children with KH 
undergo neuropsychological assessment at 5 years or at diagnosis (if age at diagnosis 
is > 5 years) to enable detection of neurocognitive deficits and institute appropriate 
management. 
 
 
 
11.3 Mechanism of white matter injury and the role of ketone bodies 
 
 
Immunohistochemical evidence of axonal injury following hypoglycaemic coma has 
been demonstrated by post-mortem adult studies (Dolinak et al., 200). In addition in 
vitro animal studies have demonstrated the susceptibility of oligodendrocytes, that form 
myelin, to hypoglycaemia (Yan and Rivkees., 2006). Thus white matter injury in 
hypoglycemia could be secondary to a combinaltion of axonal and oligodendrocyte 
injury and degeneration. 
  
 
 
Experimental studies in adult rats have indicated that in the absence of glucose KB can 
maintain high energy phosphates but cannot maintain neural activity, however in 
immature rats in addition to maintenence of high energy phophates, neural activity also 
decayed more slowly, the time of decay increasing with decreasing age (Izumi et al., 
1998; Wada et al., 1997; Arakawa et al., 1991). 
 
 
 
A recent study that sheds light on the mechanism of ketotic hypoglycemic brain injury 
was performed by Schutz et al (Schutz et al., 2011). They investigated the ability of KB 
to compensate for glucose deprivation in developing rat brain. Neuronal injury was not 
noticed in this study, however KB treated hypoglycaemic rats manifested WM injury 
with a 20 fold increase in apoptosis of mature oligodendrocytes. As KB were maintained 
in high concentrations during hypoglycaemia and infant rats have high rate for cerebral 
KB utilization, the presence of injury was attributed to biochemical factors (explained 
below) resulting in oxidative injury to WM rather than insufficient transport or enzyme 
insufficiency. 
 
 
Glucose via glycolysis and entry into Krebs cycle ensures oxidative energy production 
to maintain neuronal integrity and activity. In addition glycolytic substrates (glucose-6- 
phosphate) maintain the pentose phosphate pathway that generates nicotinamide 
adenine dinucleotide phosphate (NADPH) and 5-carbon sugars that have an anabolic 
role. The NADPH helps prevent oxidative stress and enables fatty acid synthesis, while 
the 5-carbon sugars enable nucleotides, nucleic acids and amino acids .While KB can 
enter krebs cycle and maintain oxidative phosphorylation, it is unable to compensate for 
the role of glucose in maintaining the pentose phosphate pathway. Schutz et al 
hypothesized that the lack of NADPH increases the susceptibility for oxidative stress 
injury to WM ketotic hypoglycaemia. 
  
 
 
 
 
11.4 Limitations of study 
 
 
Absence  of  a  healthy  control  group  was  the  main  limitation  of  the  study.  Ethical 
approval was refused to recruit a healthy group. In addition limited resources 
(psychologist’s time) did not permit recruitment of a greater number of children that 
may have influenced detection of subtle group differences. Absence of a healthy control 
group may lead to over estimation or under estimation of the effects of HBI. Healthy 
control group is especially essential in the quantitative imaging studies, as these newer 
techniques rely on semiautomated methods of brain segmentation and analysis and it 
would be ideal that in the absence of a gold standard, the validity of the method is 
assessed with a control group. 
 
 
Another limitation was the use of multiple comparisons or statistical tests with a small 
data set. Multiple comparisons without correction increase the likelihood of false positive 
(type I error) or significant results. But correction (such as bonferroni correction) 
increases the likelihood of type II error or false negative results. The use of bonferroni 
correction for multiple comparisons is much debated in medical statistics (Perneger et 
al., 1998).  
 
The biochemical tests and the neurocognitive tests used in this study, in clinical practice 
would be interpreted independently with reference to normal ranges. Hence it was felt 
appropriate to present findings without correction for multiple comparisons to enable 
interpretation that would be clinically relevant. The statistical tests for hippocampal 
volumetry were not significantly different between groups, hence adjustment for multiple 
comparisons would not have affected outcome. The TBSS technique used in the white 
matter studies enables correction for multiple comparisons within the statistical 
package. 
 
Alternate quantitative methods to detect hippocampal pathology, such as T2 relaxometry 
was not estimated in this study. This method involves obtaining images at different echo 
times and calculating the T2 values for each pixel within the region of interest 
(hippocampus) and constructing a T2 map for comparison with the control group. This 
 technique enables detection of pathology that is too subtle to be discerned by 
convenventional T2 imaging and better at detecting bilateral pathology. 
 
Due to the retrospective nature of data collection, additional clinical features such as 
frequency of hypoglycaemia, degree and duration of hypoglycaemia, management with 
glucose reperfusion, premorbid cognitive concerns were not available for this cohort 
that may have influenced the neurological outcome. Although neurological examination 
was normal in these children, head circumference measurements are not available to 
detect microcephaly. 
 
 
 
 
11.5 Conclusion 
 
 
In accordance with the hypothesis this study was able to establish that children with HH 
show  evidence  of  widespread  cognitive  deficits  despite  the  absence  of  overt 
neurological impairment. A novel finding is the pattern of brain injury. While previous 
studies have noted a specific pattern of occipito parietal injury following hypoglycaemia 
of different aetiologies, brain injury in this group of HH children, is predominantly in the 
form of white matter injury. The presence of WM injury has been corroborated by the 
use of qualitative (conventional neuroradiological assessments) and quantitative 
assessments (TBSS analysis of DTI). A clear relationship between cognitive deficits 
(IQ) and DTI indices, suggests that white matter structural deficits partly explain the 
neurocognitive deficits noted in the HH group.  However, this study was unable to 
conclusively establish the presence of hippocampal damage or specific memory 
impairments in children with HH. 
 
 
The biochemical studies have demonstrated novel biochemical changes in KH. Fasting 
studies have shown an increased rate and magnitude of KB response in KH children 
during hypoglycaemia relative to controls within physiological fasting time periods and 
also implicated cortisol as a possible regulator of ketogenesis in children. The increased 
KB response during fasting also supports the availability of KB’s as alternate fuels 
during KH.
  
However, contrary to the hypothesis, this study was unable to conclusively establish KH 
children as a neurologically unimpaired group. The presence of abnormalities on 
conventional  radiological  assessment  and  hippocampal  volumetry  and  the  wide 
variation   in   the   neurocognitive   scores  indicating   the   presence  of   neurological 
impairment in some of these children was unexpected and warrants further research. 
 
 
 
 
 
11.6 Future research 
The result of this study has highlighted several aspects that require further exploration. 
The findings of this study in the HH and KH group need to be replicated in a larger 
cohort of  children  recruited  prospectively  and  with  neuroimaging  and 
neuropsychological tests in comparison to a healthy control group. In KH children this 
would help confirm or refute the findings of this study. While in HH children the 
modulating effects of co-morbid conditions, treatment regimes (medical vs surgical) and 
clinical phenotype (early vs late onset) could to be explored further. Owing to the rarity 
of the condition (HH), this could be implemented as a multicentre national or 
international study. 
 
 
The hippocampal volumes in both children with HH and KH require further exploration, 
in comparison with a healthy paediatric population Concomitant administration of 
neuropsychological tests that evaluate hippocampus dependent  memory  functions, 
such as the Rivermead behavioural memory test and Rey-Osterrieth complex figure test 
are also recommended to test everyday memory and visuospatial abilities respectively 
 
 
Restricted by the small number of study participants, no attempt was made in this study 
to relate the neurocognitive or neuroimaging findings to the underlying genetic 
mechanism of HH. While it is clear that children with GLUD1 mutations, as reported in 
literature and in this study are more likely to sustain neurological injury, the impact of 
the other genetic mechanisms are less obvious and need to be explored further in 
larger cohorts with known genetics mechanisms of HH.
  
 
 
The white matter changes in the HH group also deserve further exploration. Advanced 
fibre tracking techniques (tractography) can be utilised to study specific white matter 
tracts in conjuction with appropriate neurocognitive tests. For example corpus callosum 
was vulnerable to injury in HH group in this study. Integrity of the the corpus callosum is 
necessary for bimanual coordination of hands and fingers; this can be explored further 
with tractography along with tests that assess bimanual coordination. 
 
 
Grey matter changes were not explored in this study and this can be performed using 
voxel based morphometry (VBM) analysis of 3D structural (3D FLASH) data. Group 
specific regional changes in grey and white matter can be detected using VBM. This 
method could also be utilised to detect bilateral hippocampal pathology (Gadian et al., 
2000). 
 
 
 
The fasting studies in KH and control children have revealed that cortisol plays a role in 
the regulation of ketogenesis in children independent of lipolysis. This can be explored 
further by investigating KB response following an overnight fast in children suspected of 
cortisol insufficiency. In addition adrenaline response and its impact on KH children is 
not clear and this response needs to be investigated in larger studies, with additional 
investigation of glucose kinetics. 
  
12 Appendix 
 
12.1 Appendix 1- Consent form 
Institute of Child Health 
 
and Great Ormond Street Hospital for Children NHS Trust 
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CONSENT FORM 
 
Title of Project:    Hypoglycaemia and Brain Injury 
 
Name of Researcher: Dr Khalid Hussain, Consultant Paediatric Endocrinologist (02079052128 
or K.Hussain@ich.ucl.ac.uk) , Dr Anitha Kumaran, Clinical Research Fellow 
(07930314414,0207 2429789/ Extn 2245, kumarananitha@hotmail.com) 
 
Please fill in as fully as possible and circle Yes/ No where appropriate 
 
1. I confirm that I have read and understand the information sheet dated.................... 
(version............) for the above study. I have had the opportunity to consider the information, 
ask questions and have had these answered satisfactorily. Yes/No 
 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time 
without giving any reason, without my medical care or legal rights being affected. Yes/No 
 
 
3. I understand that relevant sections of my medical notes and data collected during the study, 
 may be looked at by individuals from the NHS Trust, where it is relevant to my taking part in this 
research. I give permission for these individuals to have access to my records. Yes/No 
 
 
4. I agree for the psychologist to contact my child’s school teacher to get details of progress at 
 
school if there are any concerns. Yes/No 
 
 
 
 
5. I agree to take part in the above study.  Yes/No 
 
 
 
 
Name of Patient/Parent            Date                                                      Signature 
 
 
 
 
 
 
Name of Person                        Date                                                     Signature 
taking consent 
 
 
 
 
 
When completed, 1copy for patient; 1 for researcher site file; 1 (original) to be kept in medical 
notes 
Hypoglycaemia and Brain Injury.  Version no1. 07/05/09                                                                                    Page 2 of 2 
  
 
 
 
 
 
 
12.2 Appendix 2 – Parent Information leaftlet 
 
 
Institute of Child Health 
 
and Great Ormond Street Hospital for Children NHS Trust 
 
UNIVERSITY COLLEGE LONDON 
 
 
 
 
 
 
 
 
Participant Information Sheet (Parent information) 
 
 
 
 
Study title: Hypoglycaemia and Brain Injury 
 
 
 
You and your child are invited to take part in a research study, which is 
being carried out by Dr. Anitha Kumaran (Clinical Research Fellow) with 
the assistance of Dr. Khalid Hussain, Dr. Matthew Pitt, Professor David 
Gadian and Professor FarenehVargha-Khadem at Great Ormond Street 
 Hospital and Institute of Child Health. Before you decide to take part, 
please take time to read the following information which explains why we 
are performing this research and what it would involve for you. After 
reading the leaflet, Dr.Kumaran will contact you to explain the research in 
greater detail and answer any queries and obtain your written consent if you 
wish to take part. 
 
 
 
 
 
 
 
What is the purpose of the study? 
 
Hypoglycaemia (low blood glucose level) is one of the most common 
problems seen in children. As glucose is a major fuel for brain function, 
anything that leads to hypoglycaemia can cause brain damage, epilepsy, 
mental retardation. There are many reasons why children become 
hypoglycaemic, and can vary from severe forms like congenital 
hyperinsulinism (too much insulin is produced that lowers blood glucose 
level) to milder forms like fasting ketotic hypoglycaemia (low blood 
glucose accompanied by presence of ketone bodies which are by products 
of fat breakdown and serve as an alternate fuel for the brain). Though 
hypoglycaemia in children is common, we do not know the "safe" blood 
glucose level for normal brain function. 
 
 
This study will help us to understand the blood glucose levels at which 
changes occur in brain electrical activity and understand the connection 
between brain injury, development and if the presence of alternative fuels 
(ex ketone bodies) protect against brain injury. 
 What will happen during the study? 
 
All the tests explained below will be arranged around your routine clinic 
visits or according to your convenience. If you have to make any extra trips 
to the hospital for this study we will reimburse your travel costs. 
 
 
1.  Fasting study 
 
When your doctor admits your child for a routine fasting investigation to 
Kingfisher /Rainforest ward, a cannula will be inserted as routine and some 
bloods taken at regular intervals as specified by your doctor based on your 
child’s age and clinical condition. Most of the bloods we require would 
already be requested by your doctor as part of your fast (ex cortisol, 
growth hormone, carnitine, amino acids, Insulin, ketone bodies, 
lactate). Of the blood sample taken from your child, we will take a tiny 
amount (2 mls) extra, at the start and end of fast, to measure chemical 
substances called intermediary metabolites and hormones (ex: glycerol, 
adrenaline, noradrenaline). Our study will not involve any additional pain 
or cannula insertion for your child. 
Additionally we would also like to study electrical signals of your child’s 
brain during hypoglycaemia. To enable us to do this we will attach some 
wires with sensors to the scalp (head) only for the duration of the fast or 
towards end of fast. This procedure is commonly known as EEG (electro 
encephalogram). It is a painless (does not involve any needles) and safe 
procedure. Changes in attention and arousal will be assessed by 
 providing sound stimulus (ex clicks) via headphones and recording any 
changes in EEG. These investigations do not emit any rays which could 
harm your child. 
 
 
2.  MRI Scan of Brain 
 
We will also perform an MRI scan of brain to help us understand the impact 
of hypoglycaemia on brain size and shape. As we need detailed information 
of the brain we have to use special imaging techniques which are not part of 
routine clinical MRI. This procedure is safe as it does not involve ionising 
radiation like CT or Xray or use of dyes called contrast medium. The 
MRI scanner consists of a large doughnut-shaped magnet that has a tunnel 
in the center. Your child will be placed on a table that slides into the tunnel. 
Your child has to lie still during this procedure to prevent blurring of 
images and the scanner may be noisy. 
 
Children less than 6 years: Your child might be undergoing routine MRI 
scan of brain under general anaesthesia or sedation, if so we would like to 
add 15-20 mins extra scan time to obtain better pictures. The decision for 
MRI under general anaesthesia will be done by your doctor and is 
independent of participation in this project. 
Children more than 6 years: No sedation will be required. The scan will last 
 
40 – 50 mins. 
 
 
 
3.  Developmental assessment 
 
We would like to asses your child’s social, emotional, intellectual and 
physical development. This will help us understand areas of development 
that are affected by hypoglycaemia. Tests will be conducted by 
psychologists who are specially trained to examine children. Most children 
 enjoy this, but if your child gets tired we will take a break or stop 
altogether. We will need to see your child once for 5-6 hrs (with breaks) or 
we can split them into separate sessions if that is more convenient for you. 
These tests will give us a very clear idea of your child’s developmental 
progress and we will also be able to find any delay or problems if present. 
We will ask your child’s teacher how they are doing in school only if you 
and your child are happy for us to contact them. 
We will also ask you and your child to fill out a questionnaire to explain the 
impact of managing hypoglycaemia on your day to day quality of life. 
 
 
How long will the study take? 
 
This study will run for 3 years but your child is required for only 3 visits. 
The first visit for the fast will be part of routine hospital visit and will not 
last longer that the duration of the fast. We will need to see your child two 
more times for the MRI (1 hour) and developmental assessment (5-6 hours). 
 
 
Does my child have to take part? 
 
If you decide not to take part in this study that is entirely your right. If you 
agree to take part we will ask you to sign a consent form. You can also 
withdraw at any time during the study, without giving a reason. This will 
not affect your child’s present or future treatment. 
 
 
Will this affect my child’s clinical treatment? 
 
No treatment or investigation will be withheld from your child as a result of 
this study. 
 
 
What will happen to my child’s treatment during and after this period? 
 Our study will not affect or influence your child’s ongoing and future 
 
clinical care. 
 
 
 
What are the risks or discomforts of taking part in the study? 
 
None of the above mentioned procedures involve any additional risk as they 
are part of routine investigation and additional investigations are non 
invasive. If you child becomes uncomfortable or distressed by the sensors 
of the EEG we will discontinue the investigation. 
 
 
 
 
 
 
The MRI scan will require your child to stay still for 40-50 mins and may 
be noisy, we will try to minimise discomfort by providing head phones and 
videos to watch while in scanner. 
 
 
What are the benefits of taking part in the study? 
 
This study might not be of any direct benefit to you but will help us 
understand the level of hypoglycaemia that affects the brain. We will also 
be able to define the areas of the brain affected and correlate this with 
development. This will improve our management of children with 
hypoglycaemia in the future. 
 
 
What about my results? 
 
Once the results are available we will discuss them with you and your child. 
 
 
 
Will information about my child be confidential? 
 
All information collected about your child will be kept strictly confidential, 
only the research team and a representative of the research ethics committee 
 will have access to them. The results of the study will be published or 
presented in meetings, but no personal information will be given to any 
report or publication. 
 
 
Who has approved the study and who is funding it? 
 
The Great Ormond Street Hospital Children’s Charity is funding this study. 
An independent Research Ethics Committee who believes that it is of 
minimal risk to your child has approved this research. 
 
 
However, research can carry unforeseen risks and we are required to tell 
you that if your child is harmed and this is due to someone’s negligence, 
you may have grounds for legal action for compensation in respect of any 
harm arising out of participation in the study. 
 
 
Who do I speak to if problems arise? 
 
If you have any concerns or questions about any aspect of the study, please 
contact Dr.Kumaran who will do her best to answer your question. If still 
unresolved then you can discuss them with the Principal Investigator, Dr. 
Khalid Hussain by post at Institute of Child Health, 30 Guilford Street, 
London WC1N 1EH, or if urgent, you can contact the switchboard on 
02074059200, and they will put you in contact with him. If you wish to 
complain formally, you can do this through the NHS complaints procedure 
(details can be obtained from the hospital) 
 
 
Dr.Anitha Kumaran 
 
Clinical Research Fellow in Paediatric Endocrinology 
 
Clinical and Molecular Genetics Unit, Institute of Child Health 
 30 Guilford Street, London.WC1N 1EH 
 
Telephone: 07930314414. Email:  kumarananitha@hotmail.com. 
Thank you for taking the time to read this leaflet and considering 
taking part in this study 
  
 
 
 
 
12.3 Appendix 3 - Children information leaflet age 5-12 years 
 
 
Institute of Child Health 
 
and Great Ormond Street Hospital for Children NHS Trust 
 
UNIVERSITY COLLEGE LONDON 
 
 
 
Participant Information Sheet (Children information leaflet age 5-12 
years) 
 
 
Study title: Hypoglycaemia and Brain Injury 
 
 
 
You are invited to take part in a research study. The study will look at how 
low blood sugar levels affect your brain. Before you decide to 
say YES or NO, you need to understand why this study is 
being done. So please go through this leaflet. Your parents 
have also been told about this, so you can also discuss with 
them about taking part. 
 
 
Introduction 
 
Glucose (sugar) levels in your body need to be kept steady so your brain 
can function well, as it needs sugar for it to run smoothly (like petrol for a 
car). When you have low blood sugar this can affect the signals from your 
brain. We want to understand the level of blood sugar at which these 
changes happen. When you have been having low blood sugars for some 
time this can change the way your brain looks and also the way you act and 
learn things. 
  
 
 
 
 
 
 
 
 
Why do you want me to help? 
 
We want to look at your brain signals when your blood sugar drops and also 
see if you behave or learn differently. This can help us take better care of 
children with your condition. We ask all children who have a condition like 
yours to take part. 
 
 
What will happen if I take part? 
 
When you come to the hospital for your regular blood tests you will have a 
canula inserted as routine. From the routine blood taken in the hospital we 
will take a small amount extra from the samples (2 
mls – half a teaspoonful) without any additional 
pain for you. We will also attach some wires to 
your head to look at your brain signals. You 
will also hear some sounds through a headphone that will change the 
brain signals that we record. This will not hurt you. We would also use 
some game like tests to see how you learn new things, use words and play. 
We will have breaks so you don’t get tired. We will also take pictures of 
your brain with a special machine called an MRI scanner. This is like a big 
doughnut shaped machine with a tunnel in the middle and you will be on a 
table that slides into the tunnel (look at picture). You have to lie still when 
the pictures are taken and the scanner can make a lot of noises. We will give 
you headphones and you can even watch a video while the pictures are 
being taken. 
  
 
Is there any danger? 
 
No, all these tests are very safe. Many children routinely have these 
tests without a problem. 
 
 
 
 
 
 
 
What about my results and who will see information about me? 
 
The doctors looking after you will talk to you and your parents about the 
results of these tests. Only your doctors will have all information about 
you. We may print the results in a magazine, so everybody can learn 
more about this condition, but your name will not be revealed. 
 
 
Do I have to take part? 
 
No it’s up to you and your parents to decide. It’s fine if you do not want to 
 
take part. The doctors and nurses will look after you the same as before. 
 
 
 
Who can I speak to if I have questions? 
 
You can speak to your parents as they have also been given 
information about the study. You can also speak to the doctors and 
nurses who look after you in the hospital. 
 
 
Dr.Anitha Kumaran 
 
Clinical Research Fellow in Paediatric Endocrinology 
 
Clinical and Molecular Genetics Unit, Institute of Child Health 
 
30 Guilford Street, London 
 
WC1N 1EH. Telephone: 07930314414 
 
Email: kumarananitha@hotmail.com 
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12.4 Appendix 4 – Children information leaflet age 12-16yrs 
Institute of Child Health 
 
and Great Ormond Street Hospital for Children NHS Trust 
 
UNIVERSITY COLLEGE LONDON 
 
 
 
Participant Information Sheet (Children information leaflet age 12- 
 
16yrs) 
 
 
 
Study title: Hypoglycaemia and Brain Injury 
 
 
 
You are invited to take part in a research study. The study will look at how 
low blood sugar levels affect your brain. Before you decide to take part, you 
need to understand why this study is being done. So please go through this 
leaflet carefully.  Your parents have also been told about this, so you can 
discuss with them about taking part. 
 
 
Introduction 
 
Glucose (sugar) levels in your body need to be kept steady so 
your brain can function well, as it needs sugar for it to run 
smoothly (like petrol for a car). When you have low blood sugar 
this can affect the signals from your brain. We want to understand the level 
of blood sugar at which these changes happen. When you have been having 
low blood sugars for some time this can change the way your brain looks 
and also the way you act and learn things. 
  
 
 
 
 
 
 
 
 
 
 
Why do you want me to help? 
 
We want to look at your brain signals when your blood sugar drops and also 
see if you behave or learn differently. This can help us take better care of 
children with your condition. We ask all children who have a condition like 
yours to take part. 
 
 
What will happen if I take part? 
 
When you come to the hospital for your regular fasting blood tests you will 
be canulated as routine. Of the routine blood sample taken from you, we 
will take a small amount extra (2 mls – half a 
teaspoonful) without any additional pain for 
you, to measure certain chemical substances . 
We will also attach some wires to your head to 
look at your brain signals. This is called an EEG 
(Electroencephalogram). You will also hear some sounds through a 
headphone that will change the brain signals that we record. This will 
not cause you any pain, but can be slightly uncomfortable. We would also 
use some game like tests to see how you learn new things, use words. We 
will have breaks so you don’t get tired. We will also take pictures of your 
brain with a special machine called an MRI scanner. This is like a big 
doughnut shaped machine with a tunnel in the middle and you will be on a 
table that slides into the tunnel (look at picture). You have to lie still when 
the pictures are taken and the scanner can make a lot of noises. We will give 
 you headphones and you can even watch a video while the pictures are 
being taken. 
Is there any danger? 
 
No, all these tests are very safe. Many children routinely have these tests 
without a problem. 
 
 
What about my results and who will see information about me? 
 
The doctors looking after you will talk to you and your parents about the 
results of these tests. Only your doctors will have all information about you. 
We may print the results in a magazine, so everybody can learn more about 
this condition, but your name will not be revealed. 
 
 
Do I have to take part? 
 
No it’s up to you and your parents to decide. It’s fine if you do not want to 
 
take part. The doctors and nurses will look after you the same as before. 
 
 
 
Who can I speak to if I have questions? 
 
You can speak to your parents as they have also been given information 
about the study. You can also speak to the doctors and nurses who look 
after you in the hospital. 
Dr.Anitha Kumaran 
 
Clinical Research Fellow in Paediatric Endocrinology 
 
Clinical and Molecular Genetics Unit, Institute of Child Health 
 
30 Guilford Street, London 
 
WC1N 1EH. Telephone: 07930314414 
 
Email: kumarananitha@hotmail.com 
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